# EDGAR Filing Document

**Accession Number:** 0001702924
**File Stem:** 0001493152-25-024636
**Filing Date:** 2025-11
**Character Count:** 483515
**Document Hash:** 4eb3770ab01b4dba178e483366fc302c
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001493152-25-024636.hdr.sgml**: 20251121

**ACCESSION NUMBER**: 0001493152-25-024636

**CONFORMED SUBMISSION TYPE**: S-3

**PUBLIC DOCUMENT COUNT**: 18

**FILED AS OF DATE**: 20251121

**DATE AS OF CHANGE**: 20251121

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** WRAP TECHNOLOGIES, INC.
- **CENTRAL INDEX KEY:** 0001702924
- **STANDARD INDUSTRIAL CLASSIFICATION:** ORDNANCE & ACCESSORIES, (NO VEHICLES/GUIDED MISSILES) [3480]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 980551945
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** S-3
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 333-291707
- **FILM NUMBER:** 251508250

**BUSINESS ADDRESS:**
- **STREET 1:** 3480 MAIN HWY, SUITE 202
- **CITY:** MIAMI
- **STATE:** FL
- **ZIP:** 33133
- **BUSINESS PHONE:** 800-583-2652

**MAIL ADDRESS:**
- **STREET 1:** 3480 MAIN HWY, SUITE 202
- **CITY:** MIAMI
- **STATE:** FL
- **ZIP:** 33133

**As filed with the U.S. Securities and Exchange Commission on November 21, 2025**

**Registration No. 333-**

**UNITED STATES<br> SECURITIES AND EXCHANGE COMMISSION**

**WASHINGTON, D.C. 20549**

**FORM S-3**

**REGISTRATION STATEMENT<br> UNDER<br> THE SECURITIES ACT OF 1933**

**WRAP TECHNOLOGIES, INC.**

(Exact name of registrant as specified in its charter)

---

| | |
|:---|:---|
| **Delaware** | **98-0551945** |
| (State or other jurisdiction of<br> incorporation or organization) | (I.R.S. Employer<br> Identification Number) |

---

**3480 Main Hwy, Suite 202**

**Miami, Florida 33133**

**(800) 583-2652**<br> (Address, including zip code, and telephone number, including area code, of registrant's principal executive offices)

**Scot Cohen**

**Chief Executive Officer**

**3480 Main Hwy, Suite 202**

**Miami, Florida 33133**

**(800) 583-2652**<br> (Name, address, including zip code, and telephone number, including area code, of agent for service)

***Copies of all communications, including communications sent to agent for service, should be sent to:***

**Rick A. Werner, Esq.<br> Alla Digilova, Esq.<br> Haynes and Boone, LLP<br> 30 Rockefeller Plaza, 26th Floor<br> New York, New York 10112<br> Tel. (212) 659-7300<br> Fax (212) 884-8234**

**Approximate date of commencement of proposed sale to the public**: From time to time after the effective date of this Registration Statement.

If the only securities being registered on this Form are being offered pursuant to dividend or interest reinvestment plans, please check the following box: ☐

If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, other than securities offered only in connection with dividend or interest reinvestment plans, check the following box: ☒

If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐

If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐

If this Form is a registration statement pursuant to General Instruction I.D. or a post-effective amendment thereto that shall become effective upon filing with the Commission pursuant to Rule 462(e) under the Securities Act, check the following box. ☐

If this Form is a post-effective amendment to a registration statement filed pursuant to General Instruction I.D. filed to register additional securities or additional classes of securities pursuant to Rule 413(b) under the Securities Act, check the following box. ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act.

---

| | | | |
|:---|:---|:---|:---|
| Large accelerated filer | ☐ | Accelerated filer | ☐ |
| Non-accelerated filer | ☒ | Smaller reporting company | ☒ |
|  |  | Emerging growth company | ☐ |

---

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of Securities Act. ☐

**THE REGISTRANT HEREBY AMENDS THIS REGISTRATION STATEMENT ON SUCH DATE OR DATES AS MAY BE NECESSARY TO DELAY ITS EFFECTIVE DATE UNTIL THE REGISTRANT SHALL FILE A FURTHER AMENDMENT WHICH SPECIFICALLY STATES THAT THIS REGISTRATION STATEMENT SHALL THEREAFTER BECOME EFFECTIVE IN ACCORDANCE WITH SECTION 8(a) OF THE SECURITIES ACT OF 1933, AS AMENDED, OR UNTIL THE REGISTRATION STATEMENT SHALL BECOME EFFECTIVE ON SUCH DATE AS THE SECURITIES AND EXCHANGE COMMISSION, ACTING PURSUANT TO SAID SECTION 8(a), MAY DETERMINe.**

**The information in this prospectus is not complete and may be changed. We may not sell these securities until the registration statement filed with the Securities and Exchange Commission is effective. This prospectus is not an offer to sell these securities and it is not soliciting an offer to buy these securities in any state where the offer or sale is not permitted.**

**SUBJECT TO COMPLETION, DATED NOVEMBER 21, 2025**

**Prospectus**

**WRAP TECHNOLOGIES, INC.**

**$200,000,000**

**COMMON STOCK<br> PREFERRED STOCK<br> DEBT SECURITIES<br> WARRANTS**

**SUBSCRIPTION RIGHTS**

**UNITS**

We may offer and sell from time to time, in one or more series or issuances and on terms that we will determine at the time of the offering, any combination of the securities described in this prospectus, up to an aggregate amount of $200,000,000.

We will provide specific terms of any offering in a supplement to this prospectus. Any prospectus supplement may also add, update, or change information contained in this prospectus. You should carefully read this prospectus and the applicable prospectus supplement as well as the documents incorporated or deemed to be incorporated by reference in this prospectus before you purchase any of the securities offered hereby.

These securities may be offered and sold in the same offering or in separate offerings; to or through underwriters, dealers, and agents; or directly to purchasers. The names of any underwriters, dealers, or agents involved in the sale of our securities, their compensation and any over-allotment options held by them will be described in the applicable prospectus supplement. See "Plan of Distribution."

Our common stock is listed on The Nasdaq Capital Market ("Nasdaq") under the symbol "WRAP." On November 20, 2025, the last reported sale price of our common stock was $1.98 per share as reported on Nasdaq. We recommend that you obtain current market quotations for our common stock prior to making an investment decision. We will provide information in any applicable prospectus supplement regarding any listing of securities other than shares of our common stock on any securities exchange.

**You should carefully read this prospectus, any prospectus supplement relating to any specific offering of securities, and all information incorporated by reference herein and therein.**

**Investing in our securities involves a high degree of risk. These risks are discussed in this prospectus under "Risk Factors" beginning on page 7 and in the documents incorporated by reference in this prospectus.**

**Neither the Securities and Exchange Commission (the "SEC") nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy or accuracy of this prospectus. Any representation to the contrary is a criminal offense.**

The date of this prospectus is ______ __, 2025.

**Table of Contents**

---

| | |
|:---|:---|
|  | **Page** |
| [About This Prospectus](#a_001) | 1 |
| [Cautionary Statement Regarding Forward-Looking Statements](#a_002) | 2 |
| [Prospectus Summary](#a_003) | 3 |
| [Risk Factors](#a_004) | 7 |
| [Use of Proceeds](#a_005) | 8 |
| [Description of Capital Stock](#a_006) | 9 |
| [Description of Debt Securities](#a_007) | 13 |
| [Description of Warrants](#a_008) | 19 |
| [Description of Subscription Rights](#a_009) | 21 |
| [Description of Units](#a_010) | 22 |
| [Plan of Distribution](#a_011) | 23 |
| [Legal Matters](#a_012) | 25 |
| [Experts](#a_013) | 25 |
| [Where You Can Find More Information](#a_014) | 25 |
| [Incorporation of Documents by Reference](#a_015) | 26 |

---

i

**About this Prospectus**

This prospectus is part of a registration statement on Form S-3 that we filed with the SEC using a "shelf" registration process. Under this shelf process, we may, from time to time, sell any combination of the securities described in this prospectus in one or more offerings up to a total amount of $200,000,000.

This prospectus provides you with a general description of the securities we may offer. Each time we sell securities, we will provide a prospectus supplement that will contain specific information about the terms of that offering. The prospectus supplement may also add to, update or change information contained in the prospectus and, accordingly, to the extent inconsistent, information in this prospectus is superseded by the information in the prospectus supplement.

The prospectus supplement to be attached to the front of this prospectus may describe, as applicable: the terms of the securities offered; the public offering price; the price paid for the securities; net proceeds; and the other specific terms related to the offering of the securities.

You should only rely on the information contained or incorporated by reference in this prospectus and any prospectus supplement or issuer free writing prospectus relating to a particular offering. No person has been authorized to give any information or make any representations in connection with this offering other than those contained or incorporated by reference in this prospectus, any accompanying prospectus supplement and any related issuer free writing prospectus in connection with the offering described herein and therein, and, if given or made, such information or representations must not be relied upon as having been authorized by us. Neither this prospectus nor any prospectus supplement nor any related issuer free writing prospectus shall constitute an offer to sell or a solicitation of an offer to buy offered securities in any jurisdiction in which it is unlawful for such person to make such an offering or solicitation. This prospectus does not contain all of the information included in the registration statement. For a more complete understanding of the offering of the securities, you should refer to the registration statement, including its exhibits.

You should read the entire prospectus and any prospectus supplement and any related issuer free writing prospectus, as well as the documents incorporated by reference into this prospectus or any prospectus supplement or any related issuer free writing prospectus, before making an investment decision. Neither the delivery of this prospectus or any prospectus supplement or any issuer free writing prospectus nor any sale made hereunder shall under any circumstances imply that the information contained or incorporated by reference herein or in any prospectus supplement or issuer free writing prospectus is correct as of any date subsequent to the date hereof or of such prospectus supplement or issuer free writing prospectus, as applicable. You should assume that the information appearing in this prospectus, any prospectus supplement or any document incorporated by reference is accurate only as of the date of the applicable documents, regardless of the time of delivery of this prospectus or any sale of securities. Our business, financial condition, results of operations and prospects may have changed since that date.

All references in this prospectus to "WRAP," the "Company," "we," "us," "our," or similar terms refer to Wrap Technologies, Inc. and its subsidiaries taken as a whole, except where the context otherwise requires or as otherwise indicated.

**Cautionary Statement Regarding Forward Looking Statements**

This prospectus and the documents incorporated by reference herein may contain or incorporate by reference forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the "Securities Act"), and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). Such forward-looking statements are based upon management's assumptions, expectations, projections, intentions and beliefs about future events. In some cases, predictive, future-tense or forward-looking words such as "intend," "plan," "predict," "may," "will," "project," "target," "strategy," "estimate," "anticipate," "believe," "expect," "continue," "potential," "opportunity," "forecast," "should" and similar expressions, whether in the negative or affirmative, that reflect our current views with respect to future events and operational, economic and financial performance are intended to identify such forward-looking statements, but are not the exclusive means of identifying such statements. Such forward-looking statements are only predictions, and actual results and the timing of certain events and circumstances may differ materially from those described by the forward-looking statements as a result of risks and uncertainties, including, without limitation, the Company's ability to successfully implement training programs for the use of its products; the Company's ability to manufacture and produce its products; the Company's ability to develop sales for its new products; the acceptance of existing and future products, including the acceptance of the BolaWrap 150, Wrap Reality, WrapTactics, WrapVision, our Body-Worn Camera and our Digital Evidence Management system and our Counter-Unmanned-Aircraft-System; the risk that distributor and customer orders for future deliveries are modified, rescheduled or cancelled in the normal course of business; the availability of funding to continue to finance operations; the complexity, expense and time associated with sales to law enforcement and government entities; the lengthy evaluation and sales cycle for the Company's product solution; product defects; litigation risks from alleged product-related injuries; risks of government regulations; the impact resulting from geopolitical conflicts and any resulting sanctions; the ability to obtain export licenses for countries outside of the US; the ability to obtain patents and defend IP against competitors; the impact of competitive products and solutions; and the Company's ability to maintain and enhance its brand; the ability to maintain compliance with the Nasdaq Stock Market's listing standards; the ability of the Company to timely and effectively implement controls and procedures required by Section 404 of the Sarbanes-Oxley Act of 2002; and risks resulting from the Company's status as a smaller reporting company, including that reduced disclosure requirements may make shares of the Company's common stock less attractive to investors. Additional factors that could cause actual results to differ materially from the results anticipated in these forward-looking statements are described in this prospectus, including under the section entitled "*Risk Factors*," in "*Part I, Item 1A. — Risk Factors*" of the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2024, filed on March 31, 2025, any updates under the section entitled "*Risk Factors*," in "*Part II, Item 1A. — Risk Factors*" of any applicable Quarterly Report on Form 10-Q, and the risk factors described under the caption "*Risk Factors*" in any applicable prospectus supplement. See "*Where You Can Find More Information*" and "*Incorporation of Certain Information by Reference*." We advise you to carefully review the reports and documents we file from time to time with the SEC, particularly our annual reports on Form 10-K, our quarterly reports on Form 10-Q and our current reports on Form 8-K. The Company cautions readers that the forward-looking statements included in, or incorporated by reference into, this prospectus represent our beliefs, expectations, estimates and assumptions only as of the date hereof and are not intended to give any assurance as to future results. New factors emerge from time to time, and it is not possible for us to predict all of these factors. Further, we cannot assess the effect of each such factor on our business or the extent to which any factor, or combination of factors, may cause actual results to be materially different from those contained in any forward-looking statement.

You should read this prospectus, the applicable prospectus supplement and any related free-writing prospectus and the documents incorporated by reference in this prospectus with the understanding that our actual future results, levels of activity, performance and events and circumstances may be materially different from what we expect. The forward-looking statements contained or incorporated by reference in this prospectus or any prospectus supplement are expressly qualified in their entirety by this cautionary statement. We do not undertake any obligation to publicly update any forward-looking statement to reflect events or circumstances after the date on which any such statement is made or to reflect the occurrence of unanticipated events.

**Prospectus Summary**

*This summary provides an overview of selected information contained elsewhere or incorporated by reference in this prospectus and does not contain all of the information you should consider before investing in our securities. You should carefully read the prospectus, the information incorporated by reference and the registration statement of which this prospectus is a part in their entirety before investing in our securities, including the information discussed under "Risk Factors" in this prospectus and the documents incorporated by reference and our financial statements and notes thereto that are incorporated by reference in this prospectus. Some of the statements in this prospectus and the documents incorporated by reference herein constitute forward-looking statements that involve risks and uncertainties. See information set forth under the section "Cautionary Statement Regarding Forward-Looking Statements."*

**Overview**

We are a global public safety technology and services company that delivers safe and effective policing solutions to law enforcement and security personnel worldwide. We are leading the movement for safer outcomes by equipping law enforcement with safer, non-painful compliance tools, and immersive training fit for modern society. We began sales of our first public safety product, the BolaWrap 100 remote restraint device, in late 2018. In the first quarter of 2022, we delivered a new generation product, the BolaWrap 150. The BolaWrap 150 is electronically deployed and is more robust, smaller, lighter and simpler to deploy than the BolaWrap 100 that has since been phased out. In late 2020 we added a new solution to our public safety technologies, our virtual reality ("VR") training platform, Wrap Reality, and in August 2023 we acquired Intrensic, LLC, a Delaware limited liability company ("Intrensic"), which added a Body-Worn Camera ("BWC") and Digital Evidence Management ("DEM") solution to our portfolio of policing solutions. Wrap Reality is now sold to law enforcement agencies for simulation training as well as corrections departments for the societal reentry scenarios.

In 2025, we expanded our product portfolio with the launch of WrapTactics, a digital pre-escalation and performance training platform, and WrapVision, a North American-made body-worn camera solution designed to meet federal procurement standards. We also advanced several counter-unmanned-aircraft-system ("C-UAS") initiatives, including our MERLIN and PAN-DA programs, which apply our tether-deployment technology to non-lethal drone interdiction and defense applications. These developments broaden our reach beyond traditional policing to include defense, homeland security, and other public-safety markets, while maintaining our focus on de-escalation, accountability, and safer outcomes.

Our target market for our product and technology enabled services includes approximately 900,000 full-time sworn law enforcement officers in over 18,000 federal, state, and local law enforcement agencies in the U.S. and over 12 million police officers in more than 100 countries. Additionally, we are exploring opportunities to increase our presence in other adjacent markets, such as military and private security. Our international focus is on countries with the largest police forces. According to 360iResearch, a market research consulting firm, our non-lethal products are part of a global market segment expected to grow to $16.1 billion by 2027.

We focus our efforts on the following products and services:

*BolaWrap Remote Restraint Device* - a hand-held remote restraint device that discharges a seven and half-foot Kevlar tether to entangle an individual at a range of 10-25 feet. BolaWrap assists law enforcement to safely and effectively control encounters early without resorting to painful use of force options.

*Wrap Reality* - a law enforcement 3D training system employing immersive computer graphics VR with proprietary software-enabled content. It allows up to two participants to enter a simulated training environment simultaneously, and customized weapons controllers enable trainees to engage in strategic decision making along the force continuum. Wrap Reality has 45 scenarios for law enforcement and corrections and 15 scenarios for societal reentry. Wrap Reality is one of the most robust 3D Virtual Reality solutions on the market for law enforcement and societal reentry today.

*Wrap Intrensic* - a Body-Worn Camera and Digital Evidence Management solutions provider. BWC and DEM play crucial roles in capturing, storing, and managing digital evidence, such as video and audio recordings for various purposes, including criminal investigations and maintaining transparency in public interactions. The Wrap Intrensic X2 camera hardware and storage and data management capability, along with awareness of front-line operations, provides customers with a solution to meet their challenges. Wrap Intrensic Evidence on our cloud-based video storage platform provides an unlimited video storage platform that includes video and other evidence uploading, search, retrieval, redaction, and evidence sharing while reducing the need for resources required to manage this evidence.

*WrapTactics Digital Training Platform* - a subscription-based digital learning and training system that delivers short-form, scenario-based courses focused on pre-escalation tactics, emotional regulation, and post-deployment control techniques. The platform reinforces officer readiness through burst-learning modules and supports recurring-revenue opportunities by integrating with Wrap's bundled offerings, WrapReady and WrapPlus. WrapTactics includes an exclusive partnership with STORM Training Group, whose evidence-based defensive-tactics curriculum is incorporated into Wrap's subscription ecosystem to provide post-BolaWrap arrest and control instruction

*WrapReality Training Simulator*- a fully immersive VR training simulator that provides first responders with realistic, interactive scenarios designed to improve decision-making under pressure. The system continues to expand its content library and complements WrapTactics and BolaWrap deployments.

*WrapVision Body-Worn Camera and Evidence Management System* - a North American-made, Trade Agreements Act-compliant body-worn camera solution designed for law enforcement, public-safety, and healthcare users. The device integrates LTE, Wi-Fi, Bluetooth, and VPN connectivity for secure live streaming, provides up to twelve hours of operation per charge, and is compatible with leading video-management platforms. WrapVision complements our pre-escalation and accountability initiatives by offering secure domestic data storage and alignment with federal procurement standards.

C-UAS and Drone-Based Solutions - we have expanded into the C-UAS and aerial-interdiction markets through multiple research, development, and demonstration programs including:

● *MERLIN Platform* - a modular housing system enabling integration of our kinetic cassettes into UAS and UGV platforms for scalable aerial defense.

*● Project PAN-DA (Personal Anti-Drone Armament)* - a handheld, surface-to-air, quick-reaction C-UAS launcher derived from the BolaWrap 150 platform, providing individual operators with a portable non-lethal defense capability against small drones.

● *1KC Wide Area Kinetic Anti-Drone Cassette* - a patent-pending, modular cassette designed for integration with PAN-DA and MERLIN systems to enable wide-area coverage and multiple drone engagements per mission.

In addition to the U.S. law enforcement market, we have shipped our restraint products to 62 countries. We have distribution agreements with 22 international distributors covering 43 countries. We focus significant sales, training and business development efforts to support our distribution network in addition to our internal sales team.

We focus significant resources on research and development innovations and continue to enhance our products and plan to introduce new products. We believe we have established a strong brand and market presence globally and have established significant competitive advantages in our markets.

**Implications of Being a Smaller Reporting Company**

We are a smaller reporting company as defined in the Exchange Act. We may take advantage of certain of the scaled disclosures available to smaller reporting companies and will be able to take advantage of these scaled disclosures for so long as (i) the market value of our voting and non-voting common stock held by non-affiliates is less than $250 million measured on the last business day of our second fiscal quarter or (ii) our annual revenue is less than $100 million during the most recently completed fiscal year and the market value of our voting and non-voting common stock held by non-affiliates is less than $700 million measured on the last business day of our second fiscal quarter. Specifically, as a smaller reporting company, we may choose to present only the two most recent fiscal years of audited financial statements in our Annual Report on Form 10-K and have reduced disclosure obligations regarding executive compensation and, if we are a smaller reporting company with less than $100 million in annual revenue, we would not be required to obtain an attestation report on internal control over financial reporting issued by our independent registered public accounting firm.

**Corporate Information**

Wrap Technologies, Inc. is a Delaware corporation. Our corporate headquarters are located at 3480 Main Hwy, Suite 202, Miami, Florida 33133. Our phone number is (800) 583-2652. Our website address is *www.wrap.com*. Through our website, we will make available, free of charge, our Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and any amendments to those reports, as soon as reasonably practicable after such material is electronically filed with, or furnished to, the SEC. Information contained on, or that can be accessed through, our website is not and shall not be deemed to be a part of this prospectus or incorporated by reference hereto.

**The Securities We May Offer**

We may offer up to $200,000,000 of common stock, preferred stock, various series of debt securities, warrants, units and/or subscription rights in one or more offerings and in any combination. This prospectus provides you with a general description of the securities we may offer. A prospectus supplement, which we will provide each time we offer securities, will describe the specific amounts, prices and terms of these securities.

 

*Common Stock*

We may issue shares of our common stock from time to time. Holders of our common stock are entitled to receive ratably dividends as may be declared by the board of directors of the Company (the "Board") out of funds legally available for that purpose. We have never paid cash dividends on our common stock and do not anticipate paying any cash dividends in the foreseeable future but intend to retain our capital resources for reinvestment in our business. So long as any shares of Series A Convertible Preferred Stock, with a stated value of $1,000 ("Series A Preferred Stock") are outstanding, we are not able to declare or pay any cash dividend or distribution on any of our common stock without the prior written consent of the Required Holders (as defined in the Certificate of Designations of the Series A Preferred Stock ("Series A Certificate of Designations")). So long as any shares of Series B Convertible Preferred Stock, with a stated value of $1,000 ("Series B Preferred Stock") are outstanding, we are not able to declare or pay any cash dividend or distribution of any of our common stock. Any future disposition of dividends will be at the discretion of the Board and will depend upon, among other things, our future earnings, operating and financial condition, capital requirements, and other factors.

Each share of common stock entitles the holder to one vote, either in person or by proxy, at meetings of stockholders. The holders are not permitted to vote their shares cumulatively. Each election of directors by our stockholders will be determined by a plurality of the votes cast by the stockholders entitled to vote on the election. Other than the election of directors, all matters submitted to a vote of stockholders require the affirmative vote of a majority of the votes cast by the stockholders at the meeting and entitled to vote on the subject matter, voting affirmatively or negatively (excluding abstentions and broker non-votes) to authorize, affirm, ratify or consent to such act or action, except as otherwise provided by our amended and restated certificate of incorporation ("Certificate of Incorporation"), our amended and restated bylaws, as amended ("Bylaws"), the rules or regulations of any stock exchange applicable to us, applicable law or pursuant to any regulation applicable to us or our securities.

Holders of our common stock have no preemptive rights or other subscription rights, conversion rights, redemption or sinking fund provisions. Subject to the rights of the holders of our preferred stock, upon our liquidation, dissolution or winding up, the holders of our common stock will be entitled to share ratably in the net assets legally available for distribution to stockholders after the payment of all of our debts and other liabilities. The rights, preferences and privileges of holders of our common stock are subject to, and may be adversely affected by, the rights of the holders of any series of preferred stock, which may be designated solely by action of the Board and issued in the future.

*Preferred Stock*

We may issue shares of our preferred stock from time to time, in one or more series. The Board will determine the rights, preferences, privileges and restrictions of the preferred stock, including dividend rights, conversion rights, voting rights, terms of redemption, liquidation preferences, sinking fund terms and the number of shares constituting any series or the designation of such series, without any further vote or action by stockholders. Convertible preferred stock will be convertible into our common stock or exchangeable for our other securities. Conversion may be mandatory, at the option of the holder, or both and would be at prescribed conversion rates.

If we sell any series of preferred stock under this prospectus and applicable prospectus supplements, we will fix the rights, preferences, privileges and restrictions of the preferred stock of such series in the certificate of designation relating to that series. We will file as an exhibit to the registration statement of which this prospectus is a part, or will incorporate by reference from reports that we file with the SEC, the form of any certificate of designation that describes the terms of the series of preferred stock we are offering before the issuance of the related series of preferred stock. We urge you to read the applicable prospectus supplement related to the series of preferred stock being offered, as well as the complete certificate of designation that contains the terms of the applicable series of preferred stock.

For a description of the Series A Preferred Stock and Series B Preferred Stock, see "Description of Capital Stock" on page 9 of this prospectus.

*Debt Securities*

We may sell from time to time, in one or more offerings under this prospectus, debt securities, which may be senior or subordinated. We will issue any such senior debt securities under a senior indenture that we will enter into with a trustee to be named in the senior indenture. We will issue any such subordinated debt securities under a subordinated indenture, which we will enter into with a trustee to be named in the subordinated indenture. We have filed forms of these documents as exhibits to the registration statement, of which this prospectus is a part. We use the term "indentures" to refer to either the senior indenture or the subordinated indenture, as applicable. The indentures will be qualified under the Trust Indenture Act of 1939, as in effect on the date of the indenture. We use the term "debenture trustee" to refer to either the trustee under the senior indenture or the trustee under the subordinated indenture, as applicable.

*Warrants*

We may issue warrants for the purchase of common stock or preferred stock in one or more series. We may issue warrants independently or together with common stock or preferred stock, and the warrants may be attached to or separate from these securities. We will evidence each series of warrants by warrant certificates that we will issue under a separate agreement. We may enter into warrant agreements with a bank or trust company that we select to be our warrant agent. We will indicate the name and address of the warrant agent in the applicable prospectus supplement relating to a particular series of warrants.

In this prospectus, we have summarized certain general features of the warrants. We urge you, however, to read the applicable prospectus supplement related to the particular series of warrants being offered, as well as the warrant agreements and warrant certificates that contain the terms of the warrants. We will file as exhibits to the registration statement of which this prospectus is a part, or will incorporate by reference from reports that we file with the SEC, the form of warrant agreement or warrant certificate containing the terms of the warrants we are offering before the issuance of the warrants.

*Subscription Rights*

We may issue subscription rights to purchase shares of our common stock or other securities. These subscription rights may be issued independently or together with any other security offered hereby and may or may not be transferable by the stockholder receiving the subscription rights in such offering. In connection with any offering of subscription rights, we may enter into a standby arrangement with one or more underwriters or other purchasers pursuant to which the underwriters or other purchasers may be required to purchase any securities remaining unsubscribed for after such offering. We will file as exhibits to the registration statement of which this prospectus is a part, or will incorporate by reference reports that we file with the SEC, the form of such agreement and any supplemental agreements that describe the terms of the subscription rights we are offering before the issuance of such subscription rights.

*Units*

We may issue units consisting of common stock, preferred stock and/or warrants for the purchase of common stock or preferred stock in one or more series. In this prospectus, we have summarized certain general features of the units. We urge you, however, to read the applicable prospectus supplement related to the series of units being offered, as well as the unit agreements that contain the terms of the units. We will file as exhibits to the registration statement of which this prospectus is a part, or will incorporate by reference reports that we file with the SEC, the form of unit agreement and any supplemental agreements that describe the terms of the series of units we are offering before the issuance of the related series of units.

**Risk Factors**

*An investment in our securities involves a high degree of risk. Before deciding whether to invest in our securities, you should consider carefully the specific factors discussed under the heading "Risk Factors" in the applicable prospectus supplement, together with all of the other information contained or incorporated by reference in the prospectus supplement or appearing or incorporated by reference in this prospectus. You should also consider the risks, uncertainties and assumptions discussed under Part I, Item 1A, "Risk Factors," in our most recent Annual Report on Form 10-K or any updates in our Quarterly Reports on Form 10-Q, which are incorporated herein by reference, as updated or superseded by the risks and uncertainties described under similar headings in the other documents that are filed after the date hereof and incorporated by reference into this prospectus and any prospectus supplement related to a particular offering. The risks and uncertainties we have described are not the only ones we face. Additional risks and uncertainties not presently known to us or that we currently deem immaterial may also affect our operations. Past financial performance may not be a reliable indicator of future performance, and historical trends should not be used to anticipate results or trends in future periods. If any of these risks actually occurs, our business, business prospects, financial condition or results of operations could be seriously harmed. This could cause the trading price of our common stock to decline, resulting in a loss of all or part of your investment. Please also read carefully the section above entitled "Cautionary Statement Regarding Forward-Looking Statements."*

**Use of Proceeds**

We cannot assure you that we will receive any proceeds in connection with securities which may be offered pursuant to this prospectus. Unless otherwise indicated in the applicable prospectus supplement, we intend to use any net proceeds from the sale of securities under this prospectus for general corporate purposes, including, but not limited to, product development and manufacturing, sales and marketing and working capital and other general corporate purposes. We have not determined the amounts we plan to spend on any of the areas listed above or the timing of these expenditures. As a result, our management will have broad discretion over the allocation of net proceeds, if any, we receive in connection with securities offered pursuant to this prospectus for any purpose. We may initially invest the net proceeds in short-term, investment-grade, interest-bearing securities or apply them to the reduction of short-term indebtedness.

**Description of Capital Stock**

The following description of common stock and preferred stock summarizes the material terms and provisions of the common stock and preferred stock that we may offer under this prospectus, but is not complete. For the complete terms of our common stock and preferred stock, please refer to our Certificate of Incorporation and Bylaws and any certificates of designation for our preferred stock. While the terms we have summarized below will apply generally to any future common stock or preferred stock that we may offer, we will describe the specific terms of any series of preferred stock in more detail in the applicable prospectus supplement. If we so indicate in a prospectus supplement, the terms of any preferred stock we offer under that prospectus supplement may differ from the terms we describe below.

Our Certificate of Incorporation authorize us to issue 150,000,000 shares of common stock, $0.0001 par value per share, and 5,000,000 shares of preferred stock, par value $0.0001 per share, of which 10,000 are designated as Series A Convertible Preferred Stock ("Series A Preferred Stock") and 4,500 are designated as Series B Convertible Preferred Stock ("Series B Preferred Stock").

**Common Stock**

As of November 20, 2025, there were 51,549,094 shares of common stock outstanding.

Holders of our common stock are entitled to one vote for each share held on all matters submitted to a vote of stockholders and do not have cumulative voting rights. Each election of directors by our stockholders will be determined by a plurality of the votes cast by the stockholders entitled to vote on the election.

Holders of common stock are entitled to receive proportionately any dividends as may be declared by the Board, subject to any preferential dividend rights of outstanding preferred stock. So long as any shares of Series A Preferred Stock are outstanding, as they are at this time, we are not able to declare or pay any cash dividend or distribution on any of our common stock without the prior written consent of the Required Holders. So long as any shares of Series B Preferred Stock are outstanding, as they are at this time, we are not able to declare or pay any cash dividend or distribution on any of our common stock.

In the event of the Company's liquidation or dissolution, the holders of our common stock are entitled to receive proportionately all assets available for distribution to stockholders after the payment of all debts and other liabilities and subject to the prior rights of any of our outstanding preferred stock. Holders of our common stock have no preemptive, subscription, redemption or conversion rights. No sinking fund provisions are applicable to our common stock. The rights, preferences and privileges of holders of our common stock are subject to and may be adversely affected by the rights of the holders of shares of any series of our preferred stock that we may designate and issue in the future. All outstanding shares of our common stock are validly authorized and issued, fully paid and nonassessable.

The transfer agent and registrar for our common stock is Colonial Stock Transfer. The transfer agent's address is 7840 S 700 E Sandy, UT 84070. Our common stock is listed on Nasdaq under the symbol "WRAP."

**Preferred Stock**

The Board is authorized to issue 5,000,000 shares of preferred stock without further action by the holders of common stock. The shares of preferred stock may be issued from time to time in one or more series, each of which will have such distinctive designation or title as shall be determined by the Board prior to the issuance of any shares thereof.

The Board is authorized, subject to limitations prescribed by law, to fix by resolution or resolutions the designations, powers, preferences, and rights and the qualifications, limitations, or restrictions thereof, of each such series of preferred stock, including without limitation, authority to fix by resolution or resolutions the dividend rights, dividend rate, conversion rights, voting rights, rights and terms of redemption (including sinking fund provisions), redemption price or prices, and liquidation preferences of any wholly unissued series of preferred stock, and the number of shares constituting such series and the designation thereof, or any of the foregoing.

*Series A Convertible Preferred Stock*

As of November 20, 2025, there were 8,207 shares of Series A Preferred Stock outstanding. The following are the principal terms of the Series A Preferred Stock:

*Dividends*. Holders of Series A Preferred Stock are entitled to dividends of 8% per annum, compounded monthly, which are payable in cash or shares of common stock, or a combination thereof, at the Company's option in accordance with the terms of the Series A Certificate of Designations. Upon the occurrence and during the continuance of a Triggering Event (as defined in the Series A Certificate of Designations), the Series A Preferred Stock will accrue dividends at the rate of 20% per annum, compounded monthly.

*Voting Rights*. The Series A Preferred Stock has no voting rights, except as required by law (including without limitation, the DGCL). To the extent that under the DGCL the vote of holders of Series A Preferred Stock, voting separately as a class or series as applicable, is required to authorize a given action of the Company, the affirmative vote or consent of the Required Holders of Series A Preferred Stock, voting together in the aggregate and not in separate series, represented at a duly held meeting at which a quorum is present or by written consent of the Required Holders, voting together in the aggregate and not in separate series (in each instance, except as otherwise may be required under the DGCL), shall constitute the approval of such action by both the class or the series, as applicable.

*Liquidation*. Upon any liquidation, dissolution or winding-up of the Company, whether voluntary or involuntary, each holder of the Series A Preferred Stock shall be entitled to receive out of the assets, whether capital or surplus, of the Company an amount per share of Series A Preferred Stock equal to the greater of (A) 150% of the stated value of such share of Series A Preferred Stock (plus any applicable make-whole amount, unpaid late charge or other applicable amount) on the date of such payment and (B) the amount per share such holder would receive if such holder converted such Series A Preferred Share into common stock immediately prior to the date of such payment.

*Conversion*. The Series A Preferred Stock is convertible into shares of common stock (the "Series A Conversion Shares") at the election of the holder at any time at an initial conversion price of $1.45 (the "Series A Conversion Price"). The Series A Conversion Price is subject to customary adjustments for stock dividends, stock splits, reclassifications and the like, and subject to price-based adjustment in the event of any issuances of common stock, or securities convertible, exercisable or exchangeable for common stock, at a price below the then-applicable Series A Conversion Price (subject to certain exceptions).

*Mandatory Conversion*. If on any day after the issuance of the shares of Series A Preferred Stock the closing price of the common stock exceeds $8.00 per share (subject to adjustment for stock splits, stock dividends, stock combinations, recapitalizations or other similar events) for 20 consecutive trading days and the daily dollar trading volume of the common stock exceeds $2,000,000 per day during the same period, provided that certain equity conditions described in the Series A Certificate of Designations are satisfied, then the Company shall have the right to require the holder to mandatorily convert all or any portion of the Series A Preferred Stock, including the make-whole amount, the additional amount and any accrued but unpaid late charges, as designated in a Mandatory Conversion Notice on the Mandatory Conversion Date (each as defined in the Series A Certificate of Designations) into fully paid, validly issued and nonassessable shares of common stock at the then-applicable conversion price as of the Mandatory Conversion Date (a "Mandatory Conversion"). If any of the equity conditions shall cease to be satisfied at any time on or after the Mandatory Conversion Date through and including the actual delivery of all of the Conversion Shares to the holders, the Mandatory Conversion shall be deemed withdrawn and void ab initio.

*Beneficial Ownership Limitation*. The Company may not effect the conversion of any of the shares of Series A Preferred Stock held by a holder (other than Scot Cohen and V4 Global LLC), and such holder does not have the right to convert any of the shares of Series A Preferred Stock held by such holder pursuant to the terms and conditions of the Series A Certificate of Designations. Any such conversion shall be null and void and treated as if never made, to the extent that after giving effect to such conversion, such Holder together with the other Attribution Parties collectively would beneficially own in excess of 4.99% of the shares of Common Stock outstanding immediately after giving effect to such conversion. However, any holder may increase or decrease such percentage to any other percentage not in excess of 9.99% upon notice to us, provided that any increase in this limitation will not be effective until 61 days after such notice from the holder to the Company and such increase or decrease will apply only to the holder providing such notice.

*Series B Convertible Preferred Stock*

As of November 20, 2025, there were 4,500 shares of Series B Preferred Stock outstanding. The following are the principal terms of the Series B Preferred Stock:

*Dividends*. The holders of the Series B Preferred Stock are entitled to dividends when and as declared by the Board of Directors, from time to time, in its sole discretion, in accordance with the terms of the Series B Preferred Stock Certificate of Designations ("Series B Certificate of Designations").

*Voting Rights*. The Series B Preferred Stock has no voting rights, except as required by law (including without limitation, the DGCL and as expressly provided in the Series B Certificate of Designations. So long as any shares of Series B Preferred Stock are outstanding, we are not able to (A) alter or change adversely the powers, preferences or rights given to the Series B Preferred Stock or alter or amend the Series B Certificate of Designations, (B) amend our Certificate of Incorporation or other charter documents in any manner that adversely affects any rights of the holders, (C) increase the number of authorized shares of Series B Preferred Stock, or (D) enter into any agreement with respect to any of the foregoing without the affirmative vote of the holders of a majority of the then outstanding shares of the Series B Preferred Stock.

*Liquidation*. Upon any liquidation, dissolution or winding-up of the Company, whether voluntary or involuntary, the each holder of Series B Preferred Stock shall be entitled to receive out of the assets, whether capital or surplus, of the Company, an amount equal to $1,000, plus any declared, accrued and unpaid dividends thereon, if any, and any other fees or liquidated damages then due and owing thereon under the Series B Certificate of Designations, for each share of Series B Preferred Stock before any distribution or payment shall be made to the holders of any Junior Securities (as defined therein), and if the assets of the Company shall be insufficient to pay in full such amounts, then the entire assets to be distributed to the holders shall be ratably distributed among the holders in accordance with the respective amounts that would be payable on such shares if all amounts payable thereon were paid in full.

*Conversion*. The Series B Preferred Stock is convertible into shares of common stock (the "Series B Conversion Shares") at the election of the holder at any time at an initial conversion price of $1.50 (the "Series B Conversion Price"). The Series B Conversion Price is subject to customary adjustments for stock dividends, stock splits, reclassifications and the like, and subject to price-based adjustment in the event of any issuances of common stock, or securities convertible, exercisable or exchangeable for common stock, at a price below the then-applicable Series B Conversion Price (subject to certain exceptions).

*Exchange Cap*. The Series B Certificate of Designations provide that the Series B Preferred Stock shall not be convertible into shares of common stock in excess of 19.99% of the shares of common stock outstanding as of the Closing Date (as defined in the Series B Certificate of Designations) (the "Issuable Maximum") except in the event that the Company obtains the stockholder approval for issuances of shares of common stock in excess of the Issuable Maximum ("Stockholder Approval"). Until such approval is obtained, no holder of Series B Preferred Stock will be issued in the aggregate more shares of common stock than such holder's pro rata share of the Issuable Maximum.

*Optional Conversion*. The Series B Preferred Stock can be converted at the option of the holder at any time and from time to time after the original issuance date; provided that, shares of Series A Preferred Stock held by a holder who serves as a director, officer or is an employee of the Company shall only be convertible into shares of common stock following receipt of the Stockholder Approval.

*Beneficial Ownership Limitation*. The Series B Preferred Stock cannot be converted to common stock if the holder and its affiliates would beneficially own more than 4.99% or 9.99% at the election of the holder of the outstanding common stock. However, any holder may increase or decrease such percentage to any other percentage not in excess of 9.99% upon notice to us, provided that any increase in this limitation will not be effective until 61 days after such notice from the holder to the Company and such increase or decrease will apply only to the holder providing such notice.

**Anti-Takeover Effects of Certain Provisions of Delaware Law, Our Certificate of Incorporation and Bylaws**

*Preferred Stock*

 

The existence of authorized but unissued shares of preferred stock may enable the Board to render more difficult or to discourage an attempt to gain control of the Company by means of a merger, tender offer, proxy contest or otherwise. For example, if in the due exercise of its fiduciary obligations, the Board were to determine that a takeover proposal is not in the best interests of the Company or stockholders, the Board could cause shares of preferred stock to be issued without stockholder approval in one or more private offerings or other transactions that might dilute the voting or other rights of the proposed acquirer or insurgent stockholder or stockholder group. In this regard, the Certificate of Incorporation grants the Board broad power to establish the rights and preferences of authorized and unissued shares of preferred stock. The issuance of shares of preferred stock could decrease the amount of earnings and assets available for distribution to holders of shares of common stock. The issuance may also adversely affect the rights and powers, including voting rights, of these holders and may have the effect of delaying, deterring or preventing a change in control of the Company.

*Stockholder Action; Special Meeting of Stockholders.* 

 

The Certificate of Incorporation and Bylaws provide that stockholders may take action only at a duly called annual or special meeting of stockholders and may not take action by written consent. The Certificate of Incorporation and Bylaws further provide that special meetings of the Company's stockholders may be called by the Chairman of the Board or by the Board, and shall be called by the Chairman of the Board at the request of the holders of not less than a majority of all the outstanding shares of the Corporation entitled to vote at the meeting.

*Business Combinations.* 

 

Section 203 of the Delaware General Corporation Law, which relate to business combinations with interested stockholders, applies to the Company. Subject to certain exceptions, Section 203 prevents a publicly held Delaware corporation from engaging in a "business combination" with any "interested stockholder" for three years following the date that such person became an interested stockholder, unless either the interested stockholder attained such status with the approval of the Board, the business combination is approved by the Board and stockholders in a prescribed manner or the interested stockholder acquired at least 85% of the Company's outstanding voting stock in the transaction in which such person became an interested stockholder. A "business combination" includes, among other things, a merger or consolidation involving the Company and the "interested stockholder" and the sale of more than 10% of the Company's assets. In general, an "interested stockholder" is any entity or person beneficially owning 15% or more of the Company's outstanding voting stock and any entity or person affiliated with or controlling or controlled by such entity or person.

*Advance Notice Requirements for Stockholder Proposals and Director Nominations*.

The Company's Bylaws provide that stockholders seeking to bring business before an annual meeting of stockholders, or to nominate candidates for election as directors at an annual meeting of stockholders, must meet specified procedural requirements. These provisions may preclude stockholders from bringing matters before an annual meeting of stockholders or from making nominations for directors at an annual or special meeting of stockholders.

*Exclusive Forum Charter Provision*.

*Directors' Liability*.

The Certificate of Incorporation limits the personal liability of directors to the Company or its stockholders for monetary damages for breach of fiduciary duty as a director to the maximum extent permitted by the DGCL and provides that no director will have personal liability to the Company or to its stockholders for monetary damages for breach of fiduciary duty. However, these provisions do not eliminate or limit the liability of any of the Company's directors:

● for any breach of the director's duty of loyalty to the Company or its stockholders;

● for acts or omissions not in good faith or which involve intentional misconduct or a knowing violation of law;

● under the DGCL; or

● for any transaction from which the director derived an improper personal benefit.

**Description of Debt Securities**

The following description, together with the additional information we include in any applicable prospectus supplements, summarizes the material terms and provisions of the debt securities that we may offer under this prospectus. While the terms we have summarized below will apply generally to any future debt securities we may offer pursuant to this prospectus, we will describe the particular terms of any debt securities that we may offer in more detail in the applicable prospectus supplement. If we so indicate in a prospectus supplement, the terms of any debt securities offered under such prospectus supplement may differ from the terms we describe below, and to the extent the terms set forth in a prospectus supplement differ from the terms described below, the terms set forth in the prospectus supplement shall control.

We may sell from time to time, in one or more offerings under this prospectus, debt securities, which may be senior or subordinated. We will issue any such senior debt securities under a senior indenture that we will enter into with a trustee to be named in the senior indenture. We will issue any such subordinated debt securities under a subordinated indenture, which we will enter into with a trustee to be named in the subordinated indenture. We have filed forms of these documents as exhibits to the registration statement, of which this prospectus is a part. We use the term "indentures" to refer to either the senior indenture or the subordinated indenture, as applicable. The indentures will be qualified under the Trust Indenture Act of 1939, as in effect on the date of the indenture. We use the term "debenture trustee" to refer to either the trustee under the senior indenture or the trustee under the subordinated indenture, as applicable.

The following summaries of material provisions of the senior debt securities, the subordinated debt securities and the indentures are subject to, and qualified in their entirety by reference to, all the provisions of the indenture applicable to a particular series of debt securities.

**General**

Each indenture provides that debt securities may be issued from time to time in one or more series and may be denominated and payable in foreign currencies or units based on or relating to foreign currencies. Neither indenture limits the amount of debt securities that may be issued thereunder, and each indenture provides that the specific terms of any series of debt securities shall be set forth in, or determined pursuant to, an authorizing resolution and/or a supplemental indenture, if any, relating to such series.

We will describe in each prospectus supplement the following terms relating to a series of debt securities:

● the title or designation;

● the aggregate principal amount and any limit on the amount that may be issued;

● the currency or units based on or relating to currencies in which debt securities of such series are denominated and the currency or units in which principal or interest or both will or may be payable;

● whether we will issue the series of debt securities in global form, the terms of any global securities and who the depositary will be;

● the maturity date and the date or dates on which principal will be payable;

● the interest rate, which may be fixed or variable, or the method for determining the rate and the date interest will begin to accrue, the date or dates interest will be payable and the record dates for interest payment dates or the method for determining such dates;

● whether or not the debt securities will be secured or unsecured, and the terms of any secured debt;

● the terms of the subordination of any series of subordinated debt;

● the place or places where payments will be payable;

● our right, if any, to defer payment of interest and the maximum length of any such deferral period;

● the date, if any, after which, and the price at which, we may, at our option, redeem the series of debt securities pursuant to any optional redemption provisions;

● the date, if any, on which, and the price at which we are obligated, pursuant to any mandatory sinking fund provisions or otherwise, to redeem, or at the holder's option to purchase, the series of debt securities;

● whether the indenture will restrict our ability to pay dividends, or will require us to maintain any asset ratios or reserves;

● whether we will be restricted from incurring any additional indebtedness;

● a discussion of any material or special U.S. federal income tax considerations applicable to a series of debt securities;

● the denominations in which we will issue the series of debt securities, if other than denominations of $1,000 and any integral multiple thereof; and

● any other specific terms, preferences, rights or limitations of, or restrictions on, the debt securities

We may issue debt securities that provide for an amount less than their stated principal amount to be due and payable upon declaration of acceleration of their maturity pursuant to the terms of the indenture. We will provide you with information on the federal income tax considerations and other special considerations applicable to any of these debt securities in the applicable prospectus supplement.

**Conversion or Exchange Rights**

We will set forth in the prospectus supplement the terms, if any, on which a series of debt securities may be convertible into or exchangeable for our common stock or our other securities. We will include provisions as to whether conversion or exchange is mandatory, at the option of the holder or at our option. We may include provisions pursuant to which the number of shares of our common stock or our other securities that the holders of the series of debt securities receive would be subject to adjustment.

**Consolidation, Merger or Sale; No Protection in Event of a Change of Control or Highly Leveraged Transaction**

The indentures do not contain any covenant that restricts our ability to merge or consolidate, or sell, convey, transfer or otherwise dispose of all or substantially all of our assets. However, any successor to or acquirer of such assets must assume all of our obligations under the indentures or the debt securities, as appropriate.

Unless we state otherwise in the applicable prospectus supplement, the debt securities will not contain any provisions that may afford holders of the debt securities protection in the event we have a change of control or in the event of a highly leveraged transaction (whether or not such transaction results in a change of control), which could adversely affect holders of debt securities.

**Events of Default Under the Indenture**

The following are events of default under the indentures with respect to any series of debt securities that we may issue:

● if we fail to pay interest when due and our failure continues for 90 days and the time for payment has not been extended or deferred;

● if we fail to pay the principal, or premium, if any, when due and the time for payment has not been extended or delayed;

● if we fail to observe or perform any other covenant set forth in the debt securities of such series or the applicable indentures, other than a covenant specifically relating to and for the benefit of holders of another series of debt securities, and our failure continues for 90 days after we receive written notice from the debenture trustee or holders of not less than a majority in aggregate principal amount of the outstanding debt securities of the applicable series; and

● if specified events of bankruptcy, insolvency or reorganization occur as to us.

No event of default with respect to a particular series of debt securities (except as to certain events of bankruptcy, insolvency or reorganization) necessarily constitutes an event of default with respect to any other series of debt securities. The occurrence of an event of default may constitute an event of default under any bank credit agreements we may have in existence from time to time. In addition, the occurrence of certain events of default or an acceleration under the indenture may constitute an event of default under certain of our other indebtedness outstanding from time to time.

If an event of default with respect to debt securities of any series at the time outstanding occurs and is continuing, then the trustee or the holders of not less than a majority in principal amount of the outstanding debt securities of that series may, by a notice in writing to us (and to the debenture trustee if given by the holders), declare to be due and payable immediately the principal (or, if the debt securities of that series are discount securities, that portion of the principal amount as may be specified in the terms of that series) of and premium and accrued and unpaid interest, if any, on all debt securities of that series. Before a judgment or decree for payment of the money due has been obtained with respect to debt securities of any series, the holders of a majority in principal amount of the outstanding debt securities of that series (or, at a meeting of holders of such series at which a quorum is present, the holders of a majority in principal amount of the debt securities of such series represented at such meeting) may rescind and annul the acceleration if all events of default, other than the non-payment of accelerated principal, premium, if any, and interest, if any, with respect to debt securities of that series, have been cured or waived as provided in the applicable indenture (including payments or deposits in respect of principal, premium or interest that had become due other than as a result of such acceleration). We refer you to the prospectus supplement relating to any series of debt securities that are discount securities for the particular provisions relating to acceleration of a portion of the principal amount of such discount securities upon the occurrence of an event of default.

Subject to the terms of the indentures, if an event of default under an indenture shall occur and be continuing, the debenture trustee will be under no obligation to exercise any of its rights or powers under such indenture at the request or direction of any of the holders of the applicable series of debt securities, unless such holders have offered the debenture trustee reasonable indemnity. The holders of a majority in principal amount of the outstanding debt securities of any series will have the right to direct the time, method and place of conducting any proceeding for any remedy available to the debenture trustee, or exercising any trust or power conferred on the debenture trustee, with respect to the debt securities of that series, provided that:

● the direction so given by the holder is not in conflict with any law or the applicable indenture; and

● subject to its duties under the Trust Indenture Act, the debenture trustee need not take any action that might involve it in personal liability or might be unduly prejudicial to the holders not involved in the proceeding.

A holder of the debt securities of any series will only have the right to institute a proceeding under the indentures or to appoint a receiver or trustee, or to seek other remedies if:

● the holder previously has given written notice to the debenture trustee of a continuing event of default with respect to that series;

● the holders of at least a majority in aggregate principal amount of the outstanding debt securities of that series have made written request, and such holders have offered reasonable indemnity to the debenture trustee to institute the proceeding as trustee; and

● the debenture trustee does not institute the proceeding, and does not receive from the holders of a majority in aggregate principal amount of the outstanding debt securities of that series (or at a meeting of holders of such series at which a quorum is present, the holders of a majority in principal amount of the debt securities of such series represented at such meeting) other conflicting directions within 60 days after the notice, request and offer.

These limitations do not apply to a suit instituted by a holder of debt securities if we default in the payment of the principal, premium, if any, or interest on, the debt securities.

We will periodically file statements with the applicable debenture trustee regarding our compliance with specified covenants in the applicable indenture.

**Modification of Indenture; Waiver**

Under the indentures, the rights of holders of a series of debt securities may be changed by us and the debenture trustee with the written consent of the holders of at least a majority in aggregate principal amount of the outstanding debt securities of each series (or, at a meeting of holders of such series at which a quorum is present, the holders of a majority in principal amount of the debt securities of such series represented at such meeting) that is affected. However, the debenture trustee and we may make the following changes only with the consent of each holder of any outstanding debt securities affected:

● to fix any ambiguity, defect or inconsistency in the indenture; and

● to change anything that does not materially adversely affect the interests of any holder of debt securities of any series issued pursuant to such indenture.

 In addition, under the indentures, the rights of holders of a series of debt securities may be changed by us and the debenture trustee with the written consent of the holders of at least a majority in aggregate principal amount of the outstanding debt securities of each series (or, at a meeting of holders of such series at which a quorum is present, the holders of a majority in principal amount of the debt securities of such series represented at such meeting) that is affected. However, the debenture trustee and we may make the following changes only with the consent of each holder of any outstanding debt securities affected:

● extending the fixed maturity of the series of debt securities;

● reducing the principal amount, reducing the rate of or extending the time of payment of interest, or any premium payable upon the redemption of any debt securities;

● reducing the principal amount of discount securities payable upon acceleration of maturity;

● making the principal of or premium or interest on any debt security payable in currency other than that stated in the debt security; or

● reducing the percentage of debt securities, the holders of which are required to consent to any amendment or waiver.

Except for certain specified provisions, the holders of at least a majority in principal amount of the outstanding debt securities of any series (or, at a meeting of holders of such series at which a quorum is present, the holders of a majority in principal amount of the debt securities of such series represented at such meeting) may on behalf of the holders of all debt securities of that series waive our compliance with provisions of the indenture. The holders of a majority in principal amount of the outstanding debt securities of any series may on behalf of the holders of all the debt securities of such series waive any past default under the indenture with respect to that series and its consequences, except a default in the payment of the principal of, premium or any interest on any debt security of that series or in respect of a covenant or provision, which cannot be modified or amended without the consent of the holder of each outstanding debt security of the series affected; *provided*, *however*, that the holders of a majority in principal amount of the outstanding debt securities of any series may rescind an acceleration and its consequences, including any related payment default that resulted from the acceleration.

**Discharge**

Each indenture provides that we can elect to be discharged from our obligations with respect to one or more series of debt securities, except for obligations to:

● the transfer or exchange of debt securities of the series;

● replace stolen, lost or mutilated debt securities of the series;

● maintain paying agencies;

● hold monies for payment in trust;

● compensate and indemnify the trustee; and

● appoint any successor trustee.

In order to exercise our rights to be discharged with respect to a series, we must deposit with the trustee money or government obligations sufficient to pay all the principal of, the premium, if any, and interest on, the debt securities of the series on the dates payments are due.

**Form, Exchange and Transfer**

We will issue the debt securities of each series only in fully registered form without coupons and, unless we otherwise specify in the applicable prospectus supplement, in denominations of $1,000 and any integral multiple thereof. The indentures provide that we may issue debt securities of a series in temporary or permanent global form and as book-entry securities that will be deposited with, or on behalf of, The Depository Trust Company or another depositary named by us and identified in a prospectus supplement with respect to that series.

At the option of the holder, subject to the terms of the indentures and the limitations applicable to global securities described in the applicable prospectus supplement, the holder of the debt securities of any series can exchange the debt securities for other debt securities of the same series, in any authorized denomination and of like tenor and aggregate principal amount.

Subject to the terms of the indentures and the limitations applicable to global securities set forth in the applicable prospectus supplement, holders of the debt securities may present the debt securities for exchange or for registration of transfer, duly endorsed or with the form of transfer endorsed thereon duly executed if so required by us or the security registrar, at the office of the security registrar or at the office of any transfer agent designated by us for this purpose. Unless otherwise provided in the debt securities that the holder presents for transfer or exchange or in the applicable indenture, we will make no service charge for any registration of transfer or exchange, but we may require payment of any taxes or other governmental charges.

We will name in the applicable prospectus supplement the security registrar, and any transfer agent in addition to the security registrar, that we initially designate for any debt securities. We may at any time designate additional transfer agents or rescind the designation of any transfer agent or approve a change in the office through which any transfer agent acts, except that we will be required to maintain a transfer agent in each place of payment for the debt securities of each series.

If we elect to redeem the debt securities of any series, we will not be required to:

● issue, register the transfer of, or exchange any debt securities of that series during a period beginning at the opening of business 15 days before the day of mailing of a notice of redemption of any debt securities that may be selected for redemption and ending at the close of business on the day of the mailing; or

● register the transfer of or exchange any debt securities so selected for redemption, in whole or in part, except the unredeemed portion of any debt securities we are redeeming in part.

**Information Concerning the Debenture Trustee**

The debenture trustee, other than during the occurrence and continuance of an event of default under the applicable indenture, undertakes to perform only those duties as are specifically set forth in the applicable indenture. Upon an event of default under an indenture, the debenture trustee under such indenture must use the same degree of care as a prudent person would exercise or use in the conduct of his or her own affairs. Subject to this provision, the debenture trustee is under no obligation to exercise any of the powers given it by the indentures at the request of any holder of debt securities unless it is offered reasonable security and indemnity against the costs, expenses and liabilities that it might incur.

**Payment and Paying Agents**

Unless we otherwise indicate in the applicable prospectus supplement, we will make payment of the interest on any debt securities on any interest payment date to the person in whose name the debt securities, or one or more predecessor securities, are registered at the close of business on the regular record date for the interest.

We will pay principal of and any premium and interest on the debt securities of a particular series at the office of the paying agents designated by us, except that unless we otherwise indicate in the applicable prospectus supplement, will we make interest payments by check which we will mail to the holder. Unless we otherwise indicate in a prospectus supplement, we will designate the corporate trust office of the debenture trustee in the City of New York as our sole paying agent for payments with respect to debt securities of each series. We will name in the applicable prospectus supplement any other paying agents that we initially designate for the debt securities of a particular series. We will maintain a paying agent in each place of payment for the debt securities of a particular series.

All money we pay to a paying agent or the debenture trustee for the payment of the principal of or any premium or interest on any debt securities which remains unclaimed at the end of two years after such principal, premium or interest has become due and payable will be repaid to us, and the holder of the security thereafter may look only to us for payment thereof.

**Governing Law**

The indentures and the debt securities will be governed by and construed in accordance with the laws of the State of New York, except to the extent that the Trust Indenture Act is applicable.

**Subordination of Subordinated Debt Securities**

Our obligations pursuant to any subordinated debt securities will be unsecured and will be subordinate and junior in priority of payment to certain of our other indebtedness to the extent described in a prospectus supplement. The subordinated indenture does not limit the amount of senior indebtedness we may incur. It also does not limit us from issuing any other secured or unsecured debt.

**Description of Warrants**

We may issue warrants for the purchase of common stock or preferred stock in one or more series. We may issue warrants independently or together with common stock or preferred stock, and the warrants may be attached to or separate from these securities.

We will evidence each series of warrants by warrant certificates that we may issue under a separate agreement. We may enter into a warrant agreement with a warrant agent. Each warrant agent may be a bank that we select which has its principal office in the United States. We may also choose to act as our own warrant agent. We will indicate the name and address of any such warrant agent in the applicable prospectus supplement relating to a particular series of warrants.

We will describe in the applicable prospectus supplement the terms of the series of warrants, including:

● the offering price and aggregate number of warrants offered;

● if applicable, the designation and terms of the securities with which the warrants are issued and the number of warrants issued with each such security or each principal amount of such security;

● if applicable, the date on and after which the warrants and the related securities will be separately transferable;

● in the case of warrants to purchase common stock or preferred stock, the number or amount of shares of common stock or preferred stock, as the case may be, purchasable upon the exercise of one warrant and the price at which and currency in which these shares may be purchased upon such exercise;

● the manner of exercise of the warrants, including any cashless exercise rights;

● the warrant agreement under which the warrants will be issued;

● the effect of any merger, consolidation, sale or other disposition of our business on the warrant agreement and the warrants;

● anti-dilution provisions of the warrants, if any;

● the terms of any rights to redeem or call the warrants;

● any provisions for changes to or adjustments in the exercise price or number of securities issuable upon exercise of the warrants;

● the dates on which the right to exercise the warrants will commence and expire or, if the warrants are not continuously exercisable during that period, the specific date or dates on which the warrants will be exercisable;

● the manner in which the warrant agreement and warrants may be modified;

● the identities of the warrant agent and any calculation or other agent for the warrants;

● federal income tax consequences of holding or exercising the warrants;

● the terms of the securities issuable upon exercise of the warrants;

● any securities exchange or quotation system on which the warrants or any securities deliverable upon exercise of the warrants may be listed or quoted; and

● any other specific terms, preferences, rights or limitations of or restrictions on the warrants.

Before exercising their warrants, holders of warrants will not have any of the rights of holders of the securities purchasable upon such exercise, including, in the case of warrants to purchase common stock or preferred stock, the right to receive dividends, if any, or payments upon our liquidation, dissolution or winding up or to exercise voting rights, if any.

**Exercise of Warrants**

Each warrant will entitle the holder to purchase the securities that we specify in the applicable prospectus supplement at the exercise price that we describe in the applicable prospectus supplement. Unless we otherwise specify in the applicable prospectus supplement, holders of the warrants may exercise the warrants at any time up to 5:00 P.M. Eastern Time, the close of business, on the expiration date that we set forth in the applicable prospectus supplement. After the close of business on the expiration date, unexercised warrants will become void.

Holders of the warrants may exercise the warrants by delivering the warrant certificate representing the warrants to be exercised together with specified information, and paying the required exercise price by the methods provided in the applicable prospectus supplement. We will set forth on the reverse side of the warrant certificate, and in the applicable prospectus supplement, the information that the holder of the warrant will be required to deliver to the warrant agent.

Upon receipt of the required payment and the warrant certificate properly completed and duly executed at the corporate trust office of the warrant agent or any other office indicated in the applicable prospectus supplement, we will issue and deliver the securities purchasable upon such exercise. If fewer than all of the warrants represented by the warrant certificate are exercised, then we will issue a new warrant certificate for the remaining amount of warrants.

**Enforceability of Rights by Holders of Warrants**

Any warrant agent will act solely as our agent under the applicable warrant agreement and will not assume any obligation or relationship of agency or trust with any holder of any warrant. A single bank or trust company may act as warrant agent for more than one issue of warrants. A warrant agent will have no duty or responsibility in case of any default by us under the applicable warrant agreement or warrant, including any duty or responsibility to initiate any proceedings at law or otherwise, or to make any demand upon us. Any holder of a warrant may, without the consent of the related warrant agent or the holder of any other warrant, enforce by appropriate legal action the holder's right to exercise, and receive the securities purchasable upon exercise of, its warrants in accordance with their terms.

**Warrant Agreement Will Not Be Qualified Under Trust Indenture Act**

No warrant agreement will be qualified as an indenture, and no warrant agent will be required to qualify as a trustee, under the Trust Indenture Act of 1939. Therefore, holders of warrants issued under a warrant agreement will not have the protection of the Trust Indenture Act of 1939 with respect to their warrants.

**Governing Law**

Unless we provide otherwise in the applicable prospectus supplement, each warrant agreement and any warrants issued under the warrant agreements will be governed by New York law.

**Description of Subscription Rights**

The following is a general description of the terms of the subscription rights we may issue from time to time. Particular terms of any subscription rights we offer will be described in the prospectus supplement relating to such subscription rights, and may differ from the terms described herein.

We may issue subscription rights to purchase shares of our common stock or other securities offered hereby. These subscription rights may be issued independently or together with any other security offered hereby and may or may not be transferable by the stockholder receiving the subscription rights in such offering. Each series of subscription rights will be issued under a separate subscription rights agreement to be entered into between us and a bank or trust company, as rights agent. The rights agent will act solely as our agent in connection with the certificates relating to the subscription rights of the series of certificates and will not assume any obligation or relationship of agency or trust for or with any holders of subscription rights certificates or beneficial owners of subscription rights. In connection with any offering of subscription rights, we may enter into a standby arrangement with one or more underwriters or other purchasers pursuant to which the underwriters or other purchasers may be required to purchase any securities remaining unsubscribed for after such offering.

The applicable prospectus supplement will describe the specific terms of any offering of subscription rights for which this prospectus is being delivered, including the following:

● whether shares of our common stock or other securities will be offered under the stockholder subscription rights;

● the date of determining the stockholders entitled to the subscription rights distribution;

● the price, if any, for the subscription rights;

● the exercise price payable for each security upon the exercise of the subscription rights;

● the number of subscription rights issued to each stockholder;

● the number and terms of the securities which may be purchased per each subscription right;

● the extent to which the subscription rights are transferable and the date, if any, on and after which the rights may be separately transferred;

● any other terms of the subscription rights, including the terms, procedures and limitations relating to the exchange and exercise of the subscription rights;

● the date on which the right to exercise the subscription rights shall commence, and the date on which the subscription rights shall expire;

● the conditions to the completion of the offering, if any;

● terms relating to the withdrawal, termination or cancellation of the subscription rights, if any;

● the extent to which the subscription rights may include an over-subscription privilege with respect to unsubscribed securities;

● if appropriate, a discussion of material U.S. federal income tax considerations; and

● if applicable, the material terms of any standby underwriting or purchase arrangement entered into by us in connection with the offering of subscription rights.

The description in the applicable prospectus supplement of any subscription rights we offer will not necessarily be complete and will be qualified in its entirety by reference to the applicable subscription rights certificate or subscription rights agreement, which will be filed with the SEC if we offer subscription rights.

Each subscription right will entitle the holder thereof to purchase for cash the principal amount of shares of common stock or other securities at the exercise price provided in the applicable prospectus supplement. Subscription rights may be exercised at any time up to the close of business on the expiration date for the subscription rights provided in the applicable prospectus supplement.

Holders may exercise subscription rights as described in the applicable prospectus supplement. Upon receipt of payment and the subscription rights certificate properly completed and duly executed at the corporate trust office of the rights agent or any other office indicated in the prospectus supplement, we will, as soon as practicable, forward the shares of common stock or other securities, as applicable, purchasable upon exercise of the subscription rights. If less than all of the subscription rights issued in any subscription rights offering are exercised, we may offer any unsubscribed securities directly to persons other than stockholders, to or through agents, underwriters or dealers or through a combination of such methods, including pursuant to standby arrangements, as described in the applicable prospectus supplement.

**Rights Agent**

The rights agent for any subscription rights we offer will be set forth in the applicable prospectus supplement.

**Description of Units**

We may issue units comprised of one or more of the other securities described in this prospectus or any prospectus supplement in any combination. Each unit will be issued so that the holder of the unit is also the holder, with the rights and obligations of a holder, of each security included in the unit. The unit agreement under which a unit is issued may provide that the securities included in the unit may not be held or transferred separately, at any time or at any times before a specified date or upon the occurrence of a specified event or occurrence.

The applicable prospectus supplement will describe:

● the designation and the terms of the units and of the securities comprising the units, including whether and under what circumstances those securities may be held or transferred separately;

● any unit agreement under which the units will be issued;

● any provisions for the issuance, payment, settlement, transfer or exchange of the units or of the securities comprising the units; and

● whether the units will be issued in fully registered or global form.

**Plan of Distribution**

We may sell the securities offered pursuant to this prospectus from time to time in one or more transactions, including, without limitation:

● to or through underwriters;

● through broker-dealers (acting as agent or principal);

● through agents;

● directly by us to one or more purchasers (including our affiliates and stockholders), through a specific bidding or auction process, a rights offering or otherwise;

● through a combination of any such methods of sale; or

● through any other methods described in a prospectus supplement or free writing prospectus.

The distribution of securities may be effected, from time to time, in one or more transactions, including:

● block transactions (which may involve crosses) and transactions on Nasdaq or any other organized market where the securities may be traded;

● purchases by a broker-dealer as principal and resale by the broker-dealer for its own account pursuant to a prospectus supplement or free writing prospectus;

● ordinary brokerage transactions and transactions in which a broker-dealer solicits purchasers;

● sales "at the market" to or through a market maker or into an existing trading market, on an exchange or otherwise; and

● sales in other ways not involving market makers or established trading markets, including direct sales to purchasers.

● The applicable prospectus supplement or free writing prospectus will describe the terms of the offering of the securities, including:

● the name or names of any underwriters, if, and if required, any dealers or agents;

● the purchase price of the securities and the proceeds we will receive from the sale;

● any underwriting discounts and other items constituting underwriters' compensation;

● any discounts or concessions allowed or re-allowed or paid to dealers; and

● any securities exchange or market on which the securities may be listed or traded.

We may distribute the securities from time to time in one or more transactions at:

● a fixed price or prices, which may be changed;

● market prices prevailing at the time of sale;

● prices related to such prevailing market prices; or

● negotiated prices.

Only underwriters named in the prospectus supplement are underwriters of the securities offered by the prospectus supplement.

If underwriters are used in an offering, we will execute an underwriting agreement with such underwriters and will specify the name of each underwriter and the terms of the transaction (including any underwriting discounts and other terms constituting compensation of the underwriters and any dealers) in a prospectus supplement. The securities may be offered to the public either through underwriting syndicates represented by managing underwriters or directly by one or more investment banking firms or others, as designated. If an underwriting syndicate is used, the managing underwriter(s) will be specified on the cover of the prospectus supplement. If underwriters are used in the sale, the offered securities will be acquired by the underwriters for their own accounts and may be resold from time to time in one or more transactions, including negotiated transactions, at a fixed public offering price or at varying prices determined at the time of sale. Any public offering price and any discounts or concessions allowed or reallowed or paid to dealers may be changed from time to time. Unless otherwise set forth in the prospectus supplement, the obligations of the underwriters to purchase the offered securities will be subject to conditions precedent, and the underwriters will be obligated to purchase all of the offered securities, if any are purchased.

We may grant the underwriters options to purchase additional securities to cover over-allotments, if any, at the public offering price, with additional underwriting commissions or discounts, as may be set forth in a related prospectus supplement. The terms of any over-allotment option will be set forth in the prospectus supplement for those securities.

If we use a dealer in the sale of the securities being offered pursuant to this prospectus or any prospectus supplement, we will sell the securities to the dealer, as principal. The dealer may then resell the securities to the public at varying prices to be determined by the dealer at the time of resale. The names of the dealers and the terms of the transaction will be specified in a prospectus supplement.

We may sell the securities directly or through agents we designate from time to time. We will name any agent involved in the offering and sale of securities and we will describe any commissions we will pay the agent in the prospectus supplement. Unless the prospectus supplement states otherwise, any agent will act on a best-efforts basis for the period of its appointment.

We may authorize agents or underwriters to solicit offers by institutional investors to purchase securities from us at the public offering price set forth in the prospectus supplement pursuant to delayed delivery contracts providing for payment and delivery on a specified date in the future. We will describe the conditions to these contracts and the commissions we must pay for solicitation of these contracts in the prospectus supplement.

In connection with the sale of the securities, underwriters, dealers or agents may receive compensation from us or from purchasers of the securities for whom they act as agents, in the form of discounts, concessions or commissions. Underwriters may sell the securities to or through dealers, and those dealers may receive compensation in the form of discounts, concessions or commissions from the underwriters or commissions from the purchasers for whom they may act as agents. Underwriters, dealers and agents that participate in the distribution of the securities, and any institutional investors or others that purchase securities directly for the purpose of resale or distribution, may be deemed to be underwriters, and any discounts or commissions received by them from us and any profit on the resale of the common stock by them may be deemed to be underwriting discounts and commissions under the Securities Act.

We may provide agents, underwriters and other purchasers with indemnification against particular civil liabilities, including liabilities under the Securities Act, or contribution with respect to payments that the agents, underwriters or other purchasers may make with respect to such liabilities. Agents and underwriters may engage in transactions with, or perform services for, us in the ordinary course of business.

To facilitate the public offering of a series of securities, persons participating in the offering may engage in transactions that stabilize, maintain, or otherwise affect the market price of the securities. This may include over-allotments or short sales of the securities, which involves the sale by persons participating in the offering of more securities than have been sold to them by us. In addition, those persons may stabilize or maintain the price of the securities by bidding for or purchasing securities in the open market or by imposing penalty bids, whereby selling concessions allowed to underwriters or dealers participating in any such offering may be reclaimed if securities sold by them are repurchased in connection with stabilization transactions. The effect of these transactions may be to stabilize or maintain the market price of the securities at a level above that which might otherwise prevail in the open market. Such transactions, if commenced, may be discontinued at any time. We make no representation or prediction as to the direction or magnitude of any effect that the transactions described above, if implemented, may have on the price of our securities.

Unless otherwise specified in the applicable prospectus supplement, any common stock sold pursuant to a prospectus supplement will be eligible for listing on Nasdaq, subject to official notice of issuance. Any underwriters to whom securities are sold by us for public offering and sale may make a market in the securities, but such underwriters will not be obligated to do so and may discontinue any market making at any time without notice.

In order to comply with the securities laws of some states, if applicable, the securities offered pursuant to this prospectus will be sold in those states only through registered or licensed brokers or dealers. In addition, in some states securities may not be sold unless they have been registered or qualified for sale in the applicable state or an exemption from the registration or qualification requirement is available and complied with.

**Legal Matters**

The validity of the securities offered by this prospectus will be passed upon for us by Haynes and Boone, LLP, New York, New York.

**Experts**

The consolidated financial statements of Wrap Technologies, Inc. as of and for the years ended December 31, 2024 and 2023, incorporated by reference in this registration statement and accompanying prospectus have been audited by HTL International, LLC, an independent registered public accounting firm, as stated in their report (the report on the consolidated financial statements contains an explanatory paragraph regarding the Company's ability to continue as a going concern). Such consolidated financial statements have been incorporated herein by reference in reliance on the report of such firm given upon their authority as experts in accounting and auditing.

**Where You Can Find More Information**

We are subject to the informational requirements of the Exchange Act, and in accordance therewith file annual, quarterly and current reports, proxy statements and other information with the SEC. The SEC maintains an internet website at *www.sec.gov* that contains periodic and current reports, proxy and information statements and other information regarding registrants that are filed electronically with the SEC.

These documents are also available, free of charge, through the SEC Filings portion of the Investor Relations section of our website, which is located at *www.wrap.com*.

We have filed with the SEC a registration statement under the Securities Act, relating to the offering of these securities. The registration statement, including the attached exhibits, contains additional relevant information about us and the securities. This prospectus does not contain all of the information set forth in the registration statement. You can obtain a copy of the registration statement for free at *www.sec.gov*. The registration statement and the documents referred to below under "Incorporation of Documents by Reference" are also available on our website, *www.wrap.com*.

We have not incorporated by reference into this prospectus the information on our website, and you should not consider it to be a part of this prospectus

**Incorporation of Documents By Reference**

The SEC allows us to "incorporate by reference" the information we have filed with it, which means that we can disclose important information to you by referring you to those documents. The information we incorporate by reference is an important part of this prospectus, and later information that we file with the SEC will automatically update and supersede this information. We specifically are incorporating by reference the following documents filed with the SEC and any future documents we file with the SEC pursuant to Sections l3(a), l3(c), 14 or l5(d) of the Exchange Act (excluding those portions of any Current Report on Form 8-K that are furnished and not deemed "filed" pursuant to the General Instructions of Form 8-K), in each case, between the date of the initial registration statement and the effectiveness of the registration statement and following the effectiveness of the registration statement until the offering of the securities under the registration statement is terminated:

● our
 Annual Report on [Form 10-K](https://www.sec.gov/Archives/edgar/data/1702924/000164117225001416/form10-k.htm) for the year ended December 31, 2024, filed with the SEC on March
 31, 2025;

● our
Amendment No. 1 to the Annual Report on <u>[Form 10-K](https://www.sec.gov/Archives/edgar/data/1702924/000164117225006244/form10-ka.htm)</u> for the year ended December 31, 2024, filed with the SEC on April 25, 2025;

● our Quarterly Reports on Form 10-Q for the quarter
 ended [March 31, 2025](http://www.sec.gov/Archives/edgar/data/1702924/000164117225011065/form10-q.htm) , filed with the SEC on May 15, 2025, for the quarter ended [June 30, 2025](https://www.sec.gov/Archives/edgar/data/1702924/000164117225024162/form10-q.htm) , filed with the SEC on August 14, 2025,
 and for the quarter ended [September 30, 2025](https://www.sec.gov/Archives/edgar/data/1702924/000114036125041816/form10q.htm) , filed with the SEC on November 13, 2025;

● our Current Reports on Form 8-K filed with the SEC
 on [February 11, 2025](https://www.sec.gov/Archives/edgar/data/1702924/000143774925003433/wrap20250211_8k.htm) ; [February 24, 2025](https://www.sec.gov/Archives/edgar/data/1702924/000143774925004882/wrap20250224_8k.htm) ; [February 28, 2025](https://www.sec.gov/Archives/edgar/data/1702924/000143774925005752/wrap20250228_8k.htm) ; [March 14, 2025](https://www.sec.gov/Archives/edgar/data/1702924/000143774925007635/wrap20250314_8k.htm) ; [June 27, 2025](https://www.sec.gov/Archives/edgar/data/1702924/000164117225016914/form8-k.htm) ; [July 7, 2025](https://www.sec.gov/Archives/edgar/data/1702924/000164117225018048/form8-k.htm) ; [August 18, 2025](https://www.sec.gov/Archives/edgar/data/1702924/000164117225024642/form8-k.htm) ; [August 26, 2025](https://www.sec.gov/Archives/edgar/data/1702924/000164117225025536/form8-k.htm) ; [October 27, 2025](https://www.sec.gov/Archives/edgar/data/1702924/000149315225019686/form8-k.htm) ; and [November 5, 2025](https://www.sec.gov/Archives/edgar/data/1702924/000149315225020900/form8-k.htm) .

● the
 description of our securities that is included in [Exhibit 4.8](https://www.sec.gov/Archives/edgar/data/1702924/000143774924027942/ex_718610.htm) to our Annual Report on Form 10-K for the year ended December 31, 2024,
 filed with the SEC on March 31, 2025.

Any statement contained herein or in any document incorporated or deemed to be incorporated by reference shall be deemed to be modified or superseded for purposes of the registration statement of which this prospectus forms a part to the extent that a statement contained in any other subsequently filed document which also is or is deemed to be incorporated by reference modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed to constitute a part of the registration statement of which this prospectus forms a part, except as so modified or superseded.

You should rely only on the information incorporated by reference or provided in this prospectus. We have not authorized anyone else to provide you with different information. You should not assume that the information in this prospectus is accurate as of any date other than the date of this prospectus or the date of the documents incorporated by reference in this prospectus.

We will provide without charge to each person to whom a copy of this prospectus is delivered, upon written or oral request, a copy of any or all of the information that has been incorporated by reference in this prospectus but not delivered with this prospectus (other than an exhibit to these filings, unless we have specifically incorporated that exhibit by reference in this prospectus). Any such request should be addressed to us at:

Wrap Technologies, Inc.3480 Main Hwy, Suite 202

Miami, Florida 33133

(800) 583-2652

You may also access the documents incorporated by reference in this prospectus through our website at *www.wrap.com*. Except for the specific incorporated documents listed above, no information available on or through our website shall be deemed to be incorporated in this prospectus or the registration statement of which it forms a part.

**$200,000,000** 

**COMMON STOCK<br> PREFERRED STOCK<br> DEBT SECURITIES<br> WARRANTS**

**SUBSCRIPTION RIGHTS<br> UNITS**

**Prospectus**

**Part II**

**Information Not Required in Prospectus**

**Item 14. Other Expenses of Issuance and Distribution.**

The following table sets forth the estimated costs and expenses payable by the registrant expected to be incurred in connection with the issuance and distribution of the common stock being registered hereby (other than underwriting discounts and commissions). All of such expenses are estimates, except for the SEC registration fee.

---

| | |
|:---|:---|
|  | **Amount<br> to be Paid** |
| SEC registration fee | $27620.00 |
| FINRA fee | $\* |
| Printing fees and expenses | $\* |
| Transfer agent and registrar fees | $\* |
| Accounting fees and expenses | $\* |
| Legal fees and expenses | $\* |
| Miscellaneous | $\* |
| Total | $\* |

---

\* The amount of securities and number of offerings are indeterminable and the expenses cannot be estimated at this time. An estimate of the aggregate expenses in connection with the sale and distribution of securities being offered will be included in the applicable prospectus supplement.

**Item 15. Indemnification of Directors and Officers.**

Our Certificate of Incorporation and Bylaws contain provisions relating to the limitation of liability and indemnification of directors and officers. Our Certificate of Incorporation provides that a director will not be personally liable to us or our stockholders for monetary damages for breach of fiduciary duty as a director, except for liability:

● for any breach of the director's duty of loyalty to us or our stockholders;

● for acts or omissions not in good faith or that involve intentional misconduct or a knowing violation of law;

● under Section 174 of the DGCL; or

● for any transaction from which the director derived any improper personal benefit.

Our Certificate of Incorporation also provides that if the DGCL is amended to authorize corporate action further eliminating or limiting the personal liability of directors, then the liability of our directors will be eliminated or limited to the fullest extent permitted by the DGCL.

Our Bylaws provide that we will indemnify our directors and officers to the fullest extent not prohibited by the DGCL; provided, however, that we may limit the extent of such indemnification by individual contracts with our directors and executive officers; and provided, further, that we are not required to indemnify any director or executive officer in connection with any proceeding (or part thereof) initiated by such person or any proceeding by such person against us or our directors, officers, employees or other agents unless:

● such indemnification is expressly required to be made by law;

● the proceeding was authorized by the Board; or

● such indemnification is provided by us, in our sole discretion, pursuant to the powers vested in us under the DGCL.

Our Bylaws provide that we shall advance, prior to the final disposition of any proceeding, promptly following request therefor, all expenses by any director or executive officer in connection with any such proceeding upon receipt of any undertaking by or on behalf of such person to repay said amounts if it should be determined ultimately that such person is not entitled to be indemnified under Article XI of our Bylaws or otherwise. Notwithstanding the foregoing, unless otherwise determined, no advance shall be made by us if a determination is reasonably and promptly made by the Board by a majority vote of a quorum of directors who were not parties to the proceeding, or if such a quorum is not obtainable, or even if obtainable, a quorum of disinterested directors so directs, by independent legal counsel in a written opinion, that the facts known to the decision-making party at the time such determination is made demonstrate clearly and convincingly that such person acted in bad faith or in a manner that such person did not believe to be in or not opposed to our best interests.

Our Bylaws also authorize us to purchase insurance on behalf of any person required or permitted to be indemnified pursuant to our Bylaws.

Section 145(a) of the DGCL authorizes a corporation to indemnify any person who was or is a party, or is threatened to be made a party, to a threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative (other than an action by or in the right of the corporation), by reason of the fact that the person is or was a director, officer, employee or agent of the corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise, against expenses (including attorneys' fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by the person in connection with such action, suit or proceeding, if the person acted in good faith and in a manner the person reasonably believed to be in, or not opposed to, the best interests of the corporation and, with respect to any criminal action or proceeding, had no reasonable cause to believe the person's conduct was unlawful.

Section 145(b) of the DGCL provides in relevant part that a corporation may indemnify any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action or suit by or in the right of the corporation to procure a judgment in its favor by reason of the fact that the person is or was a director, officer, employee or agent of the corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise against expenses (including attorneys' fees) actually and reasonably incurred by the person in connection with the defense or settlement of such action or suit if the person acted in good faith and in a manner the person reasonably believed to be in or not opposed to the best interests of the corporation and except that no indemnification shall be made in respect of any claim, issue or matter as to which such person shall have been adjudged to be liable to the corporation unless and only to the extent that the Court of Chancery or the court in which such action or suit was brought shall determine upon application that, despite the adjudication of liability but in view of all the circumstances of the case, such person is fairly and reasonably entitled to indemnity for such expenses which the Court of Chancery or such other court shall deem proper.

The DGCL also provides that indemnification under Section 145(d) can only be made upon a determination that indemnification of the present or former director, officer or employee or agent is proper in the circumstances because such person has met the applicable standard of conduct set forth in Section 145(a) and (b).

Section 145(g) of the DGCL also empowers a corporation to purchase and maintain insurance on behalf of any person who is or was a director, officer, employee or agent of the corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise against any liability asserted against such person and incurred by such person in any such capacity, or arising out of such person's status as such, whether or not the corporation would have the power to indemnify such person against such liability under Section 145 of the DGCL.

Section 102(b)(7) of the DGCL permits a corporation to provide for eliminating or limiting the personal liability of one of its directors for any monetary damages related to a breach of fiduciary duty as a director, as long as the corporation does not eliminate or limit the liability of a director for acts or omissions which (1) which breached the director's duty of loyalty to the corporation or its stockholders, (2) which were not in good faith or which involve intentional misconduct or knowing violation of law, (3) under Section 174 of the DGCL; or (4) from which the director derived an improper personal benefit.

We have obtained directors' and officers' insurance to cover our directors and officers for certain liabilities.

**Item 16. Exhibits.**

---

| | |
|:---|:---|
| **Exhibit<br> Number** | **Description** |
| 1.1\*\* | Form of Underwriting Agreement. |
| 2.1 | [Stock Purchase Agreement, dated March 22, 2017, by and between Wrap Technologies, LLC, Petro River Oil Corp., and Megawest Energy Montana Corp (incorporated by reference to Exhibit 2.1 to the Company's Registration Statement on Form S-1 filed with the Securities and Exchange Commission on April 17, 2017).](https://www.sec.gov/Archives/edgar/data/1702924/000165495417003384/ex2-1.htm) |
| 2.2 | [Merger Agreement between Wrap Technologies, LLC and Megawest Energy Montana Corp., dated March 30, 2017 (incorporated by reference to Exhibit 2.2 to the Company's Registration Statement on Form S-1 filed with the Securities and Exchange Commission on April 17, 2017).](https://www.sec.gov/Archives/edgar/data/1702924/000165495417003384/ex2-2.htm) |
| 2.3 | [Asset Purchase Agreement, dated as of February 18, 2025, by and between Wrap Technologies, Inc. and W1 Global, LLC Plan (incorporated by reference to Exhibit 2.1 to the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on February 24, 2025).](https://www.sec.gov/Archives/edgar/data/1702924/000143774925004882/ex_781460.htm) |
| 4.1 | [Form of Common Stock Certificate (incorporated by reference to Exhibit 4.1 to the Company's Registration Statement on Form S-1/A filed with the Securities and Exchange Commission on May 30, 2017).](https://www.sec.gov/Archives/edgar/data/1702924/000165495417005181/ex4-1.htm) |
| 4.2 | [Form of Investor Warrant, dated October 30, 2018 (incorporated by reference to Exhibit 4.1 to the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 5, 2018).](https://www.sec.gov/Archives/edgar/data/1702924/000165495418011996/ex4-1.htm) |
| 4.3 | [Form of Placement Agent Warrant, dated October 30, 2018 (incorporated by reference to Exhibit 4.2 to the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 5, 2018).](https://www.sec.gov/Archives/edgar/data/1702924/000165495418011996/ex4-2.htm) |

---

4.4 [Form of Investor Warrant, dated June 18, 2019 (incorporated by reference to Exhibit 4.1 to the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on June 18, 2019).](https://www.sec.gov/Archives/edgar/data/1702924/000165495419007441/ex4-1.htm)

4.5 [Form of Offering Agent Warrant, dated June 18, 2019 (incorporated by reference to Exhibit 4.2 to the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on June 18, 2019).](https://www.sec.gov/Archives/edgar/data/1702924/000165495419007441/ex4-2.htm)

4.6 [Form of Warrant Agreement (incorporated by reference to Exhibit 4.1 to the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on June 2, 2020).](https://www.sec.gov/Archives/edgar/data/1702924/000165495420006265/ex4-1.htm)

4.7 [Form of Placement Agent Warrant (incorporated by reference to Exhibit 4.1 to the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on June 30, 2023).](https://www.sec.gov/Archives/edgar/data/1702924/000143774923019053/ex_540253.htm)

---

| | |
|:---|:---|
| 4.8 | [Form of Warrant (incorporated by reference to Exhibit 4.1 to the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on February 28, 2025).](https://www.sec.gov/Archives/edgar/data/1702924/000143774925005752/ex_784263.htm) |
| 4.9 | [Form of Series A Warrant Amendment, dated as of June 30, 2025, by and among Wrap Technologies, Inc. and the investors signatory thereto (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K, filed with the SEC on July 7, 2025).](https://www.sec.gov/Archives/edgar/data/1702924/000164117225018048/ex10-1.htm) |
| 4.10 | [Form of 2025 Warrant Amendment, dated as of June 30, 2025, by and among Wrap Technologies, Inc. and the investors signatory thereto (incorporated by reference to Exhibit 10.2 to the Company's Current Report on Form 8-K, filed with the SEC on July 7, 2025).](https://www.sec.gov/Archives/edgar/data/1702924/000164117225018048/ex10-2.htm) |
| 4.11 | [Form of Warrant (incorporated by reference to Exhibit 4.1 to the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on August 18, 2025).](https://www.sec.gov/Archives/edgar/data/1702924/000164117225024642/ex4-1.htm) |
| 4.12\* | [Form of Senior Indenture.](ex4-12.htm) |
| 4.13\* | [Form of Subordinated Indenture.](ex4-13.htm) |
| 4.14\*\* | Form of Senior Debt Securities. |
| 4.15\*\* | Form of Subordinated Debt Securities. |
| 4.16\*\* | Form of Warrant Agreement and Warrant Certificate. |
| 4.17\*\* | Form of Subscription Rights Agreement and Subscription Rights Certificate. |
| 4.18\*\* | Form of Unit Agreement and Unit |
| 4.19\*\* | Form of Certificate of Designations, Rights and Preferences for Preferred Stock |
| 5.1\* | [Opinion of Haynes and Boone, LLP.](ex5-1.htm) |
| 23.1\* | [Consent of HTL International, LLC.](ex23-1.htm) |
| 23.3\* | [Consent of Haynes and Boone, LLP (included in the opinion filed as Exhibit 5.1).](ex5-1.htm) |
| 24.1\* | [Power of Attorney (included on the signature page of this Registration Statement).](#a_016) |
| 25.1\*\* | Statement of Trustee Eligibility. |
| 107\* | [Filing Fee Table.](ex107.htm) |

---

\* Filed herewith. <br>\*\* To be filed by amendment or as an exhibit to a report pursuant to Section 13(a), 13(c) or 15(d) of the Exchange Act.

**Item 17. Undertakings.**

The undersigned registrant hereby undertakes:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) To include any prospectus required by section 10(a)(3) of the Securities Act of 1933;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than a 20 percent change in the maximum aggregate offering price set forth in the "Calculation of Registration Fee" table in the effective registration statement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement;

Provided, however, that:

Paragraphs (1)(i), (1)(ii) and (1)(iii) of this section do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Commission by the registrant pursuant to section 13 or section 15(d) of the Securities Exchange Act of 1934 that are incorporated by reference in the registration statement, or is contained in a form of prospectus filed pursuant to Rule 424(b) that is part of the registration statement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) That, for the purpose of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3) To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(4) That, for the purpose of determining liability under the Securities Act of 1933 to any purchaser:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) If the registrant is relying on Rule 430B (§230.430B of this chapter):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(A) Each prospectus filed by the registrant pursuant to Rule 424(b)(3) shall be deemed to be part of the registration statement as of the date the filed prospectus was deemed part of and included in the registration statement; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(B) Each prospectus required to be filed pursuant to Rule 424(b)(2), (b)(5), or (b)(7) as part of a registration statement in reliance on Rule 430B relating to an offering made pursuant to Rule 415(a)(1)(i), (vii), or (x) for the purpose of providing the information required by section 10 (a) of the Securities Act of 1933 shall be deemed to be part of and included in the registration statement as of the earlier of the date such form of prospectus is first used after effectiveness or the date of the first contract of sale of securities in the offering described in the prospectus. As provided in Rule 430B, for liability purposes of the issuer and any person that is at that date an underwriter, such date shall be deemed to be a new effective date of the registration statement relating to the securities in the registration statement to which that prospectus relates, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. Provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such effective date, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such effective date.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) If the registrant is subject to Rule 430C, each prospectus filed pursuant to Rule 424(b) as part of a registration statement relating to an offering, other than registration statements relying on Rule 430B or other than prospectuses filed in reliance on Rule 430A, shall be deemed to be part of and included in the registration statement as of the date it is first used after effectiveness. Provided, however , that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such first use, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such date of first use.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(5) That, for the purpose of determining liability of the registrant under the Securities Act to any purchaser in the initial distribution of the securities, the undersigned registrant undertakes that in a primary offering of securities of the undersigned registrant pursuant to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) Any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule 424;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) Any free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by the undersigned registrant;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) The portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant or its securities provided by or on behalf of the undersigned registrant; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) Any other communication that is an offer in the offering made by the undersigned registrant to the purchaser.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(6) That, for purposes of determining any liability under the Securities Act of 1933, each filing of the registrant's annual report pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (and, where applicable, each filing of an employee benefit plan's annual report pursuant to Section 15(d) of the Securities Exchange Act of 1934) that is incorporated by reference in the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(7) Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Securities Act of 1933 and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act of 1933 and will be governed by the final adjudication of such issue.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(8) The undersigned registrant hereby undertakes that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) For purposes of determining
 any liability under the Securities Act of 1933, the information omitted from the form of prospectus filed as part of this registration
 statement in reliance upon Rule 430A and contained in a form of prospectus filed by the registrant pursuant to Rule 424(b) (1) or
 (4) or 497(h) under the Securities Act shall be deemed to be part of this registration statement as of the time it was declared effective.

(ii) For the purpose of determining
 any liability under the Securities Act of 1933, each post-effective amendment that contains a form of prospectus shall be deemed
 to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall
 be deemed to be the initial bona fide offering thereof.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(9) The undersigned registrant hereby undertakes to file an application for the purpose of determining the eligibility of the trustee to act under subsection (a) of section 310 of the Trust Indenture Act ("Act") in accordance with the rules and regulations prescribed by the Commission under section 305(b)(2) of the Act.

**Signatures**

Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-3 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the city of New York, State of New York, on November 21, 2025.

---

| | |
|:---|:---|
| **Wrap Technologies, Inc.** | **Wrap Technologies, Inc.** |
| By: | */s/ Scot Cohen* |
| Name: | Scot Cohen |
| Title: | Chief Executive Officer |

---

**Power of Attorney**

Each person whose signature appears below hereby appoints Scot Cohen, his or her true and lawful attorney-in-fact, with full power of substitution, and with the authority to execute in the name of each such person, any and all amendments (including without limitation, post-effective amendments) to this registration statement on Form S-3, to sign any and all additional registration statements relating to the same offering of securities as this registration statement that are filed pursuant to Rule 462(b) of the Securities Act of 1933, and to file such registration statements with the Securities and Exchange Commission, together with any exhibits thereto and other documents therewith, necessary or advisable to enable the registrant to comply with the Securities Act of 1933, and any rules, regulations and requirements of the Securities and Exchange Commission in respect thereof, which amendments may make such other changes in the registration statement as the aforesaid attorney-in-fact executing the same deems appropriate.

Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the dates indicated.

---

| | | |
|:---|:---|:---|
| **Signature** | **Title** | **Date** |
| */s/ Scot Cohen* | Chief Executive Officer | November 21, 2025 |
| Scot Cohen | (Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer) |  |
| */s/ Bruce Bernstein* | Director | November 21, 2025 |
| Bruce Bernstein |  |  |
| */s/ Marc Savas* | Director | November 21, 2025 |
| Marc Savas |  |  |
| */s/ Rajiv Srinivasan* | Director | November 21, 2025 |
| Rajiv Srinivasan |  |  |
| */s/ Timothy Szymanski* | Director | November 21, 2025 |
| Timothy Szymanski |  |  |
| */s/ John Shulman* | Director | November 21, 2025 |
| Timothy Szymanski |  |  |

---

## Exhibit 4.12

**Exhibit 4.12**

**WRAP TECHNOLOGIES, INC.**

Issuer

AND

[ ]

Trustee

**INDENTURE**

Dated as of [ ]

**Senior Debt Securities**

**CROSS-REFERENCE TABLE (1)**

---

| | |
|:---|:---|
| **Section of Trust Indenture Act of 1939, as Amended** | **Section of<br> Indenture** |
| 310(a). | 7.09 |
| 310(b). | 7.08 |
|  | 7.10 |
| 310(c). | Inapplicable |
| 311(a). | 7.13(a) |
| 311(b). | 7.13(b) |
| 311(c). | Inapplicable |
| 312(a) | 5.02(a) |
| 312(b). | 5.02(b) |
| 312(c). | 5.02(c) |
| 313(a). | 5.04(a) |
| 313(b). | 5.04(a) |
| 313(c). | 5.04(a) |
|  | 5.04(b) |
| 313(d). | 5.04(b) |
| 314(a). | 5.03 |
| 314(b). | Inapplicable |
| 314(c). | 13.06 |
| 314(d). | Inapplicable |
| 314(e). | 13.06 |
| 314(f). | Inapplicable |
| 315(a). | 7.01(a) |
|  | 7.02 |
| 315(b). | 6.07 |
| 315(c). | 7.01 |
| 315(d). | 7.01(b) |
|  | 7.01(c) |
| 315(e). | 6.07 |
| 316(a). | 6.06 |
|  | 8.04 |
| 316(b). | 6.04 |
| 316(c). | 8.01 |
| 317(a). | 6.02 |
| 317(b). | 4.03 |
| 318(a). | 13.08 |

---

&nbsp;&nbsp;&nbsp;&nbsp;(1) This Cross-Reference Table
 does not constitute part of the Indenture and shall not have any bearing on the interpretation of any of its terms or provisions.

i

****TABLE OF CONTENTS** (2)**

---

| | | |
|:---|:---|:---|
| ARTICLE I DEFINITIONS | ARTICLE I DEFINITIONS | 1 |
| SECTION 1.01 | Definitions of Terms | 1 |
| ARTICLE II ISSUE, DESCRIPTION, TERMS, EXECUTION, REGISTRATION AND EXCHANGE OF SECURITIES | ARTICLE II ISSUE, DESCRIPTION, TERMS, EXECUTION, REGISTRATION AND EXCHANGE OF SECURITIES | 5 |
| SECTION 2.01 | Designation and Terms of Securities | 5 |
| SECTION 2.02 | Form of Securities and Trustee's Certificate | 7 |
| SECTION 2.03 | Denominations: Provisions for Payment | 7 |
| SECTION 2.04 | Execution and Authentications | 9 |
| SECTION 2.05 | Registration of Transfer and Exchange | 10 |
| SECTION 2.06 | Temporary Securities | 11 |
| SECTION 2.07 | Mutilated, Destroyed, Lost or Stolen Securities | 12 |
| SECTION 2.08 | Cancellation | 12 |
| SECTION 2.09 | Benefits of Indenture | 13 |
| SECTION 2.10 | Authenticating Agent | 13 |
| SECTION 2.11 | Global Securities | 13 |
| ARTICLE III REDEMPTION OF SECURITIES AND SINKING FUND PROVISIONS | ARTICLE III REDEMPTION OF SECURITIES AND SINKING FUND PROVISIONS | 15 |
| SECTION 3.01 | Redemption | 15 |
| SECTION 3.02 | Notice of Redemption | 15 |
| SECTION 3.03 | Payment Upon Redemption | 16 |
| SECTION 3.04 | Sinking Fund | 16 |
| SECTION 3.05 | Satisfaction of Sinking Fund Payments with Securities | 17 |
| SECTION 3.06 | Redemption of Securities for Sinking Fund | 17 |
| ARTICLE IV COVENANTS | ARTICLE IV COVENANTS | 17 |
| SECTION 4.01 | Payment of Principal, Premium and Interest | 17 |
| SECTION 4.02 | Maintenance of Office or Agency | 18 |
| SECTION 4.03 | Paying Agents | 18 |
| SECTION 4.04 | Appointment to Fill Vacancy in Office of Trustee | 19 |
| SECTION 4.05 | Compliance with Consolidation Provisions | 19 |
| ARTICLE V SECURITYHOLDERS' LISTS AND REPORTS BY THE COMPANY AND THE TRUSTEE | ARTICLE V SECURITYHOLDERS' LISTS AND REPORTS BY THE COMPANY AND THE TRUSTEE | 19 |
| SECTION 5.01 | Company to Furnish Trustee Names and Addresses of Securityholders | 19 |
| SECTION 5.02 | Preservation of Information; Communications with Securityholders | 20 |
| SECTION 5.03 | Reports by the Company | 20 |
| SECTION 5.04 | Reports by the Trustee | 21 |
| ARTICLE VI REMEDIES OF THE TRUSTEE AND SECURITYHOLDERS ON EVENT OF DEFAULT | ARTICLE VI REMEDIES OF THE TRUSTEE AND SECURITYHOLDERS ON EVENT OF DEFAULT | 21 |
| SECTION 6.01 | Events of Default | 21 |
| SECTION 6.02 | Collection of Indebtedness and Suits for Enforcement by Trustee | 23 |
| SECTION 6.03 | Application of Moneys Collected | 24 |
| SECTION 6.04 | Limitation on Suits. | 25 |
| SECTION 6.05 | Rights and Remedies Cumulative; Delay or Omission Not Waiver. | 26 |
| SECTION 6.06 | Control by Securityholders. | 26 |

---

ii

---

| | | |
|:---|:---|:---|
| SECTION 6.07 | Undertaking to Pay Costs. | 27 |
| ARTICLE VII CONCERNING THE TRUSTEE | ARTICLE VII CONCERNING THE TRUSTEE | 27 |
| SECTION 7.01 | Certain Duties and Responsibilities of Trustee. | 27 |
| SECTION 7.02 | Certain Rights of Trustee. | 28 |
| SECTION 7.03 | Trustee Not Responsible for Recitals or Issuance of Securities. | 30 |
| SECTION 7.04 | May Hold Securities. | 30 |
| SECTION 7.05 | Moneys Held in Trust. | 30 |
| SECTION 7.06 | Compensation and Reimbursement. | 30 |
| SECTION 7.07 | Reliance on Officers' Certificate. | 31 |
| SECTION 7.08 | Disqualification; Conflicting Interests. | 31 |
| SECTION 7.09 | Corporate Trustee Required; Eligibility. | 31 |
| SECTION 7.10 | Resignation and Removal; Appointment of Successor. | 32 |
| SECTION 7.11 | Acceptance of Appointment By Successor. | 33 |
| SECTION 7.12 | Merger, Conversion, Consolidation or Succession to Business. | 34 |
| SECTION 7.13 | Preferential Collection of Claims Against the Company. | 35 |
| ARTICLE VIII CONCERNING THE SECURITYHOLDERS | ARTICLE VIII CONCERNING THE SECURITYHOLDERS | 35 |
| SECTION 8.01 | Evidence of Action by Securityholders. | 35 |
| SECTION 8.02 | Proof of Execution by Securityholders. | 35 |
| SECTION 8.03 | Who May be Deemed Owners. | 36 |
| SECTION 8.04 | Certain Securities Owned by Company Disregarded. | 36 |
| SECTION 8.05 | Actions Binding on Future Securityholders. | 37 |
| SECTION 8.06 | Purposes for Which Meetings May Be Called. | 37 |
| SECTION 8.07 | Call Notice and Place of Meetings. | 37 |
| SECTION 8.08 | Persons Entitled To Vote at Meetings. | 38 |
| SECTION 8.09 | Quorum; Action. | 38 |
| SECTION 8.10 | Determination of Voting Rights; Conduct and Adjournment of Meetings. | 38 |
| SECTION 8.11 | Counting Votes and Recording Action of Meetings. | 39 |
| ARTICLE IX SUPPLEMENTAL INDENTURES | ARTICLE IX SUPPLEMENTAL INDENTURES | 40 |
| SECTION 9.01 | Supplemental Indentures Without the Consent of Securityholders. | 40 |
| SECTION 9.02 | Supplemental Indentures With Consent of Securityholders. | 41 |
| SECTION 9.03 | Effect of Supplemental Indentures. | 41 |
| SECTION 9.04 | Securities Affected by Supplemental Indentures. | 42 |
| SECTION 9.05 | Execution of Supplemental Indentures. | 42 |
| ARTICLE X SUCCESSOR ENTITY | ARTICLE X SUCCESSOR ENTITY | 43 |
| SECTION 10.01 | Company May Consolidate, Etc. | 43 |
| SECTION 10.02 | Successor Entity Substituted. | 43 |
| SECTION 10.03 | Evidence of Consolidation, Etc. to Trustee. | 43 |
| ARTICLE XI SATISFACTION AND DISCHARGE | ARTICLE XI SATISFACTION AND DISCHARGE | 44 |
| SECTION 11.01 | Satisfaction and Discharge of Indenture. | 44 |
| SECTION 11.02 | Discharge of Obligations. | 44 |
| SECTION 11.03 | Deposited Moneys to be Held in Trust. | 45 |
| SECTION 11.04 | Payment of Moneys Held by Paying Agents. | 45 |
| SECTION 11.05 | Repayment to Company. | 45 |
| ARTICLE XII IMMUNITY OF INCORPORATORS, STOCKHOLDERS, OFFICERS AND DIRECTORS | ARTICLE XII IMMUNITY OF INCORPORATORS, STOCKHOLDERS, OFFICERS AND DIRECTORS | 45 |
| SECTION 12.01 | No Recourse. | 45 |
| ARTICLE XIII MISCELLANEOUS PROVISIONS | ARTICLE XIII MISCELLANEOUS PROVISIONS | 46 |
| SECTION 13.01 | Effect on Successors and Assigns. | 46 |
| SECTION 13.02 | Actions by Successor. | 46 |
| SECTION 13.03 | Surrender of Company Powers. | 46 |
| SECTION 13.04 | Notices. | 46 |
| SECTION 13.05 | Governing Law. | 47 |
| SECTION 13.06 | Treatment of Securities as Debt. | 47 |
| SECTION 13.07 | Compliance Certificates and Opinions. | 47 |
| SECTION 13.08 | Payments on Business Days. | 48 |
| SECTION 13.09 | Conflict with Trust Indenture Act. | 48 |
| SECTION 13.10 | Counterparts. | 48 |
| SECTION 13.11 | Separability. | 48 |
| SECTION 13.12 | Assignment. | 48 |

---

&nbsp;&nbsp;&nbsp;&nbsp;(2) This **Table of Contents**
 does not constitute part of the Indenture and shall not have any bearing on the interpretation of any of its terms and provisions.

iii

INDENTURE, dated as of [ ], by and between Wrap Technologies, Inc., a Delaware corporation (the "Company"), and [ ], as trustee (the "Trustee"):

WHEREAS, for its lawful corporate purposes, the Company has duly authorized the execution and delivery of this Indenture to provide for the issuance of debt securities (hereinafter referred to as the "Securities"), in an unlimited aggregate principal amount to be issued from time to time in one or more series as in this Indenture provided, as registered Securities without coupons, to be authenticated by the certificate of the Trustee;

WHEREAS, to provide the terms and conditions upon which the Securities are to be authenticated, issued and delivered, the Company has duly authorized the execution of this Indenture; and

WHEREAS, all things necessary to make this Indenture a valid agreement of the Company, in accordance with its terms, have been done.

NOW, THEREFORE, in consideration of the premises and the purchase of the Securities by the holders thereof, it is mutually covenanted and agreed as follows for the equal and ratable benefit of the holders of Securities:

ARTICLE I

DEFINITIONS

SECTION 1.01 Definitions of Terms.

The terms defined in this Section (except as in this Indenture otherwise expressly provided or unless the context otherwise requires) for all purposes of this Indenture and of any indenture supplemental hereto shall have the respective meanings specified in this Section and shall include the plural as well as the singular. All other terms used in this Indenture that are defined in the Trust Indenture Act of 1939, as amended, or that are by reference in such Act defined in the Securities Act of 1933, as amended (except as herein otherwise expressly provided or unless the context otherwise requires), shall have the meanings assigned to such terms in said Trust Indenture Act and in said Securities Act as in force at the date of the execution of this instrument.

"Authenticating Agent" means an authenticating agent with respect to all or any of the series of Securities appointed with respect to all or any series of the Securities by the Trustee pursuant to Section 2.10.

"Bankruptcy Law" means Title 11, U.S. Code, or any similar federal or state law for the relief of debtors.

"Board of Directors" means the Board of Directors of the Company or any duly authorized committee of such Board.

"Board Resolution" means a copy of a resolution certified by the Secretary or an Assistant Secretary of the Company to have been duly adopted by the Board of Directors and to be in full force and effect on the date of such certification.

"Business Day" means, with respect to any series of Securities, any day other than a day on which Federal or State banking institutions in the Borough of Manhattan, the City and State of New York, are authorized or obligated by law, executive order or regulation to close.

"Certificate" means a certificate signed by the principal executive officer, the principal financial officer or the principal accounting officer of the Company. The Certificate need not comply with the provisions of Section 13.07.

"Commission" means the Securities and Exchange Commission.

"Company" means the corporation named as the "Company" in the first paragraph of this instrument until a successor corporation shall have become such pursuant to the applicable provisions of this Indenture, and thereafter "Company" shall mean such successor corporation.

"Corporate Trust Office" means the office of the Trustee at which, at any particular time, its corporate trust business shall be principally administered, which office at the date hereof is located at [ ], except that whenever a provision herein refers to an office or agency of the Trustee in the Borough of Manhattan, the City and State of New York, such office is located, at the date hereof, at [ ].

"Custodian" means any receiver, trustee, assignee, liquidator, or similar official under any Bankruptcy Law.

"Default" means an event which is, or after notice or lapse of time, or both, would constitute an Event of Default.

"Depositary" means, with respect to Securities of any series, for which the Company shall determine that such Securities will be issued as a Global Security, The Depository Trust Company, New York, New York, another clearing agency, or any successor registered as a clearing agency under the Exchange Act, or other applicable statute or regulation, which, in each case, shall be designated by the Company pursuant to either Section 2.01 or Section 2.11.

"Event of Default" means, with respect to Securities of a particular series, any event specified in Section 6.01, continued for the period of time, if any, therein designated.

"Exchange Act" means the Securities Exchange Act of 1934, as amended.

"Global Security" means, with respect to any series of Securities, a Security executed by the Company and delivered by the Trustee to the Depositary or pursuant to the Depositary's instruction, all in accordance with this Indenture, which shall be registered in the name of the Depositary or its nominee.

"Governmental Obligations" means securities that are (i) direct obligations of the United States of America for the payment of which its full faith and credit is pledged or (ii) obligations of a Person controlled or supervised by and acting as an agency or instrumentality of the United States of America, the payment of which is unconditionally guaranteed as a full faith and credit obligation by the United States of America that, in either case, are non-callable at the option of the issuer thereof, and shall also include a depositary receipt issued by a bank (as defined in Section 3(a)(2) of the Securities Act of 1933, as amended) as custodian with respect to any such Governmental Obligation or a specific payment of principal of or interest on any such Governmental Obligation held by such custodian for the account of the holder of such depositary receipt; provided, however, that (except as required by law) such custodian is not authorized to make any deduction from the amount payable to the holder of such depositary receipt from any amount received by the custodian in respect of the Governmental Obligation or the specific payment of principal of or interest on the Governmental Obligation evidenced by such depositary receipt.

"herein," "hereof" and "hereunder," and other words of similar import, refer to this Indenture as a whole and not to any particular Article, Section or other subdivision.

"Indenture" means this instrument as originally executed or as it may from time to time be supplemented or amended by one or more indentures supplemental hereto entered into in accordance with the terms hereof.

"Interest Payment Date," when used with respect to any installment of interest on a Security of a particular series, means the date specified in such Security or in a Board Resolution or in an indenture supplemental hereto with respect to such series as the fixed date on which an installment of interest with respect to Securities of that series is due and payable.

"Officers' Certificate" means a certificate signed by the President or a Vice President and by the Chief Financial Officer, Vice President of Finance, the Treasurer or an Assistant Treasurer or the Controller or an Assistant Controller or the Secretary or an Assistant Secretary of the Company that is delivered to the Trustee in accordance with the terms hereof. Certificate shall include the statements provided for in Section 13.07, if and to the extent required by the provisions thereof.

"Opinion of Counsel" means a written opinion of counsel, who may be counsel to the Company (and may include directors or employees of the Company) and which opinion is acceptable to the Trustee which acceptance shall not be unreasonably withheld.

"Outstanding", when used with reference to Securities of any series, means, subject to the provisions of Section 8.04, as of any particular time, all Securities of that series theretofore authenticated and delivered by the Trustee under this Indenture, except (a) Securities theretofore canceled by the Trustee or any paying agent, or delivered to the Trustee or any paying agent for cancellation or that have previously been canceled; (b) Securities or portions thereof for the payment or redemption of which moneys or Governmental Obligations in the necessary amount shall have been deposited in trust with the Trustee or with any paying agent (other than the Company) or shall have been set aside and segregated in trust by the Company (if the Company shall act as its own paying agent); provided, however, that if such Securities or portions of such Securities are to be redeemed prior to the maturity thereof, notice of such redemption shall have been given as in Article III provided, or provision satisfactory to the Trustee shall have been made for giving such notice; and (c) Securities in lieu of or in substitution for which other Securities shall have been authenticated and delivered pursuant to the terms of Section 2.07.

"Person" means any individual, corporation, limited liability company, partnership, joint-venture, association, joint-stock company, trust, estate, unincorporated organization or government or any agency or political subdivision thereof.

"Predecessor Security" of any particular Security means every previous Security evidencing all or a portion of the same debt as that evidenced by such particular Security; and, for the purposes of this definition, any Security authenticated and delivered under Section 2.07 in lieu of a mutilated, destroyed, lost or stolen Security shall be deemed to evidence the same debt as the mutilated, destroyed, lost or stolen Security.

"Responsible Officer," when used with respect to the Trustee, means any officer of the Trustee, including any vice president, assistant vice president, secretary, assistant secretary, the treasurer, any assistant treasurer, the managing director or any other officer of the Trustee customarily performing functions similar to those performed by any of the above designated officers and also means, with respect to a particular corporate trust matter, any other officer to whom such matter is referred because of such officer's knowledge of and familiarity with the particular subject.

"Securities" means the debt Securities authenticated and delivered under this Indenture.

"Security Register" has the meaning specified in Section 2.05.

"Security Registrar" has the meaning specified in Section 2.05.

"Securityholder," "holder of Securities," "registered holder," or other similar term, means the Person or Persons in whose name or names a particular Security shall be registered in the Security Register.

"Subsidiary" means, with respect to any Person, (i) any corporation at least a majority of whose outstanding Voting Stock shall at the time be owned, directly or indirectly, by such Person or by one or more of its Subsidiaries or by such Person and one or more of its Subsidiaries, (ii) any general partnership, joint venture or similar entity, at least a majority of whose outstanding partnership or similar interests shall at the time be owned by such Person, or by one or more of its Subsidiaries, or by such Person and one or more of its Subsidiaries and (iii) any limited partnership of which such Person or any of its Subsidiaries is a general partner.

"Trustee" means the Person named as the "Trustee" in the first paragraph of this instrument until a successor Trustee shall have become such pursuant to the applicable provisions of this Indenture, and thereafter "Trustee" shall mean such successor Trustee. The term "Trustee" as used with respect to a particular series of the Securities shall mean the trustee with respect to that series.

"Trust Indenture Act" means the Trust Indenture Act of 1939, as amended, subject to the provisions of Sections 9.01, 9.02, and 10.01, as in effect at the date of execution of this instrument; provided, however, that in the event the Trust Indenture Act is amended after such date, Trust Indenture Act means, to the extent required by such amendment, the Trust Indenture Act of 1939, as so amended, or any successor statute.

"Voting Stock," as applied to any Person, means shares, interests, participations or other equivalents in the equity interest (however designated) in such Person having ordinary voting power for the election of a majority of the directors (or the equivalent) of such Person, other than shares, interests, participations or other equivalents having such power only by reason of the occurrence of a contingency.

ARTICLE II

ISSUE, DESCRIPTION, TERMS, EXECUTION,

REGISTRATION AND EXCHANGE OF SECURITIES

SECTION 2.01 Designation and Terms of Securities.

&nbsp;&nbsp;&nbsp;&nbsp;(a) The aggregate principal amount of Securities that may
 be authenticated and delivered under this Indenture is unlimited. The Securities may be issued in one or more series up to the aggregate
 principal amount of Securities of that series from time to time authorized by or pursuant to a Board Resolution of the Company or
 pursuant to one or more indentures supplemental hereto. Prior to the initial issuance of Securities of a given series, there shall
 be established in or pursuant to a Board Resolution of the Company, and set forth in an Officers' Certificate of the Company,
 or established in one or more indentures supplemental hereto:

&nbsp;&nbsp;&nbsp;&nbsp;(1) the title of the Security of the series (which shall
 distinguish the Securities of the series from all other Securities);

&nbsp;&nbsp;&nbsp;&nbsp;(2) the aggregate principal amount of the Securities of
 such series initially to be issued and any limit upon the aggregate principal amount of the Securities of that series that may be
 authenticated and delivered under this Indenture (except for Securities authenticated and delivered upon registration of transfer
 of, or in exchange for, or in lieu of, other Securities of that series);

&nbsp;&nbsp;&nbsp;&nbsp;(3) the currency or units based on or relating to currencies
 in which debt securities of such series are denominated and the currency or units in which principal or interest or both will or
 may be payable;

&nbsp;&nbsp;&nbsp;&nbsp;(4) the date or dates on which the principal of the Securities
 of the series is payable and the place(s) of payment;

&nbsp;&nbsp;&nbsp;&nbsp;(5) the rate or rates at which the Securities of the series
 shall bear interest or the manner of calculation of such rate or rates, if any;

(6) the date or dates from which such interest shall accrue,
 the Interest Payment Dates on which such interest will be payable or the manner of determination of such Interest Payment Dates,
 the place(s) of payment, and the record date for the determination of holders to whom interest is payable on any such Interest Payment
 Dates or the method for determining such dates;

(7) the right, if any, to extend the interest payment periods
 or to defer the payment of interest and the duration of such extension;

(8) the period or periods within which, the price or prices
 at which and the terms and conditions upon which, Securities of the series may be redeemed, in whole or in part, at the option of
 the Company;

(9) the obligation, if any, of the Company to redeem or
 purchase Securities of the series pursuant to any sinking fund or analogous provisions (including payments made in cash in satisfaction
 of future sinking fund obligations) or at the option of a holder thereof and the period or periods within which, the price or prices
 at which, and the terms and conditions upon which, Securities of the series shall be redeemed or purchased, in whole or in part,
 pursuant to such obligation;

(10) whether or not the debt securities will be secured
 or unsecured, and the terms of any secured debt;

(11) the form of the Securities of the series including
 the form of the Certificate of Authentication for such series;

(12) if other than denominations of one thousand U.S. dollars
 ($1,000) or any integral multiple thereof, the denominations in which the Securities of the series shall be issuable;

(13) any and all other terms with respect to such series
 (which terms shall not be inconsistent with the terms of this Indenture, as amended by any supplemental indenture) including any
 terms which may be required by or advisable under United States laws or regulations or advisable in connection with the marketing
 of Securities of that series;

(14) whether the Securities are issuable as a Global Security
 and, in such case, the identity of the Depositary for such series;

&nbsp;&nbsp;&nbsp;&nbsp;(15) whether the Securities will be convertible into shares
 of common stock or other securities of the Company and, if so, the terms and conditions upon which such Securities will be so convertible,
 including the conversion price and the conversion period;

(16) if other than the principal amount thereof, the portion
 of the principal amount of Securities of the series which shall be payable upon declaration of acceleration of the maturity thereof
 pursuant to Section 6.01; and

(17) any additional or different Events of Default or restrictive
 covenants provided for with respect to the Securities of the series.

All Securities of any one series shall be substantially identical except as to denomination and except as may otherwise be provided in or pursuant to any such Board Resolution or in any indentures supplemental hereto.

If any of the terms of the series are established by action taken pursuant to a Board Resolution of the Company, a copy of an appropriate record of such action shall be certified by the Secretary or an Assistant Secretary of the Company and delivered to the Trustee at or prior to the delivery of the Officers' Certificate of the Company setting forth the terms of the series.

Securities of any particular series may be issued at various times, with different dates on which the principal or any installment of principal is payable, with different rates of interest, if any, or different methods by which rates of interest may be determined, with different dates on which such interest may be payable and with different redemption dates.

SECTION 2.02 Form of Securities and Trustee's Certificate.

The Securities of any series and the Trustee's certificate of authentication to be borne by such Securities shall be substantially of the tenor and purport as set forth in one or more indentures supplemental hereto or as provided in a Board Resolution of the Company and as set forth in an Officers' Certificate of the Company and may have such letters, numbers or other marks of identification or designation and such legends or endorsements printed, lithographed or engraved thereon as the Company may deem appropriate and as are not inconsistent with the provisions of this Indenture, or as may be required to comply with any law or with any rule or regulation made pursuant thereto or with any rule or regulation of any stock exchange on which Securities of that series may be listed, or to conform to usage.

SECTION 2.03 Denominations: Provisions for Payment.

The Securities shall be issuable as registered Securities and in the denominations of one thousand U.S. dollars ($1,000) or any integral multiple thereof, subject to Section 2.01(a)(12). The Securities of a particular series shall bear interest payable on the dates and at the rate specified with respect to that series. The principal of and the interest on the Securities of any series, as well as any premium thereon in case of redemption thereof prior to maturity, shall be payable in the coin or currency of the United States of America that at the time is legal tender for public and private debt, at the office or agency of the Company maintained for that purpose in the Borough of Manhattan, the City and State of New York. Each Security shall be dated the date of its authentication. Interest on the Securities shall be computed on the basis of a 360-day year composed of twelve 30-day months.

The interest installment on any Security that is payable, and is punctually paid or duly provided for, on any Interest Payment Date for Securities of that series shall be paid to the Person in whose name said Security (or one or more Predecessor Securities) is registered at the close of business on the regular record date for such interest installment. In the event that any Security of a particular series or portion thereof is called for redemption and the redemption date is subsequent to a regular record date with respect to any Interest Payment Date and prior to such Interest Payment Date, interest on such Security will be paid upon presentation and surrender of such Security as provided in Section 3.03.

Any interest on any Security that is payable, but is not punctually paid or duly provided for, on any Interest Payment Date for Securities of the same series (herein called "Defaulted Interest") shall forthwith cease to be payable to the registered holder on the relevant regular record date by virtue of having been such holder; and such Defaulted Interest shall be paid by the Company, at its election, as provided in clause (1) or clause (2) below:

&nbsp;&nbsp;&nbsp;&nbsp;(1) The Company may make payment of any Defaulted Interest
 on Securities to the Persons in whose names such Securities (or their respective Predecessor Securities) are registered at the close
 of business on a special record date for the payment of such Defaulted Interest, which shall be fixed in the following manner: the
 Company shall notify the Trustee in writing of the amount of Defaulted Interest proposed to be paid on each such Security and the
 date of the proposed payment, and at the same time the Company shall deposit with the Trustee an amount of money equal to the aggregate
 amount proposed to be paid in respect of such Defaulted Interest or shall make arrangements satisfactory to the Trustee for such
 deposit prior to the date of the proposed payment, such money when deposited to be held in trust for the benefit of the Persons entitled
 to such Defaulted Interest as in this clause provided. Thereupon the Trustee shall fix a special record date for the payment of such
 Defaulted Interest which shall not be more than 15 nor less than 10 days prior to the date of the proposed payment and not less than
 10 days after the receipt by the Trustee of the notice of the proposed payment. The Trustee shall promptly notify the Company of
 such special record date and, in the name and at the expense of the Company, shall cause notice of the proposed payment of such Defaulted
 Interest and the special record date therefor to be mailed, first class postage prepaid, to each Securityholder at his or her address
 as it appears in the Security Register, not less than 10 days prior to such special record date. Notice of the proposed payment of
 such Defaulted Interest and the special record date therefor having been mailed as aforesaid, such Defaulted Interest shall be paid
 to the Persons in whose names such Securities (or their respective Predecessor Securities) are registered on such special record
 date.

&nbsp;&nbsp;&nbsp;&nbsp;(2) The Company may make payment of any Defaulted Interest
 on any Securities in any other lawful manner not inconsistent with the requirements of any securities exchange on which such Securities
 may be listed, and upon such notice as may be required by such exchange, if, after notice given by the Company to the Trustee of
 the proposed payment pursuant to this clause, such manner of payment shall be deemed practicable by the Trustee.

Unless otherwise set forth in a Board Resolution of the Company or one or more indentures supplemental hereto establishing the terms of any series of Securities pursuant to Section 2.01 hereof, the term "regular record date" as used in this Section with respect to a series of Securities with respect to any Interest Payment Date for such series shall mean either the fifteenth day of the month immediately preceding the month in which an Interest Payment Date established for such series pursuant to Section 2.01 hereof shall occur, if such Interest Payment Date is the first day of a month, or the last day of the month immediately preceding the month in which an Interest Payment Date established for such series pursuant to Section 2.01 hereof shall occur, if such Interest Payment Date is the fifteenth day of a month, whether or not such date is a Business Day.

Subject to the foregoing provisions of this Section, each Security of a series delivered under this Indenture upon transfer of or in exchange for or in lieu of any other Security of such series shall carry the rights to interest accrued and unpaid, and to accrue, that were carried by such other Security.

SECTION 2.04 Execution and Authentications.

The Securities shall be signed on behalf of the Company by its President, or one of its Vice Presidents, or its Treasurer, or one of its Assistant Treasurers, or its Secretary, or one of its Assistant Secretaries, under its corporate seal attested by its Secretary or one of its Assistant Secretaries. Signatures may be in the form of a manual or facsimile signature. The Company may use the facsimile signature of any Person who shall have been a President or Vice President thereof, or of any Person who shall have been a Treasurer or Assistant Treasurer thereof, or of any Person who shall have been a Secretary or Assistant Secretary thereof, notwithstanding the fact that at the time the Securities shall be authenticated and delivered or disposed of such Person shall have ceased to be the President or a Vice President, the Treasurer or an Assistant Treasurer or the Secretary or an Assistant Secretary, of the Company. The seal of the Company may be in the form of a facsimile of such seal and may be impressed, affixed, imprinted or otherwise reproduced on the Securities. The Securities may contain such notations, legends or endorsements required by law, stock exchange rule or usage. Each Security shall be dated the date of its authentication.

A Security shall not be valid or obligatory for any purpose and shall not be entitled to any benefit under this Indenture, in each case, until authenticated with a certificate of authentication manually signed by an authorized signatory of the Trustee, or by an Authenticating Agent. Such certificate shall be conclusive evidence, and the only evidence, that the Security so authenticated has been duly authenticated and delivered hereunder and that the Security is entitled to the benefits of this Indenture. At any time and from time to time after the execution and delivery of this Indenture, the Company may deliver Securities of any series executed by the Company to the Trustee for authentication, together with a written order of the Company for the authentication and delivery of such Securities, signed by its President or any Vice President and its Secretary or any Assistant Secretary, and the Trustee in accordance with such written order shall authenticate and deliver such Securities.

In authenticating such Securities and accepting the additional responsibilities under this Indenture in relation to such Securities, the Trustee shall be entitled to receive, and (subject to Section 7.01) shall be fully protected in relying upon, an Opinion of Counsel stating that the form and terms thereof have been established in conformity with the provisions of this Indenture.

The Trustee shall not be required to authenticate such Securities if the issue of such Securities pursuant to this Indenture will affect the Trustee's own rights, duties or immunities under the Securities and this Indenture or otherwise in a manner that is not reasonably acceptable to the Trustee.

SECTION 2.05 Registration of Transfer and Exchange.

&nbsp;&nbsp;&nbsp;&nbsp;(a) Securities of any series may be exchanged upon presentation
 thereof at the office or agency of the Company designated for such purpose in the Borough of Manhattan, the City and State of New
 York, for other Securities of such series of authorized denominations, and for a like aggregate principal amount, upon payment of
 a sum sufficient to cover any tax or other governmental charge in relation thereto, all as provided in this Section. In respect of
 any Securities so surrendered for exchange, the Company shall execute, the Trustee shall authenticate and such office or agency shall
 deliver in exchange therefor the Security or Securities of the same series that the Securityholder making the exchange shall be entitled
 to receive, bearing numbers not contemporaneously outstanding.

(b) The Company shall keep, or cause to be kept, at its
 office or agency designated for such purpose in the Borough of Manhattan, the City and State of New York, or such other location
 designated by the Company a register or registers (herein referred to as the "Security Register") in which, subject to
 such reasonable regulations as it may prescribe, the Company shall register the Securities and the transfers of Securities as in
 this Article provided and which at all reasonable times shall be open for inspection by the Trustee. The registrar for the purpose
 of registering Securities and transfer of Securities as herein provided shall be appointed as authorized by Board Resolution (the
 "Security Registrar").

Upon surrender for transfer of any Security at the office or agency of the Company designated for such purpose, the Company shall execute, the Trustee shall authenticate and such office or agency shall deliver in the name of the transferee or transferees a new Security or Securities of the same series as the Security presented for a like aggregate principal amount.

All Securities presented or surrendered for exchange or registration of transfer, as provided in this Section, shall be accompanied (if so required by the Company or the Security Registrar) by a written instrument or instruments of transfer, in form satisfactory to the Company or the Security Registrar, duly executed by the registered holder or by such holder's duly authorized attorney in writing.

&nbsp;&nbsp;&nbsp;&nbsp;(c) No service charge shall be made for any exchange or
 registration of transfer of Securities, or issue of new Securities in case of partial redemption of any series, but the Company may
 require payment of a sum sufficient to cover any tax or other governmental charge in relation thereto, other than exchanges pursuant
 to Section 2.06, Section 3.03(b) and Section 9.04 not involving any transfer.

(d) The Company shall not be required (i) to issue, exchange
 or register the transfer of any Securities during a period beginning at the opening of business 15 days before the day of the mailing
 of a notice of redemption of less than all the Outstanding Securities of the same series and ending at the close of business on the
 day of such mailing, nor (ii) to register the transfer of or exchange any Securities of any series or portions thereof called for
 redemption. The provisions of this Section 2.05 are, with respect to any Global Security, subject to Section 2.11 hereof.

SECTION 2.06 Temporary Securities.

Pending the preparation of definitive Securities of any series, the Company may execute, and the Trustee shall authenticate and deliver, temporary Securities (printed, lithographed or typewritten) of any authorized denomination. Such temporary Securities shall be substantially in the form of the definitive Securities in lieu of which they are issued, but with such omissions, insertions and variations as may be appropriate for temporary Securities, all as may be determined by the Company. Every temporary Security of any series shall be executed by the Company and be authenticated by the Trustee upon the same conditions and in substantially the same manner, and with like effect, as the definitive Securities of such series. Without unnecessary delay the Company will execute and will furnish definitive Securities of such series and thereupon any or all temporary Securities of such series may be surrendered in exchange therefor (without charge to the holders), at the office or agency of the Company designated for the purpose in the Borough of Manhattan, the City and State of New York, and the Trustee shall authenticate and such office or agency shall deliver in exchange for such temporary Securities an equal aggregate principal amount of definitive Securities of such series, unless the Company advises the Trustee to the effect that definitive Securities need not be executed and furnished until further notice from the Company. Until so exchanged, the temporary Securities of such series shall be entitled to the same benefits under this Indenture as definitive Securities of such series authenticated and delivered hereunder.

SECTION 2.07 Mutilated, Destroyed, Lost or Stolen Securities.

In case any temporary or definitive Security shall become mutilated or be destroyed, lost or stolen, the Company (subject to the next succeeding sentence) shall execute, and upon the Company's request the Trustee (subject as aforesaid) shall authenticate and deliver, a new Security of the same series, bearing a number not contemporaneously outstanding, in exchange and substitution for the mutilated Security, or in lieu of and in substitution for the Security so destroyed, lost or stolen. In every case the applicant for a substituted Security shall furnish to the Company and the Trustee such security or indemnity as may be required by them to save each of them harmless, and, in every case of destruction, loss or theft, the applicant shall also furnish to the Company and the Trustee evidence to their satisfaction of the destruction, loss or theft of the applicant's Security and of the ownership thereof. The Trustee may authenticate any such substituted Security and deliver the same upon the written request or authorization of any officer of the Company. Upon the issuance of any substituted Security, the Company may require the payment of a sum sufficient to cover any tax or other governmental charge that may be imposed in relation thereto and any other expenses (including the fees and expenses of the Trustee) connected therewith. In case any Security that has matured or is about to mature shall become mutilated or be destroyed, lost or stolen, the Company may, instead of issuing a substitute Security, pay or authorize the payment of the same (without surrender thereof except in the case of a mutilated Security) if the applicant for such payment shall furnish to the Company and the Trustee such security or indemnity as they may require to save them harmless, and, in case of destruction, loss or theft, evidence to the satisfaction of the Company and the Trustee of the destruction, loss or theft of such Security and of the ownership thereof.

Every replacement Security issued pursuant to the provisions of this Section shall constitute an additional contractual obligation of the Company whether or not the mutilated, destroyed, lost or stolen Security shall be found at any time, or be enforceable by anyone, and shall be entitled to all the benefits of this Indenture equally and proportionately with any and all other Securities of the same series duly issued hereunder. All Securities shall be held and owned upon the express condition that the foregoing provisions are exclusive with respect to the replacement or payment of mutilated, destroyed, lost or stolen Securities, and shall preclude (to the extent lawful) any and all other rights or remedies, notwithstanding any law or statute existing or hereafter enacted to the contrary with respect to the replacement or payment of negotiable instruments or other securities without their surrender.

SECTION 2.08 Cancellation.

All Securities surrendered for the purpose of payment, redemption, exchange or registration of transfer shall, if surrendered to the Company or any paying agent, be delivered to the Trustee for cancellation, or, if surrendered to the Trustee, shall be cancelled by it, and no Securities shall be issued in lieu thereof except as expressly required or permitted by any of the provisions of this Indenture. On request of the Company at the time of such surrender, the Trustee shall deliver to the Company canceled Securities held by the Trustee. In the absence of such request the Trustee may dispose of canceled Securities in accordance with its standard procedures and deliver a certificate of disposition to the Company. If the Company shall otherwise acquire any of the Securities, however, such acquisition shall not operate as a redemption or satisfaction of the indebtedness represented by such Securities unless and until the same are delivered to the Trustee for cancellation.

SECTION 2.09 Benefits of Indenture.

Nothing in this Indenture or in the Securities, express or implied, shall give or be construed to give to any Person, other than the parties hereto and the holders of the Securities any legal or equitable right, remedy or claim under or in respect of this Indenture, or under any covenant, condition or provision herein contained; all such covenants, conditions and provisions being for the sole benefit of the parties hereto and of the holders of the Securities.

SECTION 2.10 Authenticating Agent.

So long as any of the Securities of any series remain Outstanding there may be an Authenticating Agent for any or all such series of Securities which the Trustee shall have the right to appoint. Said Authenticating Agent shall be authorized to act on behalf of the Trustee to authenticate Securities of such series issued upon exchange, transfer or partial redemption thereof, and Securities so authenticated shall be entitled to the benefits of this Indenture and shall be valid and obligatory for all purposes as if authenticated by the Trustee hereunder. All references in this Indenture to the authentication of Securities by the Trustee shall be deemed to include authentication by an Authenticating Agent for such series. Each Authenticating Agent shall be acceptable to the Company and shall be a corporation that has a combined capital and surplus, as most recently reported or determined by it, sufficient under the laws of any jurisdiction under which it is organized or in which it is doing business to conduct a trust business, and that is otherwise authorized under such laws to conduct such business and is subject to supervision or examination by Federal or State authorities. If at any time any Authenticating Agent shall cease to be eligible in accordance with these provisions, it shall resign immediately.

Any Authenticating Agent may at any time resign by giving written notice of resignation to the Trustee and to the Company. The Trustee may at any time (and upon request by the Company shall) terminate the agency of any Authenticating Agent by giving written notice of termination to such Authenticating Agent and to the Company. Upon resignation, termination or cessation of eligibility of any Authenticating Agent, the Trustee may appoint an eligible successor Authenticating Agent acceptable to the Company. Any successor Authenticating Agent, upon acceptance of its appointment hereunder, shall become vested with all the rights, powers and duties of its predecessor hereunder as if originally named as an Authenticating Agent pursuant hereto.

SECTION 2.11 Global Securities

&nbsp;&nbsp;&nbsp;&nbsp;(a) If the Company shall establish pursuant to Section
 2.01 that some or all of the Securities of a particular series are to be issued as a Global Security, then the Company shall execute
 and the Trustee shall, in accordance with Section 2.04, authenticate and deliver, a Global Security that (i) shall represent, and
 shall be denominated in an amount equal to the aggregate principal amount of, the Outstanding Securities of such series which are
 to be issued as a Global Security, (ii) shall be registered in the name of the Depositary or its nominee, (iii) shall be delivered
 by the Trustee to the Depositary or pursuant to the Depositary's instruction and (iv) shall bear a legend substantially to
 the following effect: "Except as otherwise provided in Section 2.11 of the Indenture, this Security may be transferred, in
 whole but not in part, only to another nominee of the Depositary or to a successor Depositary or to a nominee of such successor Depositary."

&nbsp;&nbsp;&nbsp;&nbsp;(b) Notwithstanding the provisions of Section 2.05, the
 Global Security of a series may be transferred, in whole but not in part and in the manner provided in Section 2.05, only to another
 nominee of the Depositary for such series, or to a successor Depositary for such series selected or approved by the Company or to
 a nominee of such successor Depositary.

(c) If at any time the Depositary for a series of the Securities
 notifies the Company that it is unwilling or unable to continue as Depositary for such series or if at any time the Depositary for
 such series shall no longer be registered or in good standing under the Exchange Act, or other applicable statute or regulation,
 and a successor Depositary for such series is not appointed by the Company within 90 days after the Company receives such notice
 or becomes aware of such condition, as the case may be, this Section 2.11 shall no longer be applicable to the Securities of such
 series and the Company will execute, and subject to Section 2.05, the Trustee will authenticate and deliver the Securities of such
 series in definitive registered form without coupons, in authorized denominations, and in an aggregate principal amount equal to
 the principal amount of the Global Security of such series in exchange for such Global Security. In addition, the Company may at
 any time determine that the Securities of any series shall no longer be represented by a Global Security and that the provisions
 of this Section 2.11 shall no longer apply to the Securities of such series. In such event the Company will execute and subject to
 Section 2.05, the Trustee, upon receipt of an Officers' Certificate evidencing such determination by the Company, will authenticate
 and deliver the Securities of such series in definitive registered form without coupons, in authorized denominations, and in an aggregate
 principal amount equal to the principal amount of the Global Security of such series in exchange for such Global Security. Upon the
 exchange of the Global Security for such Securities in definitive registered form without coupons, in authorized denominations, the
 Global Security shall be canceled by the Trustee. Such Securities in definitive registered form issued in exchange for the Global
 Security pursuant to this Section 2.11(c) shall be registered in such names and in such authorized denominations as the Depositary,
 pursuant to instructions from its direct or indirect participants or otherwise, shall instruct the Trustee. The Trustee shall deliver
 such Securities to the Depositary for delivery to the Persons in whose names such Securities are so registered.

ARTICLE III

REDEMPTION OF SECURITIES AND

SINKING FUND PROVISIONS

SECTION 3.01 Redemption.

The Company may redeem the Securities of any series issued hereunder on and after the dates and in accordance with the terms established for such series pursuant to Section 2.01 hereof.

SECTION 3.02 Notice of Redemption.

&nbsp;&nbsp;&nbsp;&nbsp;(a) In case the Company shall desire to exercise such right
 to redeem all or, as the case may be, a portion of the Securities of any series in accordance with the right reserved so to do, the
 Company shall, or shall cause the Trustee to, give notice of such redemption to holders of the Securities of such series to be redeemed
 by mailing, first class postage prepaid, a notice of such redemption not less than 30 days and not more than 90 days before the date
 fixed for redemption of that series to such holders at their last addresses as they shall appear upon the Security Register unless
 a shorter period is specified in the Securities to be redeemed. Any notice that is mailed in the manner herein provided shall be
 conclusively presumed to have been duly given, whether or not the registered holder receives the notice. In any case, failure duly
 to give such notice to the holder of any Security of any series designated for redemption in whole or in part, or any defect in the
 notice, shall not affect the validity of the proceedings for the redemption of any other Securities of such series or any other series.
 In the case of any redemption of Securities prior to the expiration of any restriction on such redemption provided in the terms of
 such Securities or elsewhere in this Indenture, the Company shall furnish the Trustee with an Officers' Certificate evidencing
 compliance with any such restriction.

Each such notice of redemption shall specify the date fixed for redemption and the redemption price at which Securities of that series are to be redeemed, and shall state that payment of the redemption price of such Securities to be redeemed will be made at the office or agency of the Company in the Borough of Manhattan, the City and State of New York, upon presentation and surrender of such Securities, that interest accrued to the date fixed for redemption will be paid as specified in said notice, that from and after said date interest will cease to accrue and that the redemption is for a sinking fund, if such is the case. If less than all the Securities of a series are to be redeemed, the notice to the holders of Securities of that series to be redeemed in whole or in part shall specify the particular Securities to be so redeemed. In case any Security is to be redeemed in part only, the notice that relates to such Security shall state the portion of the principal amount thereof to be redeemed, and shall state that on and after the redemption date, upon surrender of such Security, a new Security or Securities of such series in principal amount equal to the unredeemed portion thereof will be issued.

&nbsp;&nbsp;&nbsp;&nbsp;(b) If less than all the Securities of a series are to
 be redeemed, the Company shall give the Trustee at least 30 days' notice in advance of the date fixed for redemption as to
 the aggregate principal amount of Securities of the series to be redeemed, and thereupon the Trustee shall select, by lot or in such
 other manner as it shall deem appropriate and fair in its discretion and that may provide for the selection of a portion or portions
 (equal to one thousand U.S. dollars ($1,000) or any integral multiple thereof) of the principal amount of such Securities of a denomination
 larger than $1,000, the Securities to be redeemed and shall thereafter promptly notify the Company in writing of the numbers of the
 Securities to be redeemed, in whole or in part. The Company may, if and whenever it shall so elect, by delivery of instructions signed
 on its behalf by its President or any Vice President, instruct the Trustee or any paying agent to call all or any part of the Securities
 of a particular series for redemption and to give notice of redemption in the manner set forth in this Section, such notice to be
 in the name of the Company or its own name as the Trustee or such paying agent may deem advisable. In any case in which notice of
 redemption is to be given by the Trustee or any such paying agent, the Company shall deliver or cause to be delivered to, or permit
 to remain with, the Trustee or such paying agent, as the case may be, such Security Register, transfer books or other records, or
 suitable copies or extracts therefrom, sufficient to enable the Trustee or such paying agent to give any notice by mail that may
 be required under the provisions of this Section.

SECTION 3.03 Payment Upon Redemption.

&nbsp;&nbsp;&nbsp;&nbsp;(a) If the giving of notice of redemption shall have been
 completed as above provided, the Securities or portions of Securities of the series to be redeemed specified in such notice shall
 become due and payable on the date and at the place stated in such notice at the applicable redemption price, together with interest
 accrued to the date fixed for redemption and interest on such Securities or portions of Securities shall cease to accrue on and after
 the date fixed for redemption, unless the Company shall default in the payment of such redemption price and accrued interest with
 respect to any such Security or portion thereof. On presentation and surrender of such Securities on or after the date fixed for
 redemption at the place of payment specified in the notice, said Securities shall be paid and redeemed at the applicable redemption
 price for such series, together with interest accrued thereon to the date fixed for redemption (but if the date fixed for redemption
 is an interest payment date, the interest installment payable on such date shall be payable to the registered holder at the close
 of business on the applicable record date pursuant to Section 2.03).

(b) Upon presentation of any Security of such series that
 is to be redeemed in part only, the Company shall execute and the Trustee shall authenticate and the office or agency where the Security
 is presented shall deliver to the holder thereof, at the expense of the Company, a new Security of the same series of authorized
 denominations in principal amount equal to the unredeemed portion of the Security so presented.

SECTION 3.04 Sinking Fund.

The provisions of Sections 3.04, 3.05 and 3.06 shall be applicable to any sinking fund for the retirement of Securities of a series, except as otherwise specified as contemplated by Section 2.01 for Securities of such series.

The minimum amount of any sinking fund payment provided for by the terms of Securities of any series is herein referred to as a "mandatory sinking fund payment," and any payment in excess of such minimum amount provided for by the terms of Securities of any series is herein referred to as an "optional sinking fund payment." If provided for by the terms of Securities of any series, the cash amount of any sinking fund payment may be subject to reduction as provided in Section 3.05. Each sinking fund payment shall be applied to the redemption of Securities of any series as provided for by the terms of Securities of such series.

SECTION 3.05 Satisfaction of Sinking Fund Payments with Securities.

The Company (i) may deliver Outstanding Securities of a series (other than any Securities previously called for redemption) and (ii) may apply as a credit Securities of a series that have been redeemed either at the election of the Company pursuant to the terms of such Securities or through the application of permitted optional sinking fund payments pursuant to the terms of such Securities, in each case in satisfaction of all or any part of any sinking fund payment with respect to the Securities of such series required to be made pursuant to the terms of such Securities as provided for by the terms of such series, provided that such Securities have not been previously so credited. Such Securities shall be received and credited for such purpose by the Trustee at the redemption price specified in such Securities for redemption through operation of the sinking fund and the amount of such sinking fund payment shall be reduced accordingly.

SECTION 3.06 Redemption of Securities for Sinking Fund.

Not less than 45 days prior to each sinking fund payment date for any series of Securities, the Company will deliver to the Trustee an Officers' Certificate specifying the amount of the next ensuing sinking fund payment for that series pursuant to the terms of the series, the portion thereof, if any, that is to be satisfied by delivering and crediting Securities of that series pursuant to Section 3.05 and the basis for such credit and will, together with such Officers' Certificate, deliver to the Trustee any Securities to be so delivered. Not less than 30 days before each such sinking fund payment date the Trustee shall select the Securities to be redeemed upon such sinking fund payment date in the manner specified in Section 3.02 and cause notice of the redemption thereof to be given in the name of and at the expense of the Company in the manner provided in Section 3.02. Such notice having been duly given, the redemption of such Securities shall be made upon the terms and in the manner stated in Section 3.03.

ARTICLE IV

COVENANTS

SECTION 4.01 Payment of Principal, Premium and Interest.

The Company will duly and punctually pay or cause to be paid the principal of (and premium, if any) and interest on the Securities of that series at the time and place and in the manner provided herein and established with respect to such Securities.

SECTION 4.02 Maintenance of Office or Agency.

So long as any series of the Securities remain Outstanding, the Company agrees to maintain an office or agency in the Borough of Manhattan, the City and State of New York, with respect to each such series and at such other location or locations as may be designated as provided in this Section 4.02, where (i) Securities of that series may be presented or surrendered for payment, (ii) Securities of that series may be presented as herein above authorized for registration of transfer and exchange, and (iii) notices and demands to or upon the Company in respect of the Securities of that series and this Indenture may be given or served, such designation to continue with respect to such office or agency until the Company shall, by written notice signed by its President or a Vice President and delivered to the trustee, designate some other office or agency for such purposes or any of them. If at any time the Company shall fail to maintain any such required office or agency or shall fail to furnish the Trustee with the address thereof, such presentations, notices and demands may be made or served at the Corporate Trust Office of the Trustee, and the Company hereby appoints the Trustee as its agent to receive all such presentations, notices and demands.

SECTION 4.03 Paying Agents.

&nbsp;&nbsp;&nbsp;&nbsp;(a) If the Company shall appoint one or more paying agents
 for all or any series of the Securities, other than the Trustee, the Company will cause each such paying agent to execute and deliver
 to the Trustee an instrument in which such agent shall agree with the Trustee, subject to the provisions of this Section:

(1) that it will hold all sums held by it as such agent
 for the payment of the principal of (and premium, if any) or interest on the Securities of that series (whether such sums have been
 paid to it by the Company or by any other obligor of such Securities) in trust for the benefit of the Persons entitled thereto;

(2) that it will give the Trustee notice of any failure
 by the Company (or by any other obligor of such Securities) to make any payment of the principal of (and premium, if any) or interest
 on the Securities of that series when the same shall be due and payable;

(3) that it will, at any time during the continuance of
 any failure referred to in the preceding paragraph (a)(2) above, upon the written request of the Trustee, forthwith pay to the Trustee
 all sums so held in trust by such paying agent; and

(4) that it will perform all other duties of paying agent
 as set forth in this Indenture.

(b) If the Company shall act as its own paying agent with
 respect to any series of the Securities, it will on or before each due date of the principal of (and premium, if any) or interest
 on Securities of that series, set aside, segregate and hold in trust for the benefit of the Persons entitled thereto a sum sufficient
 with monies held by all other paying agents to pay such principal (and premium, if any) or interest so becoming due on Securities
 of that series until such sums shall be paid to such Persons or otherwise disposed of as herein provided and will promptly notify
 the Trustee of such action, or any failure (by it or any other obligor on such Securities) to take such action. Whenever the Company
 shall have one or more paying agents for any series of Securities, it will, prior to each due date of the principal of (and premium,
 if any) or interest on any Securities of that series, deposit with the paying agent a sum sufficient to pay the principal (an premium,
 if any) or interest so becoming due, such sum to be held in trust for the benefit of the Persons entitled to such principal, premium
 or interest, and (unless such paying agent is the Trustee) the Company will promptly notify the Trustee of this action or failure
 so to act.

&nbsp;&nbsp;&nbsp;&nbsp;(c) Notwithstanding anything in this Section to the contrary,
 (i) the agreement to hold sums in trust as provided in this Section is subject to the provisions of Section 11.05, and (ii) the Company
 may at any time, for the purpose of obtaining the satisfaction and discharge of this Indenture or for any other purpose, pay, or
 direct any paying agent to pay, to the Trustee all sums held in trust by the Company or such paying agent, such sums to be held by
 the Trustee upon the same terms and conditions as those upon which such sums were held by the Company or such paying agent; and,
 upon such payment by any paying agent to the Trustee, such paying agent shall be released from all further liability with respect
 to such money.

SECTION 4.04 Appointment to Fill Vacancy in Office of Trustee.

The Company, whenever necessary to avoid or fill a vacancy in the office of Trustee, will appoint, in the manner provided in Section 7.10, a Trustee, so that there shall at all times be a Trustee hereunder.

SECTION 4.05 Compliance with Consolidation Provisions.

The Company will not, while any of the Securities remain Outstanding, consolidate with or merge into any other Person, in either case where the Company is not the survivor of such transaction, or sell or convey all or substantially all of its property to any other company unless the provisions of Article X hereof are complied with.

ARTICLE V

SECURITYHOLDERS' LISTS AND REPORTS BY THE COMPANY AND THE TRUSTEE

SECTION 5.01 Company to Furnish Trustee Names and Addresses of Securityholders.

If the Company is not the Security Register, the Company will furnish or use reasonable efforts to cause to be furnished to the Trustee (a) on each regular record date (as defined in Section 2.03) a list, in such form as the Trustee may reasonably require, of the names and addresses of the holders of each series of Securities as of such regular record date, provided that the Company shall not be obligated to furnish or cause to furnish such list at any time that the list shall not differ in any respect from the most recent list furnished to the Trustee by the Company and (b) at such other times as the Trustee may request in writing within 30 days after the receipt by the Company of any such request, a list of similar form and content as of a date not more than 15 days prior to the time such list is furnished; provided, however, that, in either case, no such list need be furnished for any series for which the Trustee shall be the Security Registrar.

SECTION 5.02 Preservation of Information; Communications with Securityholders.

&nbsp;&nbsp;&nbsp;&nbsp;(a) The Trustee shall preserve, in as current a form as
 is reasonably practicable, all information as to the names and addresses of the holders of Securities contained in the most recent
 list furnished to it as provided in Section 5.01 and as to the names and addresses of holders of Securities received by the Trustee
 in its capacity as Security Registrar (if acting in such capacity) and shall otherwise comply with Section 312(a) of the Trust Indenture
 Act.

(b) The Trustee may destroy any list furnished to it as
 provided in Section 5.01 upon receipt of a new list so furnished.

(c) Securityholders may communicate as provided in Section
 312(b) of the Trust Indenture Act with other Securityholders with respect to their rights under this Indenture or under the Securities.

SECTION 5.03 Reports by the Company.

&nbsp;&nbsp;&nbsp;&nbsp;(a) The Company covenants and agrees to file with the Trustee,
 within 15 days after the Company is required to file the same with the Commission, copies of the annual reports and of the information,
 documents and other reports (or copies of such portions of any of the foregoing as the Commission may from time to time by rules
 and regulations prescribe) that the Company may be required to file with the Commission pursuant to Section 13 or Section 15(d) of
 the Exchange Act; or, if the Company is not required to file information, documents or reports pursuant to either of such sections,
 then to file with the Trustee and the Commission, in accordance with the rules and regulations prescribed from time to time by the
 Commission, such of the supplementary and periodic information, documents and reports that may be required pursuant to Section 13
 of the Exchange Act, in respect of a security listed and registered on a national securities exchange as may be prescribed from time
 to time in such rules and regulations; provided, however, the Company shall not be required to deliver to the Trustee any materials
 for which the Company has sought and received confidential treatment by the Commission. The Company also shall comply with the other
 provisions of Section 314(a) of the Trust Indenture Act.

(b) The Company covenants and agrees to file with the Trustee
 and the Commission, in accordance with the rules and regulations prescribed from to time by the Commission, such additional information,
 documents and reports with respect to compliance by the Company with the conditions and covenants provided for in this Indenture
 as may be required from time to time by such rules and regulations.

(c) The Company covenants and agrees to transmit by mail,
 first class postage prepaid, or reputable over-night delivery service that provides for evidence of receipt, to the Securityholders,
 as their names and addresses appear upon the Security Register, within 30 days after the filing thereof with the Trustee, such summaries
 of any information, documents and reports required to be filed by the Company pursuant to subsections (a) and (b) of this Section
 as may be required by rules and regulations prescribed from time to time by the Commission.

SECTION 5.04 Reports by the Trustee.

&nbsp;&nbsp;&nbsp;&nbsp;(a) The Trustee shall transmit to holders as provided in
 Section 313 of the Trust Indenture Act such reports concerning the Trustee and its actions under this Indenture as may be required
 by Section 313 of the Trust Indenture Act at the times and in the manner provided by the Trust Indenture Act.

(b) A copy of each such report shall, at the time of such
 transmission to Securityholders, be filed by the Trustee with the Company, with each stock exchange upon which any Securities are
 listed (if so listed) and, if required by Section 313 of the Trust Indenture Act, also with the Commission. The Company agrees to
 notify the Trustee when any Securities become listed on any stock exchange.

ARTICLE VI

REMEDIES OF THE TRUSTEE AND SECURITYHOLDERS ON EVENT OF DEFAULT

SECTION 6.01 Events of Default.

&nbsp;&nbsp;&nbsp;&nbsp;(a) Whenever used herein with respect to Securities of
 a particular series, "Event of Default" means any one or more of the following events that has occurred and is continuing:

(1) the Company defaults in
 the payment of any installment of interest upon any of the Securities of that series, as and when the same shall become due and payable,
 and continuance of such default for a period of 90 days; provided, however, that a valid extension of an interest payment period
 by the Company in accordance with the terms of any indenture supplemental hereto shall not constitute a default in the payment of
 interest for this purpose;

(2) the Company defaults in the payment of the principal
 of (or premium, if any, on) any of the Securities of that series as and when the same shall become due and payable whether at maturity,
 upon redemption, by declaration or otherwise, or in any payment required by any sinking or analogous fund established with respect
 to that series; provided, however, that a valid extension of the maturity of such Securities in accordance with the terms of any
 indenture supplemental hereto shall not constitute a default in the payment of principal or premium, if any;

(3) the Company fails to observe or perform any other of
 its covenants or agreements with respect to that series contained in this Indenture or otherwise established with respect to that
 series of Securities pursuant to Section 2.01 hereof (other than a covenant or agreement that has been expressly included in this
 Indenture solely for the benefit of one or more series of Securities other than such series) for a period of 90 days after the date
 on which written notice of such failure, requiring the same to be remedied and stating that such notice is a "Notice of Default"
 hereunder, shall have been given to the Company by the Trustee, by registered or certified mail, or to the Company and the Trustee
 by the holders of not less than a majority in principal amount of the Securities of that series at the time Outstanding;

&nbsp;&nbsp;&nbsp;&nbsp;(4) the Company pursuant to or within the meaning of any
 Bankruptcy Law (i) commences a voluntary case, (ii) consents to the entry of an order for relief against it in an involuntary case,
 (iii) consents to the appointment of a Custodian of it or for all or substantially all of its property or (iv) makes a general assignment
 for the benefit of its creditors; or

(5) a court of competent jurisdiction enters an order under
 any Bankruptcy Law that (i) is for relief against the Company in an involuntary case, (ii) appoints a Custodian of the Company for
 all or substantially all of its property, or (iii) orders the liquidation of the Company, and the order or decree remains unstayed
 and in effect for 90 consecutive days.

(b) In each and every such case, unless the principal of
 all the Securities of that series shall have already become due and payable, either the Trustee or the holders of not less than a
 majority in aggregate principal amount of the Securities of that series then Outstanding hereunder, by notice in writing to the Company
 (and to the Trustee if given by such Securityholders), may declare the principal (or, if any Securities of that series are discount
 securities, that portion of the principal amount as may be specified in the terms of that series pursuant to Section 2.01(a)(16))
 of (and premium, if any, on) and accrued and unpaid interest, if any, on all the Securities of that series to be due and payable
 immediately, and upon any such declaration the same shall become and shall be immediately due and payable.

(c) At any time after the principal of the Securities of
 that series shall have been so declared due and payable, and before a judgment or decree for the payment of the moneys due shall
 have been obtained or entered as hereinafter provided, the holders of a majority in aggregate principal amount of the Securities
 of that series then Outstanding hereunder (or, by action at a meeting of holders of the Securities of such series in accordance with
 Section 8.09, the holders of a majority in aggregate principal amount of the Securities of such series then Outstanding represented
 at such meeting), by written notice to the Company and the Trustee, may rescind and annul such declaration and its consequences if:
 (i) the Company has paid or deposited with the Trustee a sum sufficient to pay all matured installments of interest upon all the
 Securities of that series and the principal of (and premium, if any, on) any and all Securities of that series that shall have become
 due otherwise than by acceleration and (ii) any and all Events of Default under this Indenture with respect to such series, other
 than the nonpayment of principal of (and premium, if any, on) and accrued and unpaid interest, if any, on Securities of that series
 that shall have become due solely because of such acceleration, shall have been remedied, cured or waived as provided in Section
 6.06. No such rescission and annulment shall extend to or shall affect any subsequent default or impair any right consequent thereon.

&nbsp;&nbsp;&nbsp;&nbsp;(d) In case the Trustee shall have proceeded to enforce
 any right with respect to Securities of that series under this Indenture and such proceedings shall have been discontinued or abandoned
 because of such rescission or annulment or for any other reason or shall have been determined adversely to the Trustee, then and
 in every such case, subject to any determination in such proceedings, the Company, and the Trustee shall be restored respectively
 to their former positions and rights hereunder, and all rights, remedies and powers of the Company and the Trustee shall continue
 as though no such proceedings had been taken.

SECTION 6.02 Collection of Indebtedness and Suits for Enforcement by Trustee.

&nbsp;&nbsp;&nbsp;&nbsp;(a) The Company covenants that (1) in case it shall default
 in the payment of any installment of interest on any of the Securities of a series, or any payment required by any sinking or analogous
 fund established with respect to that series as and when the same shall have become due and payable, and such default shall have
 continued for a period of 90 Business Days, or (2) in case it shall default in the payment of the principal of (or premium, if any,
 on) any of the Securities of a series when the same shall have become due and payable, whether upon maturity of the Securities of
 a series or upon redemption or upon declaration or otherwise, then, upon demand of the Trustee, the Company will pay to the Trustee,
 for the benefit of the holders of the Securities of that series, the whole amount that then shall have been become due and payable
 on all such Securities for principal (and premium, if any) or interest, or both, as the case may be, with interest upon the overdue
 principal (and premium, if any) and (to the extent that payment of such interest is enforceable under applicable law) upon overdue
 installments of interest at the rate per annum expressed in the Securities of that series; and, in addition thereto, such further
 amount as shall be sufficient to cover the costs and expenses of collection, and the amount payable to the Trustee under Section
 7.06.

(b) If the Company shall fail to pay such amounts forthwith
 upon such demand, the Trustee, in its own name and as trustee of an express trust, shall be entitled and empowered to institute any
 action or proceedings at law or in equity for the collection of the sums so due and unpaid, and may prosecute any such action or
 proceeding to judgment or final decree, and may enforce any such judgment or final decree against the Company or other obligor upon
 the Securities of that series and collect the moneys adjudged or decreed to be payable in the manner provided by law out of the property
 of the Company or other obligor upon the Securities of that series, wherever situated.

(c) In case of any receivership, insolvency, liquidation,
 bankruptcy, reorganization, readjustment, arrangement, composition or judicial proceedings affected the Company, or its creditors
 or property, the Trustee shall have power to intervene in such proceedings and take any action therein that may be permitted by the
 court and shall (except as may be otherwise provided by law) be entitled to file such proofs of claim and other papers and documents
 as may be necessary or advisable in order to have the claims of the Trustee and of the holders of Securities of such series allowed
 for the entire amount due and payable by the Company under this Indenture at the date of institution of such proceedings and for
 any additional amount that may become due and payable by the Company after such date, and to collect and receive any moneys or other
 property payable or deliverable on any such claim, and to distribute the same after the deduction of the amount payable to the Trustee
 under Section 7.06; and any receiver, assignee or trustee in bankruptcy or reorganization is hereby authorized by each of the holders
 of Securities of such series to make such payments to the Trustee, and, in the event that the Trustee shall consent to the making
 of such payments directly to such Securityholders, to pay to the Trustee any amount due it under Section 7.06.

&nbsp;&nbsp;&nbsp;&nbsp;(d) All rights of action and of asserting claims under
 this Indenture, or under any of the terms established with respect to Securities of that series, may be enforced by the Trustee without
 the possession of any of such Securities, or the production thereof at any trial or other proceeding relative thereto, and any such
 suit or proceeding instituted by the Trustee shall be brought in its own name as trustee of an express trust, and any recovery of
 judgment shall, after provision for payment to the Trustee of any amounts due under Section 7.06, be for the ratable benefit of the
 holders of the Securities of such series.

In case of an Event of Default hereunder, the Trustee may in its discretion proceed to protect and enforce the rights vested in it by this Indenture by such appropriate judicial proceedings as the Trustee shall deem most effectual to protect and enforce any of such rights, either at law or in equity or in bankruptcy or otherwise, whether for the specific enforcement of any covenant or agreement contained in this Indenture or in aid of the exercise of any power granted in this Indenture, or to enforce any other legal or equitable right vested in the Trustee by this Indenture or by law.

Nothing contained herein shall be deemed to authorize the Trustee to authorize or consent to or accept or adopt on behalf of any Securityholder any plan of reorganization, arrangement, adjustment or composition affecting the Securities of that series or the rights of any holder thereof or to authorize the Trustee to vote in respect of the claim of any Securityholder in any such proceeding.

SECTION 6.03 Application of Moneys Collected.

Any moneys collected by the Trustee pursuant to this Article with respect to a particular series of Securities shall be applied in the following order, at the date or dates fixed by the Trustee and, in case of the distribution of such moneys on account of principal (or premium, if any) or interest, upon presentation of the Securities of that series, and notation thereon the payment, if only partially paid, and upon surrender thereof if fully paid:

---

| | |
|:---|:---|
| FIRST: | To the payment of costs and expenses of collection and of all amounts payable to the Trustee under Section 7.06; and |

---

---

| | |
|:---|:---|
| SECOND: | To the payment of the amounts then due and unpaid upon Securities of such series for principal (and premium, if any) and interest, in respect of which or for the benefit of which such money has been collected, ratably, without preference or priority of any kind, according to the amounts due and payable on such Securities for principal (and premium, if any) and interest, respectively. |

---

SECTION 6.04 Limitation on Suits.

No holder of any Security of any series shall have any right by virtue or by availing of any provision of this Indenture to institute any suit, action or proceeding in equity or at law upon or under or with respect to this Indenture or for the appointment of a receiver or trustee, or for any other remedy hereunder, unless (i) such holder previously shall have given to the Trustee written notice of an Event of Default and of the continuance thereof with respect to the Securities of such series specifying such Event of Default, as hereinbefore provided; (ii) the holders of not less than a majority in aggregate principal amount of the Securities of such series then Outstanding shall have made written request upon the Trustee to institute such action, suit or proceeding in its own name as trustee hereunder; (iii) such holder or holders shall have offered to the Trustee such reasonable indemnity as it may require against the costs, expenses and liabilities to be incurred therein or thereby; and (iv) the Trustee for 60 days after its receipt of such notice, request and offer of indemnity, shall have failed to institute any such action, suit or proceeding and (v) during such 60 day period, the holders of a majority in principal amount of the Securities of that series (or such amount as shall have acted at a meeting of the holders of Securities of such series pursuant to the provisions of this Indenture) do not give the Trustee a direction inconsistent with the request; provided, however, that no one or more of such holders may use this Indenture to prejudice the rights of another holder or to obtain preference or priority over another holder.

Notwithstanding anything contained herein to the contrary, any other provisions of this Indenture, the right of any holder of any Security to receive payment of the principal of (and premium, if any) and interest on such Security, as therein provided, on or after the respective due dates expressed in such Security (or in the case of redemption, on the redemption date), or to institute suit for the enforcement of any such payment on or after such respective dates or redemption date, shall not be impaired or affected without the consent of such holder and by accepting a Security hereunder it is expressly understood, intended and covenanted by the taker and holder of every Security of such series with every other such taker and holder and the Trustee, that no one or more holders of Securities of such series shall have any right in any manner whatsoever by virtue or by availing of any provision of this Indenture to affect, disturb or prejudice the rights of the holders of any other of such Securities, or to obtain or seek to obtain priority over or preference to any other such holder, or to enforce any right under this Indenture, except in the manner herein provided and for the equal, ratable and common benefit of all holders of Securities of such series. For the protection and enforcement of the provisions of this Section, each and every Securityholder and the Trustee shall be entitled to such relief as can be given either at law or in equity.

SECTION 6.05 Rights and Remedies Cumulative; Delay or Omission Not Waiver.

&nbsp;&nbsp;&nbsp;&nbsp;(a) Except as otherwise provided in Section 2.07, all powers
 and remedies given by this Article to the Trustee or to the Securityholders shall, to the extent permitted by law, be deemed cumulative
 and not exclusive of any other powers and remedies available to the Trustee or the holders of the Securities, by judicial proceedings
 or otherwise, to enforce the performance or observance of the covenants and agreements contained in this Indenture or otherwise established
 with respect to such Securities.

(b) No delay or omission of the Trustee or of any holder
 of any of the Securities to exercise any right or power accruing upon any Event of Default occurring and continuing as aforesaid
 shall impair any such right or power, or shall be construed to be a waiver of any such default or on acquiescence therein; and, subject
 to the provisions of Section 6.04, every power and remedy given by this Article or by law to the Trustee or the Securityholders may
 be exercised from time to time, and as often as shall be deemed expedient, by the Trustee or by the Securityholders.

SECTION 6.06 Control by Securityholders.

The holders of a majority in aggregate principal amount of the Securities of any series at the time Outstanding, determined in accordance with Section 8.01, shall have the right to direct the time, method and place of conducting any proceeding for any remedy available to the Trustee, or exercising any trust or power conferred on the Trustee with respect to such series; provided, however, that such direction shall not be in conflict with any rule of law or with this Indenture or be unduly prejudicial to the rights of holders of Securities of any other series at the time Outstanding determined in accordance with Section 8.01. Subject to the provisions of Section 7.01, the Trustee shall have the right to decline to follow any such direction if the Trustee in good faith shall, by a Responsible Officer or Officers of the Trustee, determine that the proceeding so directed would involve the Trustee in personal liability. The holders either (a) through the written consent of not less than a majority in aggregate principal amount of the Securities of any series at the time Outstanding or (b) by action at a meeting of holders of the Securities of such series in accordance with Section 8.09, by the holders of a majority in aggregate principal amount of the Securities of such series then Outstanding represented at such meeting, may on behalf of the holders of all of the Securities of such series waive any past default in the performance of any of the covenants contained herein or established pursuant to Section 2.01 with respect to such series and its consequences, except a default in the payment of the principal of, or premium, if any, or interest on, any of the Securities of that series as and when the same shall become due by the terms of such Securities otherwise than by acceleration (unless such default has been cured and a sum sufficient to pay all matured installments of interest and principal and any premium has been deposited with the Trustee (in accordance with Section 6.01(c)) and except in respect a provision hereof which, under Section 9.02, cannot be modified or amended without the consent of the holders of each Outstanding Security affected; provided however that this Section shall not limit the right of holders of Securities of a series to rescind and annul any acceleration as set forth in Section 6.01. Upon any such waiver, the default covered thereby shall be deemed to be cured for all purposes of this Indenture and the Company, the Trustee and the holders of the Securities of such series shall be restored to their former positions and rights hereunder, respectively; but no such waiver shall extend to any subsequent or other default or impair any right consequent thereon. The provisions which otherwise would be automatically deemed to be contained in this Indenture pursuant to Section (316)(a)(1) of the Trust Indenture Act are hereby expressly excluded from this Indenture, except to the extent such provisions are expressly included herein.

SECTION 6.07 Undertaking to Pay Costs.

All parties to this Indenture agree, and each holder of any Securities by such holder's acceptance thereof shall be deemed to have agreed, that any court may in its discretion require, in any suit for the enforcement of any right or remedy under this Indenture, or in any suit against the Trustee for any action taken or omitted by it as Trustee, the filing by any party litigant in such suit of an undertaking to pay the costs of such suit, and that such court may in its discretion assess reasonable costs, including reasonable attorneys' fees, against any party litigant in such suit, having due regard to the merits and good faith of the claims or defenses made by such party litigant; but the provisions of this Section shall not apply to any suit instituted by the Trustee, to any suit instituted by any Securityholder, or group of Securityholders, holding more than 10% in aggregate principal amount of the Outstanding Securities of any series, or to any suit instituted by any Securityholder for the enforcement of the payment of the principal of (or premium, if any) or interest on any Security of such series, on or after the respective due dates expressed in such Security or established pursuant to this Indenture.

ARTICLE VII

CONCERNING THE TRUSTEE

SECTION 7.01 Certain Duties and Responsibilities of Trustee.

&nbsp;&nbsp;&nbsp;&nbsp;(a) The Trustee, prior to the occurrence of an Event of
 Default with respect to the Securities of a series and after the curing of all Events of Default with respect to the Securities of
 that series that may have occurred, shall undertake to perform with respect to the Securities of such series such duties and only
 such duties as are specifically set forth in this Indenture, and no implied covenants shall be read into this Indenture against the
 Trustee. In case an Event of Default with respect to the Securities of a series has occurred (that has not been cured or waived),
 the Trustee shall exercise with respect to Securities of that series such of the rights and powers vested in it by this Indenture,
 and use the same degree of care and skill in their exercise, as a prudent man would exercise or use under the circumstances in the
 conduct of his own affairs.

(b) No provision of this Indenture shall be construed to
 relieve the Trustee from liability for its own negligent action, its own negligent failure to act, or its own willful misconduct,
 except that:

(1) prior to the occurrence of an Event of Default with
 respect to the Securities of a series and after the curing or waiving of all such Events of Default with respect to that series that
 may have occurred:

&nbsp;&nbsp;&nbsp;&nbsp;(i) the duties and obligations of the Trustee shall with
 respect to the Securities of such series be determined solely by the express provisions of this Indenture, and the Trustee shall
 not be liable with respect to the Securities of such series except for the performance of such duties and obligations as are specifically
 set forth in this Indenture, and no implied covenants or obligations shall be read into this Indenture against the Trustee; and

(ii) in the absence of bad faith on the part of the Trustee,
 the Trustee may with respect to the Securities of such series conclusively rely, as to the truth of the statements and the correctness
 of the opinions expressed therein, upon any certificates or opinions furnished to the Trustee and conforming to the requirements
 of this Indenture; but in the case of any such certificates or opinions that by any provision hereof are specifically required to
 be furnished to the Trustee, the Trustee shall be under a duty to examine the same to determine whether or not they conform to the
 requirement of this Indenture;

(2) the Trustee shall not be liable for any error of judgment
 made in good faith by a Responsible Officer or Responsible Officers of the Trustee, unless it shall be proved that the Trustee, was
 negligent in ascertaining the pertinent facts;

(3) the Trustee shall not be liable with respect to any
 action taken or omitted to be taken by it in good faith in accordance with the direction of the holders of not less than a majority
 in principal amount of the Securities of any series at the time Outstanding relating to the time, method and place of conducting
 any proceeding for any remedy available to the Trustee, or exercising any trust or power conferred upon the Trustee under this Indenture
 with respect to the Securities of that series; and

(4) None of the provisions contained in this Indenture
 shall require the Trustee to expend or risk its own funds or otherwise incur personal financial liability in the performance of any
 of its duties or in the exercise of any of its rights or powers, if there is reasonable ground for believing that the repayment of
 such funds or liability is not reasonably assured to it under the terms of this Indenture or adequate indemnity against such risk
 is not reasonably assured to it.

SECTION 7.02 Certain Rights of Trustee.

Except as otherwise provided in Section 7.01:

&nbsp;&nbsp;&nbsp;&nbsp;(a) The Trustee may rely and shall be protected in acting
 or refraining from acting upon any resolution, certificate, statement, instrument, opinion, report, notice, request, consent, order,
 approval, bond, security or other paper or document believed by it to be genuine and to have been signed or presented by the proper
 party or parties;

&nbsp;&nbsp;&nbsp;&nbsp;(b) Any request, direction, order or demand of the Company
 mentioned herein shall be sufficiently evidenced by a Board Resolution or an instrument signed in the name of the Company, by the
 President or any Vice President and by the Secretary or an Assistant Secretary or the Treasurer or an Assistant Treasurer thereof
 (unless other evidence in respect thereof is specifically prescribed herein);

(c) The Trustee may consult with counsel and the written
 advice of such counsel or any Opinion of Counsel shall be full and complete authorization and protection in respect of any action
 taken or suffered or omitted hereunder in good faith and in reliance thereon;

(d) The Trustee shall be under no obligation to exercise
 any of the rights or powers vested in it by this Indenture at the request, order or direction of any of the Securityholders, pursuant
 to the provisions of this Indenture, unless such Securityholders shall have offered to the Trustee reasonable security or indemnity
 against the costs, expenses and liabilities that may be incurred therein or thereby; nothing contained herein shall, however, relieve
 the Trustee of the obligation, upon the occurrence of an Event of Default with respect to a series of the Securities (that has not
 been cured or waived) to exercise with respect to Securities of that series such of the rights and powers vested in it by this Indenture,
 and to use the same degree of care and skill in their exercise, as a prudent man would exercise or use under the circumstances in
 the conduct of his own affairs;

(e) The Trustee shall not be liable for any action taken
 or omitted to be taken by it in good faith and believed by it to be authorized or within the discretion or rights or powers conferred
 upon it by this Indenture;

(f) The Trustee shall not be bound to make any investigation
 into the facts or matters stated in any resolution, certificate, statement, instrument, opinion, report, notice, request, consent,
 order, approval, bond, security, or other papers or documents, unless requested in writing so to do by the holders of not less than
 a majority in principal amount of the Outstanding Securities of the particular series affected thereby (determined as provided in
 Section 8.04); provided, however, that if the payment within a reasonable time to the Trustee of the costs, expenses or liabilities
 likely to be incurred by it in the making of such investigation is, in the opinion of the Trustee, not reasonably assured to the
 Trustee by the security afforded to it by the terms of this Indenture, the Trustee may require reasonable indemnity against such
 costs, expenses or liabilities as a condition to so proceeding. The reasonable expense of every such examination shall be paid by
 the Company or, if paid by the Trustee, shall be repaid by the Company upon demand; and

The Trustee may execute any of the trusts or powers hereunder or perform any duties hereunder either directly or by or through agents or attorneys and the Trustee shall not be responsible for any misconduct or negligence on the part of any agent or attorney appointed with due care by it hereunder.

SECTION 7.03 Trustee Not Responsible for Recitals or Issuance of Securities.

&nbsp;&nbsp;&nbsp;&nbsp;(a) The recitals contained herein and in the Securities
 shall be taken as the statements of the Company, and the Trustee assumes no responsibility for the correctness of the same.

(b) The Trustee makes no representations as to the validity
 or sufficiency of this Indenture or of the Securities.

(c) The Trustee shall not be accountable for the use or
 application by the Company of any of the Securities or of the proceeds of such Securities, or for the use or application of any moneys
 paid over by the Trustee in accordance with any provision of this Indenture or established pursuant to Section 2.01, or for the use
 or application of any moneys received by any paying agent other than the Trustee.

SECTION 7.04 May Hold Securities.

The Trustee or any paying agent or Security Registrar, in its individual or any other capacity, may become the owner or pledgee of Securities with the same rights it would have if it were not Trustee, paying agent or Security Registrar.

SECTION 7.05 Moneys Held in Trust.

Subject to the provisions of Section 11.05, all moneys received by the Trustee shall, until used or applied as herein provided, be held in trust for the purposes for which they were received, but need not be segregated from other funds except to the extent required by law. The Trustee shall be under no liability for interest on any moneys received by it hereunder except such as it may agree with the Company to pay thereon.

SECTION 7.06 Compensation and Reimbursement.

&nbsp;&nbsp;&nbsp;&nbsp;(a) The Company covenants and agrees to pay to the Trustee,
 and the Trustee shall be entitled to, such reasonable compensation (which shall not be limited by any provision of law in regard
 to the compensation of a trustee of an express trust), as the Company, and the Trustee may from time to time agree in writing, for
 all services rendered by it in the execution of the trusts hereby created and in the exercise and performance of any of the powers
 and duties hereunder of the Trustee, and, except as otherwise expressly provided herein, the Company will pay or reimburse the Trustee
 upon its request for all reasonable expenses, disbursements and advances incurred or made by the Trustee in accordance with any of
 the provisions of this Indenture (including the reasonable compensation and the expenses and disbursements of its counsel and of
 all Persons not regularly in its employ) except any such expense, disbursement or advance as may arise from its negligence or bad
 faith. The Company also covenants to indemnify the Trustee (and its officers, agents, directors and employees) for, and to hold it
 harmless against, any loss, liability or expense incurred without negligence or bad faith on the part of the Trustee and arising
 out of or in connection with the acceptance or administration of this trust, including the costs and expenses of defending itself
 against any claim of liability in the premises.

&nbsp;&nbsp;&nbsp;&nbsp;(b) The obligations of the Company under this Section to
 compensate and indemnify the Trustee and to pay or reimburse the Trustee for expenses, disbursements and advances shall constitute
 additional indebtedness hereunder. Such additional indebtedness shall be secured by a lien prior to that of the Securities upon all
 property and funds held or collected by the Trustee as such, except funds held in trust for the benefit of the holders of particular
 Securities.

SECTION 7.07 Reliance on Officers' Certificate.

Except as otherwise provided in Section 7.01, whenever in the administration of the provisions of this Indenture the Trustee shall deem it necessary or desirable that a matter be proved or established prior to taking or suffering or omitting to take any action hereunder, such matter (unless other evidence in respect thereof be herein specifically prescribed) may, in the absence of negligence or bad faith on the part of the Trustee, be deemed to be conclusively proved and established by an Officers' Certificate delivered to the Trustee and such certificate, in the absence of negligence or bad faith on the part of the Trustee, shall be full warrant to the Trustee for any action taken, suffered or omitted to be taken by it under the provisions of this Indenture upon the faith thereof.

SECTION 7.08 Disqualification; Conflicting Interests.

If the Trustee has or shall acquire any "conflicting interest" within the meaning of Section 310(b) of the Trust Indenture Act, the Trustee and the Company shall in all respects comply with the provisions of Section 310(b) of the Trust Indenture Act.

SECTION 7.09 Corporate Trustee Required; Eligibility.

There shall at all times be a Trustee with respect to the Securities issued hereunder which shall at all times be a corporation organized and doing business under the laws of the United States of America or any State or Territory thereof or of the District of Columbia, or a corporation or other Person permitted to act as trustee by the Commission, authorized under such laws to exercise corporate trust powers, having a combined capital and surplus of at least 50 million U.S. dollars ($50,000,000), and subject to supervision or examination by Federal, State, Territorial, or District of Columbia authority. If such corporation publishes reports of condition at least annually, pursuant to law or to the requirements of the aforesaid supervising or examining authority, then for the purposes of this Section, the combined capital and surplus of such corporation shall be deemed to be its combined capital and surplus as set forth in its most recent report of condition so published. The Company may not, nor may any Person directly or indirectly controlling, controlled by, or under common control with the Company, serve as Trustee. In case at any time the Trustee shall cease to be eligible in accordance with the provisions of this Section, the Trustee shall resign immediately in the manner and with the effect specified in Section 7.10.

SECTION 7.10 Resignation and Removal; Appointment of Successor.

&nbsp;&nbsp;&nbsp;&nbsp;(a) The Trustee or any successor hereafter appointed, may
 at any time resign with respect to the Securities of one or more series by giving written notice thereof to the Company and by transmitting
 notice of resignation by mail, first class postage prepaid, to the Securityholders of such series, as their names and addresses appear
 upon the Security Register. Upon receiving such notice of resignation, the Company shall promptly appoint a successor trustee with
 respect to Securities of such series by written instrument, in duplicate, executed by order of the Board of Directors, one copy of
 which instrument shall be delivered to the resigning Trustee and one copy to the successor trustee. If no successor trustee shall
 have been so appointed and have accepted appointment within 30 days after the mailing of such notice of resignation, the resigning
 Trustee may petition any court of competent jurisdiction for the appointment of a successor trustee with respect to Securities of
 such series, or any Securityholder of that series who has been a bona fide holder of a Security or Securities for at least six months
 may on behalf of himself and all others similarly situated, petition any such court for the appointment of a successor trustee. Such
 court may thereupon after such notice, if any, as it may deem proper and prescribe, appoint a successor trustee.

(b) In case at any time any one of the following shall
 occur:

(1) the Trustee shall fail to comply with the provisions
 of Section 7.08 after written request therefor by the Company or by any Securityholder who has been a bona fide holder of a Security
 or Securities for at least six months; or

(2) the Trustee shall cease to be eligible in accordance
 with the provisions of Section 7.09 and shall fail to resign after written request therefor by the Company or by any such Securityholder;
 or

(3) the Trustee shall become incapable of acting, or shall
 be adjudged a bankrupt or insolvent, or commence a voluntary bankruptcy proceeding, or a receiver of the Trustee or of its property
 shall be appointed or consented to, or any public officer shall take charge or control of the Trustee or of its property or affairs
 for the purpose of rehabilitation, conservation or liquidation, then, in any such case, the Company may remove the Trustee with respect
 to all Securities and appoint a successor trustee by written instrument, in duplicate, executed by order of the Board of Directors,
 one copy of which instrument shall be delivered to the Trustee so removed and one copy to the successor trustee, or, unless the Trustee's
 duty to resign is stayed as provided herein, any Securityholder who has been a bona fide holder of a Security or Securities for at
 least six months may, on behalf of that holder and all others similarly situated, petition any court of competent jurisdiction for
 the removal of the Trustee and the appointment of a successor trustee. Such court may thereupon after such notice, if any, as it
 may deem proper and prescribe, remove the Trustee and appoint a successor trustee.

&nbsp;&nbsp;&nbsp;&nbsp;(c) The holders of a majority in aggregate principal amount
 of the Securities of any series at the time Outstanding may at any time remove the Trustee with respect to such series by so notifying
 the Trustee and the Company and may appoint a successor Trustee for such series with the consent of the Company.

(d) Any resignation or removal of the Trustee and appointment
 of a successor trustee with respect to the Securities of a series pursuant to any of the provisions of this Section shall become
 effective upon acceptance of appointment by the successor trustee as provided in Section 7.11.

(e) Any successor trustee appointed pursuant to this Section
 may be appointed with respect to the Securities of one or more series or all of such series, and at any time there shall be only
 one Trustee with respect to the Securities of any particular series.

SECTION 7.11 Acceptance of Appointment By Successor.

&nbsp;&nbsp;&nbsp;&nbsp;(a) In case of the appointment hereunder of a successor
 trustee with respect to all Securities, every such successor trustee so appointed shall execute, acknowledge and deliver to the Company
 and to the retiring Trustee an instrument accepting such appointment, and thereupon the resignation or removal of the retiring Trustee
 shall become effective and such successor trustee, without any further act, deed or conveyance, shall become vested with all the
 rights, powers, trusts and duties of the retiring Trustee; but, on the request of the Company or the successor trustee, such retiring
 Trustee shall, upon payment of its charges, execute and deliver an instrument transferring to such successor trustee all the rights,
 powers, and trusts of the retiring Trustee and shall duly assign, transfer and deliver to such successor trustee all property and
 money held by such retiring Trustee hereunder.

&nbsp;&nbsp;&nbsp;&nbsp;(b) In case of the appointment hereunder of a successor
 trustee with respect to the Securities of one or more (but not all) series, the Company, the retiring Trustee and each successor
 trustee with respect to the Securities of one or more series shall execute and deliver an indenture supplemental hereto wherein each
 successor trustee shall accept such appointment and which (1) shall contain such provisions as shall be necessary or desirable to
 transfer and confirm to, and to vest in, each successor trustee all the rights, powers, trusts and duties of the retiring Trustee
 with respect to the Securities of that or those series to which the appointment of such successor trustee relates, (2) shall contain
 such provisions as shall be deemed necessary or desirable to confirm that all the rights, powers, trusts and duties of the retiring
 Trustee with respect to the Securities of that or those series as to which the retiring Trustee is not retiring shall continue to
 be vested in the retiring Trustee, and (3) shall add to or change any of the provisions of this Indenture as shall be necessary to
 provide for or facilitate the administration of the trusts hereunder by more than one Trustee, it being understood that nothing herein
 or in such supplemental indenture shall constitute such Trustees co-trustees of the same trust, that each such Trustee shall be trustee
 of a trust or trusts hereunder separate and apart from any trust or trusts hereunder administered by any other such Trustee and that
 no Trustee shall be responsible for any act or failure to act on the part of any other Trustee hereunder; and upon the execution
 and delivery of such supplemental indenture the resignation or removal of the retiring Trustee shall become effective to the extent
 provided therein, such retiring Trustee shall with respect to the Securities of that or those series to which the appointment of
 such successor trustee relates have no further responsibility for the exercise of rights and powers or for the performance of the
 duties and obligations vested in the Trustee under this Indenture, and each such successor trustee, without any further act, deed
 or conveyance, shall become vested with all the rights, powers, trusts and duties of the retiring Trustee with respect to the Securities
 of that or those series to which the appointment of such successor trustee relates; but, on request of the Company or any successor
 trustee, such retiring Trustee shall duly assign, transfer and deliver to such successor trustee, to the extent contemplated by such
 supplemental indenture, the property and money held by such retiring Trustee hereunder with respect to the Securities of that or
 those series to which the appointment of such successor trustee relates.

(c) Upon request of any such successor trustee, the Company
 shall execute any and all instruments for more fully and certainly vesting in and confirming to such successor trustee all such rights,
 powers and trusts referred to in paragraph (a) or (b) of this Section, as the case may be.

(d) No successor trustee shall accept its appointment unless
 at the time of such acceptance such successor trustee shall be qualified and eligible under this Article.

(e) Upon acceptance of appointment by a successor trustee
 as provided in this Section, the Company shall transmit notice of the succession of such trustee hereunder by mail, first class postage
 prepaid, to the Securityholders, as their names and addresses appear upon the Security Register. If the Company fails to transmit
 such notice within ten days after acceptance of appointment by the successor trustee, the successor trustee shall cause such notice
 to be transmitted at the expense of the Company.

SECTION 7.12 Merger, Conversion, Consolidation or Succession to Business.

Any corporation into which the Trustee may be merged or converted or with which it may be consolidated, or any corporation resulting from any merger, conversion or consolidation to which the Trustee shall be a party, or any corporation succeeding to the corporate trust business of the Trustee, shall be the successor of the Trustee hereunder, provided that such corporation shall be qualified under the provisions of Section 7.08 and eligible under the provisions of Section 7.09, without the execution or filing of any paper or any further act on the part of any of the parties hereto, anything herein to the contrary notwithstanding. In case any Securities shall have been authenticated, but not delivered, by the Trustee then in office, any successor by merger, conversion or consolidation to such authenticating Trustee may adopt such authentication and deliver the Securities so authenticated with the same effect as if such successor Trustee had itself authenticated such Securities.

SECTION 7.13 Preferential Collection of Claims Against the Company.

The Trustee shall comply with Section 311(a) of the Trust Indenture Act, excluding any creditor relationship described in Section 311(b) of the Trust Indenture Act. A Trustee who has resigned or been removed shall be subject to Section 311(a) of the Trust Indenture Act to the extent included therein.

ARTICLE VIII

CONCERNING THE SECURITYHOLDERS

SECTION 8.01 Evidence of Action by Securityholders.

Whenever in this Indenture it is provided that the holders of a majority or specified percentage in aggregate principal amount of the Securities of a particular series may take any action (including the making of any demand or request, the giving of any notice, consent or waiver or the taking of any other action), the fact that at the time of taking any such action the holders of such majority or specified percentage of that series have joined therein may be evidenced by any instrument or any number of instruments of similar tenor executed by such holders of Securities of that series in Person or by agent or proxy appointed in writing.

If the Company shall solicit from the Securityholders of any series any request, demand, authorization, direction, notice, consent, waiver or other action, the Company may, at its option, as evidenced by an Officers' Certificate, fix in advance a record date for such series for the determination of Securityholders entitled to give such request, demand, authorization, direction, notice, consent, waiver or other action, but the Company shall have no obligation to do so. If such a record date is fixed, such request, demand, authorization, direction, notice, consent, waiver or other action may be given before or after the record date, but only the Securityholders of record at the close of business on the record date shall be deemed to be Securityholders for the purposes of determining whether Securityholders of the requisite proportion of Outstanding Securities of that series have authorized or agreed or consented to such request, demand, authorization, direction, notice, consent, waiver or other action, and for that purpose the Outstanding Securities of that series shall be computed as of the record date; provided, however, that no such authorization, agreement or consent by such Securityholders on the record date shall be deemed effective unless it shall become effective pursuant to the provisions of this Indenture not later than six months after the record date.

SECTION 8.02 Proof of Execution by Securityholders.

Subject to the provisions of Section 7.01, proof of the execution of any instrument by a Securityholder (such proof will not require notarization) or his agent or proxy and proof of the holding by any Person of any of the Securities shall be sufficient if made in the following manner:

&nbsp;&nbsp;&nbsp;&nbsp;(a) The fact and date of the execution by any such Person
 of any instrument may be proved in any reasonable manner acceptable to the Trustee.

&nbsp;&nbsp;&nbsp;&nbsp;(b) The ownership of Securities shall be proved by the
 Security Register of such Securities or by a certificate of the Security Registrar thereof.

(c) The Trustee may require such additional proof of any
 matter referred to in this Section as it shall deem necessary.

SECTION 8.03 Who May be Deemed Owners.

Prior to the due presentment for registration of transfer of any Security, the Company, the Trustee, any paying agent and any Security Registrar may deem and treat the Person in whose name such Security shall be registered upon the books of the Company as the absolute owner of such Security (whether or not such Security shall be overdue and notwithstanding any notice of ownership or writing thereon made by anyone other than the Security Registrar) for the purpose of receiving payment of or on account of the principal of, premium, if any, and (subject to Section 2.03) interest on such Security and for all other purposes; and neither the Company nor the Trustee nor any paying agent nor any Security Registrar shall be affected by any notice to the contrary.

SECTION 8.04 Certain Securities Owned by Company Disregarded.

In determining whether the holders of the requisite aggregate principal amount of Securities of a particular series have concurred in any direction, consent of waiver under this Indenture, the Securities of that series that are owned by the Company or any other obligor on the Securities of that series or by any Person directly or indirectly controlling or controlled by or under common control with the Company or any other obligor on the Securities of that series shall be disregarded and deemed not to be Outstanding for the purpose of any such determination, except that for the purpose of determining whether the Trustee shall be protected in relying on any such direction, consent or waiver, only Securities of such series that the Trustee actually knows are so owned shall be so disregarded. The Securities so owned that have been pledged in good faith may be regarded as Outstanding for the purposes of this Section, if the pledgee shall establish to the satisfaction of the Trustee the pledgee's right so to act with respect to such Securities and that the pledgee is not a Person directly or indirectly controlling or controlled by or under direct or indirect common control with the Company or any such other obligor. In case of a dispute as to such right, any decision by the Trustee taken upon the advice of counsel shall be full protection to the Trustee.

SECTION 8.05 Actions Binding on Future Securityholders.

At any time prior to (but not after) the evidencing to the Trustee, as provided in Section 8.01, of the taking of any action by the holders of the majority or percentage in aggregate principal amount of the Securities of a particular series specified in this Indenture in connection with such action, any holder of a Security of that series that is shown by the evidence to be included in the Securities the holders of which have consented to such action may, by filing written notice with the Trustee, and upon proof of holding as provided in Section 8.02, revoke such action so far as concerns such Security. Except as aforesaid any such action taken by the holder of any Security shall be conclusive and binding upon such holder and upon all future holders and owners of such Security, and of any Security issued in exchange therefor, on registration of transfer thereof or in place thereof, irrespective of whether or not any notation in regard thereto is made upon such Security. Any action taken by the holders of the majority or percentage in aggregate principal amount of the Securities of a particular series specified in this Indenture in connection with such action shall be conclusively binding upon the Company, the Trustee and the holders of all the Securities of that series.

SECTION 8.06 Purposes for Which Meetings May Be Called.

A meeting of holders of any series of Securities may be called at any time and from time to time pursuant to this Article to make, give or take any request, demand, authorization, direction, notice, consent, waiver or other action provided by this Indenture to be made, given or taken by holders of such series of Securities.

Notwithstanding anything contained in this Article VIII, the Trustee may, during the pendency of a Default or an Event of Default, call a meeting of holders of any series of Securities in accordance with its standard practices.

SECTION 8.07 Call Notice and Place of Meetings.

&nbsp;&nbsp;&nbsp;&nbsp;(a) The Trustee may at any time call a meeting of holders
 of any series of Securities for any purpose specified in Section 8.06 hereof, to be held at such time and at such place in The City
 of New York. Notice of every meeting of holders of any series of Securities, setting forth the time and the place of such meeting,
 in general terms the action proposed to be taken at such meeting and the percentage of the principal amount of the Outstanding Securities
 of such series which shall constitute a quorum at such meeting, shall be given, in the manner provided in Section 13.04 hereof, not
 less than 21 nor more than 180 days prior to the date fixed for the meeting to holders of Outstanding Securities of such series.

In case at any time the Company, pursuant to a Board Resolution, or the holders of at least 10% in principal amount of the Outstanding Securities of any series shall have requested the Trustee to call a meeting of the holders of Securities of such series for any purpose specified in Section 8.06 hereof, by written request setting forth in reasonable detail the action proposed to be taken at the meeting, and the Trustee shall not have made the first publication of the notice of such meeting within 21 days after receipt of such request or shall not thereafter proceed to cause the meeting to be held as provided herein, then the Company or the holders of Securities of such series in the amount specified, as the case may be, may determine the time and the place in The City of New York for such meeting and may call such meeting for such purposes by giving notice thereof as provided in paragraph (a) of this Section.

SECTION 8.08 Persons Entitled To Vote at Meetings.

To be entitled to vote at any meeting of holders of Securities of a given series, a Person shall be (a) a holder of one or more Outstanding Securities of such series or (b) a Person appointed by an instrument in writing as proxy for a holder or holders of one or more Outstanding Securities of such series by such holder or holders. The only Persons who shall be entitled to be present or to speak at any meeting of holders shall be the Persons entitled to vote at such meeting and their counsel, any representatives of the Trustee and its counsel and any representatives of the Company and its counsel.

SECTION 8.09 Quorum; Action.

The Persons entitled to vote a majority in aggregate principal amount of the Outstanding Securities of a given series shall constitute a quorum with respect to a meeting of holders of Outstanding Securities of such series. In the absence of a quorum within 30 minutes of the time appointed for any such meeting, the meeting shall, if convened at the request of holders of Securities of such series, be dissolved. In any other case, the meeting may be adjourned for a period of not less than 10 days as determined by the chairman of the meeting prior to the adjournment of such meeting. In the absence of a quorum at any such adjourned meeting, such adjourned meeting may be further adjourned for a period of not less than 10 days as determined by the chairman of the meeting prior to the adjournment of such adjourned meeting. Notice of the reconvening of any adjourned meeting shall be given as provided in Section 8.07(a) hereof, except that such notice need be given only once and not less than five days prior to the date on which the meeting is scheduled to be reconvened.

At a meeting or an adjourned meeting duly reconvened and at which a quorum is present as aforesaid, any resolution and all matters (except as limited by the proviso to the first paragraph of Section 9.02 hereof) shall be effectively passed and decided if passed or decided by the Persons entitled to vote not less than a majority in aggregate principal amount of Outstanding Securities of a series represented and voting at such meeting with respect to a meeting of holders of Outstanding Securities of such series.

Any resolution passed or decisions taken at any meeting of holders of Securities duly held in accordance with this Section shall be binding on all the holders of Securities of such series, whether or not present or represented at the meeting.

SECTION 8.10 Determination of Voting Rights; Conduct and Adjournment of Meetings.

&nbsp;&nbsp;&nbsp;&nbsp;(a) Notwithstanding any other provisions of this Indenture,
 the Trustee may make such reasonable regulations as it may deem advisable for any meeting of holders of Securities in regard to proof
 of the holding of Securities and of the appointment of proxies and in regard to the appointment and duties of inspectors of votes,
 the submission and examination of proxies, certificates and other evidence of the right to vote, and such other matters concerning
 the conduct of the meeting as it shall deem appropriate.

&nbsp;&nbsp;&nbsp;&nbsp;(b) The Trustee shall, by an instrument in writing, appoint
 a temporary chairman (which may be the Trustee) of the meeting, unless the meeting shall have been called by the Company or by holders
 of Securities of a given series as provided in Section 8.07(b) hereof, in which case the Company or the holders of Securities of
 such series calling the meeting, as the case may be, shall in like manner appoint a temporary chairman. A permanent chairman and
 a permanent secretary of the meeting shall be elected by vote of the Persons entitled to vote a majority in principal amount of the
 Outstanding Securities of such series represented at the meeting.

(c) At any meeting, each holder of a Security of the series
 in respect of which such meeting is being held or proxy shall be entitled to one vote for each $1,000 principal amount of Securities
 of such series held or represented by him; provided, however, that no vote shall be cast or counted at any meeting in respect of
 any Security of such series challenged as not Outstanding and ruled by the chairman of the meeting to be not Outstanding. The chairman
 of the meeting shall have no right to vote, except as a holder of a Security of such series or proxy.

(d) Any meeting of holders of Securities duly called pursuant
 to Section 8.07 hereof at which a quorum is present may be adjourned from time to time by Persons entitled to vote a majority in
 principal amount of the Outstanding Securities of the series in respect of which such meeting is being held represented at the meeting,
 and the meeting may be held as so adjourned without further notice.

SECTION 8.11 Counting Votes and Recording Action of Meetings.

The vote upon any resolution submitted to any meeting of holders of Securities of a given series shall be by written ballots on which shall be subscribed the signatures of the holders of Securities of such series or of their representatives by proxy and the principal amounts and serial numbers of the Outstanding Securities of such series held or represented by them. The permanent chairman of the meeting shall appoint two inspectors of votes who shall count all votes cast at the meeting for or against any resolution and who shall make and file with the secretary of the meeting their verified written reports in duplicate of all votes cast at the meeting. A record, at least in duplicate, of the proceedings of each meeting of holders of Securities of such series shall be prepared by the secretary of the meeting and there shall be attached to said record the original reports of the inspectors of votes on any vote by ballot taken thereat and affidavits by one or more Persons having knowledge of the facts setting forth a copy of the notice of the meeting and showing that said notice was given as provided in Section 8.07 hereof and, if applicable, Section 8.09 hereof. Each copy shall be signed and verified by the affidavits of the permanent chairman and secretary of the meeting and one such copy shall be delivered to the Company and another to the Trustee to be preserved by the Trustee, the latter to have attached thereto the ballots voted at the meeting. Any record so signed and verified shall be conclusive evidence of the matters therein stated.

ARTICLE IX

SUPPLEMENTAL INDENTURES

SECTION 9.01 Supplemental Indentures Without the Consent of Securityholders.

In addition to any supplemental indenture otherwise authorized by this Indenture, the Company and the Trustee may from time to time and at any time enter into an indenture or indentures supplemental hereto (which shall conform to the provisions of the Trust Indenture Act as then in effect), without the consent of the Securityholders, for one or more of the following purposes:

&nbsp;&nbsp;&nbsp;&nbsp;(a) cure any ambiguity, correct or supplement any provision
 herein which may be inconsistent with any other provision herein or which is otherwise defective, or make any other provisions with
 respect to matters or questions arising under this Indenture which the Company and the Trustee may deem necessary or desirable and
 which shall not be inconsistent with the provisions of this Indenture;

(b) to comply with Article X;

(c) to provide for uncertificated Securities in addition
 to or in place of certificated Securities;

(d) to add to the covenants of the Company for the benefit
 of the holders of all or any Series of Securities (and if such covenants are to be for the benefit of less than all series of Securities,
 stating that such covenants are expressly being included solely for the benefit of such series) or to surrender any right or power
 herein conferred upon the Company;

(e) to add to, delete from, or revise the conditions, limitations,
 and restrictions on the authorized amount, terms, or purposes of issue, authentication, and delivery of Securities, as herein set
 forth;

(f) to make any change that does not adversely affect the
 rights of any Securityholder in any material respect;

(g) to provide for the issuance of and establish the form
 and terms and conditions of the Securities of any series as provided in Section 2.01, to establish the form of any certifications
 required to be furnished pursuant to the terms of this Indenture or any series of Securities, or to add to the rights of the holders
 of any series of Securities; or

(h) comply with the requirements of the Commission in order
 to effect or maintain the qualification of this Indenture under the Trust Indenture Act.

The Trustee is hereby authorized to join with the Company in the execution of any such supplemental indenture, and to make any further appropriate agreements and stipulations that may be therein contained, but the Trustee shall not be obligated to enter into any such supplemental indenture that affects the Trustee's own rights, duties or immunities under this Indenture or otherwise.

Any supplemental indenture authorized by the provisions of this Section may be executed by the Company and the Trustee without the consent of the holders of any of the Securities at the time Outstanding, notwithstanding any of the provisions of Section 9.02.

SECTION 9.02 Supplemental Indentures With Consent of Securityholders.

With the written consent of the holders of at least a majority in aggregate principal amount of the Outstanding Securities of any series or by action at a meeting of holders of the Securities of such series in accordance with Section 8.09, by the holders of a majority in aggregate principal amount of the Securities of such series then Outstanding represented at such meeting, the Company, when authorized by Board Resolutions, and the Trustee may from time to time and at any time enter into an indenture or indentures supplemental hereto (which shall conform to the provisions of the Trust Indenture Act as then in effect) for the purpose of adding any provisions to or changing in any manner or eliminating any of the provisions of this Indenture or of any supplemental indenture or of modifying in any manner not covered by Section 9.01 the rights of the holders of the Securities of such series under this Indenture; provided, however, that no such supplemental indenture shall, without the consent of the holders of each Security then Outstanding and affected thereby, (i) extend the fixed maturity of any Securities of any series, or reduce the principal amount thereof, or reduce the rate or extend the time of payment of interest thereon, or reduce any premium payable upon the redemption thereof, (ii) reduce the aforesaid percentage of Securities, the holders of which are required to consent to any such supplemental indenture, or any consent or waiver, (iii) reduce the principal amount of discount securities payable upon acceleration of the maturity of any Securities of any series or (iv) make the principal of or premium or interest on any Security of a series payable in currency or currency units other than that stated in the Securities of such series.

It shall not be necessary for the consent of the Securityholders of any series affected thereby under this Section to approve the particular form of any proposed supplemental indenture, but it shall be sufficient if such consent shall approve the substance thereof.

SECTION 9.03 Effect of Supplemental Indentures.

Upon the execution of any supplemental indenture pursuant to the provisions of this Article or of Section 10.01, this Indenture shall, with respect to such series, be and be deemed to be modified and amended in accordance therewith and the respective rights, limitations of rights, obligations, duties and immunities under this Indenture of the Trustee, the Company and the holders of Securities of the series affected thereby shall thereafter be determined, exercised and enforced hereunder subject in all respects to such modifications and amendments, and all the terms and conditions of any such supplemental indenture shall be and be deemed to be part of the terms and conditions of this Indenture for any and all purposes.

SECTION 9.04 Securities Affected by Supplemental Indentures.

Securities of any series affected by a supplemental indenture, authenticated and delivered after the execution of such supplemental indenture pursuant to the provisions of this Article or of Section 10.01, may bear a notation in form approved by the Company, provided such form meets the requirements of any exchange upon which such series may be listed, as to any matter provided for in such supplemental indenture. If the Company shall so determine, new Securities of that series so modified as to conform, in the opinion of the Board of Directors of the Company, to any modification of this Indenture contained in any such supplemental indenture may be prepared by the Company, authenticated by the Trustee and delivered in exchange for the Securities of that series then Outstanding.

SECTION 9.05 Execution of Supplemental Indentures.

Upon the request of the Company, accompanied by its Board Resolutions authorizing the execution of any such supplemental indenture, and upon the filing with the Trustee of evidence of the consent of Securityholders required to consent thereto as aforesaid, the Trustee shall join with the Company in the execution of such supplemental indenture unless such supplemental indenture affects the Trustee's own rights, duties or immunities under this Indenture or otherwise, in which case the Trustee may in its discretion but shall not be obligated to enter into such supplemental indenture. The Trustee, subject to the provisions of Section 7.01, may receive an Opinion of Counsel as conclusive evidence that any supplemental indenture executed pursuant to this Article is authorized or permitted by, and conforms to, the terms of this Article and that it is proper for the Trustee under the provisions of this Article to join in the execution thereof; provided, however, that such Opinion of Counsel need not be provided in connection with the execution of a supplemental indenture that establishes the terms of a series of Securities pursuant to Section 2.01 hereof.

Promptly after the execution by the Company and the Trustee of any supplemental indenture pursuant to the provisions of this Section, the Trustee shall transmit by mail, first class postage prepaid, a notice, setting forth in general terms the substance of such supplemental indenture, to the Securityholders of all series affected thereby as their names and addresses appear upon the Security Register. Any failure of the Trustee to mail such notice, or any defect therein, shall not, however, in any way impair or affect the validity of any such supplemental indenture.

ARTICLE X

SUCCESSOR ENTITY

SECTION 10.01 Company May Consolidate, Etc.

Nothing contained in this Indenture or in any of the Securities shall prevent any consolidation or merger of the Company with or into any other Person (whether or not affiliated with the Company) or successive consolidations or mergers in which the Company or its successor or successors shall be a party or parties, or shall prevent any sale, conveyance, transfer or other disposition of the property of the Company or its successor or successors as an entirety, or substantially as an entirety, to any other corporation (whether or not affiliated with the Company or its successor or successors) authorized to acquire and operate the same; provided, however, the Company hereby covenants and agrees that, upon any such consolidation or merger (in each case, if the Company is not the survivor of such transaction), sale, conveyance, transfer or other disposition, the due and punctual payment of the principal of (premium, if any) and interest on all of the Securities of all series in accordance with the terms of each series, according to their tenor and the due and punctual performance and observance of all the covenants and conditions of this Indenture with respect to each series or established with respect to such series pursuant to Section 2.01 to be kept or performed by the Company shall be expressly assumed, by supplemental indenture (which shall conform to the provisions of the Trust Indenture Act, as then in effect) satisfactory in form to the Trustee executed and delivered to the Trustee by the entity formed by such consolidation, or into which the Company shall have been merged, or by the entity which shall have acquired such property.

SECTION 10.02 Successor Entity Substituted.

&nbsp;&nbsp;&nbsp;&nbsp;(a) In case of any such consolidation, merger, sale, conveyance,
 transfer or other disposition and upon the assumption by the successor entity by supplemental indenture, executed and delivered to
 the Trustee and satisfactory in form to the Trustee, of the due and punctual payment of the principal of, premium, if any, and interest
 on all of the Securities of all series Outstanding and the due and punctual performance of all of the covenants and conditions of
 this Indenture or established with respect to each series of the Securities pursuant to Section 2.01 to be performed by the Company
 with respect to each series, such successor entity shall succeed to and be substituted for the Company with the same effect as if
 it had been named as the Company herein, and thereupon the predecessor corporation shall be relieved of all obligations and covenants
 under this Indenture and the Securities.

(b) In case of any such consolidation, merger, sale, conveyance,
 transfer or other disposition such changes in phraseology and form (but not in substance) may be made in the Securities thereafter
 to be issued as may be appropriate.

(c) Nothing contained in this Article shall require any
 action by the Company in the case of a consolidation or merger of any Person into the Company where the Company is the survivor of
 such transaction, or the acquisition by the Company, by purchase or otherwise, of all or any part of the property of any other Person
 (whether or not affiliated with the Company).

SECTION 10.03 Evidence of Consolidation, Etc. to Trustee.

The Trustee, subject to the provisions of Section 7.01, may receive an Opinion of Counsel as conclusive evidence that any such consolidation, merger, sale, conveyance, transfer or other disposition, and any such assumption, comply with the provisions of this Article.

ARTICLE XI

SATISFACTION AND DISCHARGE

SECTION 11.01 Satisfaction and Discharge of Indenture.

If at any time: (a) the Company shall have delivered to the Trustee for cancellation all Securities of a series theretofore authenticated (other than any Securities that shall have been destroyed, lost or stolen and that shall have been replaced or paid as provided in Section 2.07) and Securities for whose payment money or Governmental Obligations have theretofore been deposited in trust or segregated and held in trust by the Company (and thereupon repaid to the Company or discharged from such trust, as provided in Section 11.05); or (b) all such Securities of a particular series not theretofore delivered to the Trustee for cancellation shall have become due and payable, or are by their terms to become due and payable within one year or are to be called for redemption within one year under arrangements satisfactory to the Trustee for the giving of notice of redemption, and the Company shall deposit or cause to be deposited with the Trustee as trust funds the entire amount in moneys or Governmental Obligations sufficient or a combination thereof, sufficient (assuming that no tax liability will be imposed on the Trustee) in the opinion of a nationally recognized firm of independent public accountants expressed in a written certification thereof delivered to the Trustee, to pay at maturity or upon redemption all Securities of that series not theretofore delivered to the Trustee for cancellation, including principal (and premium, if any) and interest due or to become due to such date of maturity or date fixed for redemption, as the case may be, and if the Company shall also pay or cause to be paid all other sums payable hereunder with respect to such series by the Company then this Indenture shall thereupon cease to be of further effect with respect to such series except for the provisions of Sections 2.03, 2.05, 2.07, 4.01, 4.02, 4.03 and 7.10, that shall survive until the date of maturity or redemption date, as the case may be, and Sections 7.06 and 11.05, that shall survive to such date and thereafter, and the Trustee, on demand of the Company and at the cost and expense of the Company shall execute proper instruments acknowledging satisfaction of and discharging this Indenture with respect to such series.

SECTION 11.02 Discharge of Obligations.

If at any time all such Securities of a particular series not heretofore delivered to the Trustee for cancellation or that have not become due and payable as described in Section 11.01 shall have been paid by the Company by depositing irrevocably with the Trustee as trust funds moneys or an amount of Governmental Obligations sufficient to pay at maturity or upon redemption all such Securities of that series not theretofore delivered to the Trustee for cancellation, including principal (and premium, if any) and interest due or to become due to such date of maturity or date fixed for redemption, as the case may be, and if the Company shall also pay or cause to be paid all other sums payable hereunder by the Company with respect to such series, then after the date such moneys or Governmental Obligations, as the case may be, are deposited with the Trustee the obligations of the Company under this Indenture with respect to such series shall cease to be of further effect except for the provisions of Sections 2.03, 2.05, 2.07, 4,01, 4.02, 4.03, 7.06, 7.10 and 11.05 hereof that shall survive until such Securities shall mature and be paid thereafter, Sections 7.06 and 11.05 shall survive.

SECTION 11.03 Deposited Moneys to be Held in Trust.

Subject to Section 11.05, all moneys or Governmental Obligations deposited with the Trustee pursuant to Sections 11.01 or 11.02 shall be held in trust and shall be available for payment as due, either directly or through any paying agent (including the Company acting as its own paying agent), to the holders of the particular series of Securities for the payment or redemption of which such moneys or Governmental Obligations have been deposited with the Trustee.

SECTION 11.04 Payment of Moneys Held by Paying Agents.

In connection with the satisfaction and discharge of this Indenture all moneys or Governmental Obligations then held by any paying agent under the provisions of this Indenture shall, upon demand of the Company, be paid to the Trustee and thereupon such paying agent shall be released from all further liability with respect to such moneys or Governmental Obligations.

SECTION 11.05 Repayment to Company.

Any moneys or Governmental Obligations deposited with any paying agent or the Trustee, or then held by the Company, in trust for payment of principal of or premium or interest on the Securities of a particular series that are not applied but remain unclaimed by the holders of such Securities for two years after the date upon which the principal of (and premium, if any) or interest on such Securities shall have respectively become due and payable, shall be repaid to the Company or (if then held by the Company) shall be discharged from such trust in each case, promptly after the end of any such two-year period or, at the request of the Company, on a later date specified by the Company; and thereupon the paying agent and the Trustee shall be released from all further liability with respect to such moneys or Governmental Obligations, and the holder of any of the Securities entitled to receive such payment shall thereafter, as an unsecured general creditor, look only to the Company for the payment thereof.

ARTICLE XII

IMMUNITY OF INCORPORATORS, STOCKHOLDERS, OFFICERS AND DIRECTORS

SECTION 12.01 No Recourse.

No recourse under or upon any obligation, covenant or agreement of this Indenture, or of any Security, or for any claim based thereon or otherwise in respect thereof, shall be had against any incorporator, stockholder, officer or director, past, present or future as such, of the Company or of any predecessor or successor corporation, either directly or through the Company or any such predecessor or successor corporation, whether by virtue of any constitution, statute or rule of law, or by the enforcement of any assessment or penalty or otherwise; it being expressly understood that this Indenture and the obligations issued hereunder are solely corporate obligations, and that no such personal liability whatever shall attach to, or is or shall be incurred by, the incorporators, stockholders, officers or directors as such, of the Company or of any predecessor or successor corporation, or any of them, because of the creation of the indebtedness hereby authorized, or under or by reason of the obligations, covenants or agreements contained in this Indenture or in any of the Securities or implied therefrom; and that any and all such personal liability of every name and nature, either at common law or in equity or by constitution or statute, of, and any and all such rights and claims against, every such incorporator, stockholder, officer or director as such, because of the creation of the indebtedness hereby authorized, or under or by reason of the obligations, covenants or agreements contained in this Indenture or in any of the Securities or implied therefrom, are hereby expressly waived and released as a condition of, and as a consideration for, the execution of this Indenture and the issuance of such Securities.

ARTICLE XIII

MISCELLANEOUS PROVISIONS

SECTION 13.01 Effect on Successors and Assigns.

All the covenants, stipulations, promises and agreements in this Indenture contained by or on behalf of the Company shall bind its successors and assigns, whether so expressed or not.

SECTION 13.02 Actions by Successor.

Any act or proceeding by any provision of this Indenture authorized or required to be done or performed by any board, committee or officer of the Company shall and may be done and performed with like force and effect by the corresponding board, committee or officer of any corporation that shall at the time be the lawful successor of the Company.

SECTION 13.03 Surrender of Company Powers.

The Company by instrument in writing executed by authority of its Board of Directors and delivered to the Trustee may surrender any of the powers reserved to the Company, and thereupon such power so surrendered shall terminate both as to the Company and as to any successor corporation.

SECTION 13.04 Notices.

Except as otherwise expressly provided herein any notice or demand that by any provision of this Indenture is required or permitted to be given or served by the Trustee or by the holders of Securities to or on the Company may be given or served by being deposited first class postage prepaid in a post-office letterbox addressed (until another address is filed in writing by the Company with the Trustee), as follows: Wrap Technologies, Inc., Attn: [ ], 3480 Main Hwy, Suite 202, Miami, Florida 33133. Any notice, election, request or demand by the Company or any Securityholder to or upon the Trustee shall be deemed to have been sufficiently given or made, for all purposes, if given or made in writing at the Corporate Trust Office of the Trustee. Any notice or communication to a holder shall be mailed by first-class mail to his address shown on the Security Register kept by the Security Registrar.

Failure to mail a notice or communication to a holder or any defect in such notice or communication shall not affect its sufficiency with respect to other holders. If a notice or communication is mailed or sent in the manner provided above within the time prescribed, it is duly given as of the date it is mailed, whether or not the addressee receives it, except that notice to the Trustee or the Company shall only be effective upon receipt thereof by the Trustee or the Company, respectively. If the Company mails a notice or communication to holders of Securities, it shall mail a copy to the Trustee at the same time.

SECTION 13.05 Governing Law.

This Indenture and each Security shall be deemed to be a contract made under the internal laws of the State of New York, and for all purposes shall be construed in accordance with the laws of said State.

SECTION 13.06 Treatment of Securities as Debt.

It is intended that the Securities will be treated as indebtedness and not as equity for federal income tax purposes. The provisions of this Indenture shall be interpreted to further this intention.

SECTION 13.07 Compliance Certificates and Opinions.

&nbsp;&nbsp;&nbsp;&nbsp;(a) Upon any application or demand by the Company to the
 Trustee to take any action under any of the provisions of this Indenture, the Company, shall furnish to the Trustee an Officers'
 Certificate stating that all conditions precedent provided for in this Indenture relating to the proposed action have been complied
 with and an Opinion of Counsel stating that in the opinion of such counsel all such conditions precedent have been complied with,
 except that in the case of any such application or demand as to which the furnishing of such documents is specifically required by
 any provision of this Indenture relating to such particular application or demand, no additional certificate or opinion need be furnished.

(b) Each certificate or opinion provided for in this Indenture
 and delivered to the Trustee with respect to compliance with a condition or covenant in this Indenture shall include (1) a statement
 that the Person making such certificate or opinion has read such covenant or condition; (2) a brief statement as to the nature and
 scope of the examination or investigation upon which the statements or opinions contained in such certificate or opinion are based;
 (3) a statement that, in the opinion of such Person, he has made such examination or investigation as is necessary to enable him
 to express an informed opinion as to whether or not such covenant or condition has been complied with; and (4) a statement as to
 whether or not, in the opinion of such Person, such condition or covenant has been complied with.

SECTION 13.08 Payments on Business Days.

Except as provided pursuant to Section 2.01 pursuant to a Board Resolution, and as set forth in an Officers' Certificate, or established in one or more indentures supplemental to this Indenture, in any case where the date of maturity of interest or principal of any Security or the date of redemption of any Security shall not be a Business Day, then payment of interest or principal (and premium, if any) may be made on the next succeeding Business Day with the same force and effect as if made on the nominal date of maturity or redemption, and no interest shall accrue for the period after such nominal date.

SECTION 13.09 Conflict with Trust Indenture Act.

If and to the extent that any provision of this Indenture limits, qualifies or conflicts with the duties imposed by Sections 310 to 317, inclusive, of the Trust Indenture Act, such imposed duties shall control.

SECTION 13.10 Counterparts.

This Indenture may be executed in any number of counterparts, each of which shall be an original, but such counterparts shall together constitute but one and the same instrument.

SECTION 13.11 Separability.

In case any one or more of the provisions contained in this Indenture or in the Securities of any series shall for any reason be held to be invalid, illegal or unenforceable in any respect, such invalidity, illegality or unenforceability shall not affect any other provisions of this Indenture or of such Securities, but this Indenture and such Securities shall be construed as if such invalid or illegal or unenforceable provision had never been contained herein or therein.

SECTION 13.12 Assignment.

The Company will have the right at all times to assign any of its rights or obligations under this Indenture to a direct or indirect wholly-owned Subsidiary of the Company, provided that, in the event of any such assignment, the Company, will remain liable for all such obligations. Subject to the foregoing, this Indenture is binding upon and inures to the benefit of the parties thereto and their respective successors and assigns. This Indenture may not otherwise be assigned by the parties thereto.

IN WITNESS WHEREOF, the parties hereto have caused this Indenture to be duly executed all as of the day and year first above written.

---

| |
|:---|
| WRAP TECHNOLOGIES, INC. |
| By: |
| Name: |
| Title: |
| [ ], |
| As Trustee |
| By: |
| Name: |
| Title: |

---

## Exhibit 4.13

**Exhibit 4.13**

**WRAP TECHNOLOGIES, INC.**

Issuer

AND

[ ]

Trustee

**INDENTURE**

Dated as of [ ]

**Subordinated Debt Securities**

**CROSS-REFERENCE TABLE (1)**

---

| | |
|:---|:---|
| **Section of Trust Indenture Act of 1939, as Amended** | **Section of <br> Indenture** |
| 310(a). | 7.09 |
| 310(b). | 7.08 |
| 7.10 |  |
| 310(c). | Inapplicable |
| 311(a). | 7.13(a) |
| 311(b). | 7.13(b) |
| 311(c). | Inapplicable |
| 312(a). | 5.02(a) |
| 312(b). | 5.02(b) |
| 312(c). | 5.02(c) |
| 313(a). | 5.04(a) |
| 313(b). | 5.04(a) |
| 313(c). | 5.04(a) |
|  | 5.04(b) |
| 313(d). | 5.04(b) |
| 314(a). | 5.03 |
| 314(b). | Inapplicable |
| 314(c). | 13.06 |
| 314(d). | Inapplicable |
| 314(e). | 13.06 |
| 314(f). | Inapplicable |
| 315(a). | 7.01(a) |
|  | 7.02 |
| 315(b). | 6.07 |
| 315(c). | 7.01 |
| 315(d). | 7.01(b) |
|  | 7.01(c) |
| 315(e). | 6.07 |
| 316(a). | 6.06 |
|  | 8.04 |
| 316(b). | 6.04 |
| 316(c). | 8.01 |
| 317(a). | 6.02 |
| 317(b). | 4.03 |
| 318(a). | 13.08 |

---

&nbsp;&nbsp;&nbsp;&nbsp;(1) This
 Cross-Reference Table does not constitute part of the Indenture and shall not have any bearing on the interpretation of any of its
 terms or provisions.

i

****TABLE OF CONTENTS** (2)**

---

| | | |
|:---|:---|:---|
| ARTICLE I | DEFINITIONS | 1 |
| &nbsp;&nbsp;&nbsp;SECTION 1.01 | Definitions of Terms | 1 |
| ARTICLE II | ISSUE, DESCRIPTION, TERMS, EXECUTION, | 5 |
| &nbsp;&nbsp;&nbsp;SECTION 2.01 | Designation and Terms of Securities | 5 |
| &nbsp;&nbsp;&nbsp;SECTION 2.02 | Form of Securities and Trustee's Certificate | 7 |
| &nbsp;&nbsp;&nbsp;SECTION 2.03 | Denominations: Provisions for Payment | 8 |
| &nbsp;&nbsp;&nbsp;SECTION 2.04 | Execution and Authentications | 9 |
| &nbsp;&nbsp;&nbsp;SECTION 2.05 | Registration of Transfer and Exchange | 10 |
| &nbsp;&nbsp;&nbsp;SECTION 2.06 | Temporary Securities | 11 |
| &nbsp;&nbsp;&nbsp;SECTION 2.07 | Mutilated, Destroyed, Lost or Stolen Securities | 12 |
| &nbsp;&nbsp;&nbsp;SECTION 2.08 | Cancellation | 12 |
| &nbsp;&nbsp;&nbsp;SECTION 2.09 | Benefits of Indenture | 13 |
| &nbsp;&nbsp;&nbsp;SECTION 2.10 | Authenticating Agent | 13 |
| &nbsp;&nbsp;&nbsp;SECTION 2.11 | Global Securities | 14 |
| ARTICLE III | REDEMPTION OF SECURITIES AND SINKING FUND PROVISIONS | 15 |
| &nbsp;&nbsp;&nbsp;SECTION 3.01 | Redemption | 15 |
| &nbsp;&nbsp;&nbsp;SECTION 3.02 | Notice of Redemption | 15 |
| &nbsp;&nbsp;&nbsp;SECTION 3.03 | Payment Upon Redemption | 16 |
| &nbsp;&nbsp;&nbsp;SECTION 3.04 | Sinking Fund | 17 |
| &nbsp;&nbsp;&nbsp;SECTION 3.05 | Satisfaction of Sinking Fund Payments with Securities | 17 |
| &nbsp;&nbsp;&nbsp;SECTION 3.06 | Redemption of Securities for Sinking Fund | 17 |
| ARTICLE IV | COVENANTS | 18 |
| &nbsp;&nbsp;&nbsp;SECTION 4.01 | Payment of Principal, Premium and Interest | 18 |
| &nbsp;&nbsp;&nbsp;SECTION 4.02 | Maintenance of Office or Agency | 18 |
| &nbsp;&nbsp;&nbsp;SECTION 4.03 | Paying Agents | 18 |
| &nbsp;&nbsp;&nbsp;SECTION 4.04 | Appointment to Fill Vacancy in Office of Trustee | 19 |
| &nbsp;&nbsp;&nbsp;SECTION 4.05 | Compliance with Consolidation Provisions | 19 |
| ARTICLE V | SECURITYHOLDERS' LISTS AND REPORTS BY THE COMPANY AND THE TRUSTEE | 19 |
| &nbsp;&nbsp;&nbsp;SECTION 5.01 | Company to Furnish Trustee Names and Addresses of Securityholders | 19 |
| &nbsp;&nbsp;&nbsp;SECTION 5.02 | Preservation of Information; Communications with Securityholders | 20 |
| &nbsp;&nbsp;&nbsp;SECTION 5.03 | Reports by the Company | 20 |
| &nbsp;&nbsp;&nbsp;SECTION 5.04 | Reports by the Trustee | 21 |
| ARTICLE VI | REMEDIES OF THE TRUSTEE AND SECURITYHOLDERS ON EVENT OF DEFAULT | 21 |
| &nbsp;&nbsp;&nbsp;SECTION 6.01 | Events of Default | 21 |
| &nbsp;&nbsp;&nbsp;SECTION 6.02 | Collection of Indebtedness and Suits for Enforcement by Trustee | 23 |
| &nbsp;&nbsp;&nbsp;SECTION 6.03 | Application of Moneys Collected | 25 |
| &nbsp;&nbsp;&nbsp;SECTION 6.04 | Limitation on Suits | 25 |
| &nbsp;&nbsp;&nbsp;SECTION 6.05 | Rights and Remedies Cumulative; Delay or Omission Not Waiver | 26 |
| &nbsp;&nbsp;&nbsp;SECTION 6.06 | Control by Securityholders | 26 |
| &nbsp;&nbsp;&nbsp;SECTION 6.07 | Undertaking to Pay Costs | 27 |

---

ii

---

| | | |
|:---|:---|:---|
| ARTICLE VII | CONCERNING THE TRUSTEE | 28 |
| &nbsp;&nbsp;&nbsp;SECTION 7.01 | Certain Duties and Responsibilities of Trustee | 28 |
| &nbsp;&nbsp;&nbsp;SECTION 7.02 | Certain Rights of Trustee | 29 |
| &nbsp;&nbsp;&nbsp;SECTION 7.03 | Trustee Not Responsible for Recitals or Issuance of Securities | 30 |
| &nbsp;&nbsp;&nbsp;SECTION 7.04 | May Hold Securities | 30 |
| &nbsp;&nbsp;&nbsp;SECTION 7.05 | Moneys Held in Trust | 30 |
| &nbsp;&nbsp;&nbsp;SECTION 7.06 | Compensation and Reimbursement | 31 |
| &nbsp;&nbsp;&nbsp;SECTION 7.07 | Reliance on Officers' Certificate | 31 |
| &nbsp;&nbsp;&nbsp;SECTION 7.08 | Disqualification; Conflicting Interests | 32 |
| &nbsp;&nbsp;&nbsp;SECTION 7.09 | Corporate Trustee Required; Eligibility | 32 |
| &nbsp;&nbsp;&nbsp;SECTION 7.10 | Resignation and Removal; Appointment of Successor | 32 |
| &nbsp;&nbsp;&nbsp;SECTION 7.11 | Acceptance of Appointment By Successor | 33 |
| &nbsp;&nbsp;&nbsp;SECTION 7.12 | Merger, Conversion, Consolidation or Succession to Business | 35 |
| &nbsp;&nbsp;&nbsp;SECTION 7.13 | Preferential Collection of Claims Against the Company | 35 |
| ARTICLE VIII | CONCERNING THE SECURITYHOLDERS | 35 |
| &nbsp;&nbsp;&nbsp;SECTION 8.01 | Evidence of Action by Securityholders | 35 |
| &nbsp;&nbsp;&nbsp;SECTION 8.02 | Proof of Execution by Securityholders | 36 |
| &nbsp;&nbsp;&nbsp;SECTION 8.03 | Who May be Deemed Owners | 36 |
| &nbsp;&nbsp;&nbsp;SECTION 8.04 | Certain Securities Owned by Company Disregarded | 36 |
| &nbsp;&nbsp;&nbsp;SECTION 8.05 | Actions Binding on Future Securityholders | 37 |
| &nbsp;&nbsp;&nbsp;SECTION 8.06 | Purposes for Which Meetings May Be Called | 37 |
| &nbsp;&nbsp;&nbsp;SECTION 8.07 | Call Notice and Place of Meetings | 37 |
| &nbsp;&nbsp;&nbsp;SECTION 8.08 | Persons Entitled To Vote at Meetings | 38 |
| &nbsp;&nbsp;&nbsp;SECTION 8.09 | Quorum; Action | 38 |
| &nbsp;&nbsp;&nbsp;SECTION 8.10 | Determination of Voting Rights; Conduct and Adjournment of Meetings | 39 |
| &nbsp;&nbsp;&nbsp;SECTION 8.11 | Counting Votes and Recording Action of Meetings | 40 |
| ARTICLE IX | SUPPLEMENTAL INDENTURES | 40 |
| &nbsp;&nbsp;&nbsp;SECTION 9.01 | Supplemental Indentures Without the Consent of Securityholders | 40 |
| &nbsp;&nbsp;&nbsp;SECTION 9.02 | Supplemental Indentures With Consent of Securityholders | 41 |
| &nbsp;&nbsp;&nbsp;SECTION 9.03 | Effect of Supplemental Indentures | 42 |
| &nbsp;&nbsp;&nbsp;SECTION 9.04 | Securities Affected by Supplemental Indentures | 42 |
| &nbsp;&nbsp;&nbsp;SECTION 9.05 | Execution of Supplemental Indentures | 42 |
| ARTICLE X | SUCCESSOR ENTITY | 43 |
| &nbsp;&nbsp;&nbsp;SECTION 10.01 | Company May Consolidate, Etc | 43 |
| &nbsp;&nbsp;&nbsp;SECTION 10.02 | Successor Entity Substituted | 43 |
| &nbsp;&nbsp;&nbsp;SECTION 10.03 | Evidence of Consolidation, Etc | 44 |
| ARTICLE XI | SATISFACTION AND DISCHARGE | 44 |
| &nbsp;&nbsp;&nbsp;SECTION 11.01 | Satisfaction and Discharge of Indenture | 44 |
| &nbsp;&nbsp;&nbsp;SECTION 11.02 | Discharge of Obligations | 45 |
| &nbsp;&nbsp;&nbsp;SECTION 11.03 | Deposited Moneys to be Held in Trust | 45 |
| &nbsp;&nbsp;&nbsp;SECTION 11.04 | Payment of Moneys Held by Paying Agents | 45 |
| &nbsp;&nbsp;&nbsp;SECTION 11.05 | Repayment to Company | 45 |
| ARTICLE XII | IMMUNITY OF INCORPORATORS, STOCKHOLDERS, OFFICERS AND DIRECTORS | 46 |
| &nbsp;&nbsp;&nbsp;SECTION 12.01 | No Recourse | 46 |
| ARTICLE XIII | MISCELLANEOUS PROVISIONS | 46 |
| &nbsp;&nbsp;&nbsp;SECTION 13.01 | Effect on Successors and Assigns | 46 |
| &nbsp;&nbsp;&nbsp;SECTION 13.02 | Actions by Successor | 46 |
| &nbsp;&nbsp;&nbsp;SECTION 13.03 | Surrender of Company Powers | 47 |
| &nbsp;&nbsp;&nbsp;SECTION 13.04 | Notices | 47 |
| &nbsp;&nbsp;&nbsp;SECTION 13.05 | Governing Law | 47 |
| &nbsp;&nbsp;&nbsp;SECTION 13.06 | Treatment of Securities as Debt | 47 |
| &nbsp;&nbsp;&nbsp;SECTION 13.07 | Compliance Certificates and Opinions | 47 |
| &nbsp;&nbsp;&nbsp;SECTION 13.08 | Payments on Business Days | 48 |
| &nbsp;&nbsp;&nbsp;SECTION 13.09 | Conflict with Trust Indenture Act | 48 |
| &nbsp;&nbsp;&nbsp;SECTION 13.10 | Counterparts | 48 |
| &nbsp;&nbsp;&nbsp;SECTION 13.11 | Separability | 48 |
| &nbsp;&nbsp;&nbsp;SECTION 13.12 | Assignment | 49 |
| ARTICLE XIV | SUBORDINATION OF SECURITIES | 49 |
| &nbsp;&nbsp;&nbsp;SECTION 14.01 | Subordination Terms | 49 |

---

2) This **Table of Contents** does not constitute part of the Indenture and shall not have any bearing on the interpretation of any of its terms or provisions.

iii

INDENTURE, dated as of [ ], by and between Wrap Technologies, Inc., a Delaware corporation (the "Company"), and [ ], as trustee (the "Trustee"):

WHEREAS, for its lawful corporate purposes, the Company has duly authorized the execution and delivery of this Indenture to provide for the issuance of subordinated debt securities (hereinafter referred to as the "Securities"), in an unlimited aggregate principal amount to be issued from time to time in one or more series as in this Indenture provided, as registered Securities without coupons, to be authenticated by the certificate of the Trustee;

WHEREAS, to provide the terms and conditions upon which the Securities are to be authenticated, issued and delivered, the Company has duly authorized the execution of this Indenture; and

WHEREAS, all things necessary to make this Indenture a valid agreement of the Company, in accordance with its terms, have been done.

NOW, THEREFORE, in consideration of the premises and the purchase of the Securities by the holders thereof, it is mutually covenanted and agreed as follows for the equal and ratable benefit of the holders of Securities:

ARTICLE I

DEFINITIONS

SECTION 1.01 Definitions of Terms.

The terms defined in this Section (except as in this Indenture otherwise expressly provided or unless the context otherwise requires) for all purposes of this Indenture and of any indenture supplemental hereto shall have the respective meanings specified in this Section and shall include the plural as well as the singular. All other terms used in this Indenture that are defined in the Trust Indenture Act of 1939, as amended, or that are by reference in such Act defined in the Securities Act of 1933, as amended (except as herein otherwise expressly provided or unless the context otherwise requires), shall have the meanings assigned to such terms in said Trust Indenture Act and in said Securities Act as in force at the date of the execution of this instrument.

"Authenticating Agent" means an authenticating agent with respect to all or any of the series of Securities appointed with respect to all or any series of the Securities by the Trustee pursuant to Section 2.10.

"Bankruptcy Law" means Title 11, U.S. Code, or any similar federal or state law for the relief of debtors.

"Board of Directors" means the Board of Directors of the Company or any duly authorized committee of such Board.

"Board Resolution" means a copy of a resolution certified by the Secretary or an Assistant Secretary of the Company to have been duly adopted by the Board of Directors and to be in full force and effect on the date of such certification.

"Business Day" means, with respect to any series of Securities, any day other than a day on which Federal or State banking institutions in the Borough of Manhattan, the City and State of New York, are authorized or obligated by law, executive order or regulation to close.

"Certificate" means a certificate signed by the principal executive officer, the principal financial officer or the principal accounting officer of the Company. The Certificate need not comply with the provisions of Section 13.07.

"Commission" means the Securities and Exchange Commission.

"Company" means the corporation named as the "Company" in the first paragraph of this instrument until a successor corporation shall have become such pursuant to the applicable provisions of this Indenture, and thereafter "Company" shall mean such successor corporation.

"Corporate Trust Office" means the office of the Trustee at which, at any particular time, its corporate trust business shall be principally administered, which office at the date hereof is located at [ ], except that whenever a provision herein refers to an office or agency of the Trustee in the Borough of Manhattan, the City and State of New York, such office is located, at the date hereof, at [ ].

"Custodian" means any receiver, trustee, assignee, liquidator, or similar official under any Bankruptcy Law.

"Default" means an event which is, or after notice or lapse of time, or both, would constitute an Event of Default.

"Depositary" means, with respect to Securities of any series, for which the Company shall determine that such Securities will be issued as a Global Security, The Depository Trust Company, New York, New York, another clearing agency, or any successor registered as a clearing agency under the Exchange Act, or other applicable statute or regulation, which, in each case, shall be designated by the Company pursuant to either Section 2.01 or Section 2.11.

"Event of Default" means, with respect to Securities of a particular series, any event specified in Section 6.01, continued for the period of time, if any, therein designated.

"Exchange Act" means the Securities Exchange Act of 1934, as amended.

"Global Security" means, with respect to any series of Securities, a Security executed by the Company and delivered by the Trustee to the Depositary or pursuant to the Depositary's instruction, all in accordance with this Indenture, which shall be registered in the name of the Depositary or its nominee.

"Governmental Obligations" means securities that are (i) direct obligations of the United States of America for the payment of which its full faith and credit is pledged or (ii) obligations of a Person controlled or supervised by and acting as an agency or instrumentality of the United States of America, the payment of which is unconditionally guaranteed as a full faith and credit obligation by the United States of America that, in either case, are non-callable at the option of the issuer thereof, and shall also include a depositary receipt issued by a bank (as defined in Section 3(a)(2) of the Securities Act of 1933, as amended) as custodian with respect to any such Governmental Obligation or a specific payment of principal of or interest on any such Governmental Obligation held by such custodian for the account of the holder of such depositary receipt; provided, however, that (except as required by law) such custodian is not authorized to make any deduction from the amount payable to the holder of such depositary receipt from any amount received by the custodian in respect of the Governmental Obligation or the specific payment of principal of or interest on the Governmental Obligation evidenced by such depositary receipt.

"herein," "hereof" and "hereunder," and other words of similar import, refer to this Indenture as a whole and not to any particular Article, Section or other subdivision.

"Indenture" means this instrument as originally executed or as it may from time to time be supplemented or amended by one or more indentures supplemental hereto entered into in accordance with the terms hereof.

"Interest Payment Date," when used with respect to any installment of interest on a Security of a particular series, means the date specified in such Security or in a Board Resolution or in an indenture supplemental hereto with respect to such series as the fixed date on which an installment of interest with respect to Securities of that series is due and payable.

"Officers' Certificate" means a certificate signed by the President or a Vice President and by the Chief Financial Officer, Vice President of Finance, the Treasurer or an Assistant Treasurer or the Controller or an Assistant Controller or the Secretary or an Assistant Secretary of the Company that is delivered to the Trustee in accordance with the terms hereof. Certificate shall include the statements provided for in Section 13.07, if and to the extent required by the provisions thereof.

"Opinion of Counsel" means a written opinion of counsel, who may be counsel to the Company (and may include directors or employees of the Company) and which opinion is acceptable to the Trustee which acceptance shall not be unreasonably withheld.

"Outstanding", when used with reference to Securities of any series, means, subject to the provisions of Section 8.04, as of any particular time, all Securities of that series theretofore authenticated and delivered by the Trustee under this Indenture, except (a) Securities theretofore canceled by the Trustee or any paying agent, or delivered to the Trustee or any paying agent for cancellation or that have previously been canceled; (b) Securities or portions thereof for the payment or redemption of which moneys or Governmental Obligations in the necessary amount shall have been deposited in trust with the Trustee or with any paying agent (other than the Company) or shall have been set aside and segregated in trust by the Company (if the Company shall act as its own paying agent); provided, however, that if such Securities or portions of such Securities are to be redeemed prior to the maturity thereof, notice of such redemption shall have been given as in Article III provided, or provision satisfactory to the Trustee shall have been made for giving such notice; and (c) Securities in lieu of or in substitution for which other Securities shall have been authenticated and delivered pursuant to the terms of Section 2.07.

"Person" means any individual, corporation, limited liability company, partnership, joint-venture, association, joint-stock company, trust, estate, unincorporated organization or government or any agency or political subdivision thereof.

"Predecessor Security" of any particular Security means every previous Security evidencing all or a portion of the same debt as that evidenced by such particular Security; and, for the purposes of this definition, any Security authenticated and delivered under Section 2.07 in lieu of a mutilated, destroyed, lost or stolen Security shall be deemed to evidence the same debt as the mutilated, destroyed, lost or stolen Security.

"Responsible Officer," when used with respect to the Trustee, means any officer of the Trustee, including any vice president, assistant vice president, secretary, assistant secretary, the treasurer, any assistant treasurer, the managing director or any other officer of the Trustee customarily performing functions similar to those performed by any of the above designated officers and also means, with respect to a particular corporate trust matter, any other officer to whom such matter is referred because of such officer's knowledge of and familiarity with the particular subject.

"Securities" means the debt Securities authenticated and delivered under this Indenture.

"Security Register" has the meaning specified in Section 2.05.

"Security Registrar" has the meaning specified in Section 2.05.

"Securityholder," "holder of Securities," "registered holder," or other similar term, means the Person or Persons in whose name or names a particular Security shall be registered in the Security Register.

"Subsidiary" means, with respect to any Person, (i) any corporation at least a majority of whose outstanding Voting Stock shall at the time be owned, directly or indirectly, by such Person or by one or more of its Subsidiaries or by such Person and one or more of its Subsidiaries, (ii) any general partnership, joint venture or similar entity, at least a majority of whose outstanding partnership or similar interests shall at the time be owned by such Person, or by one or more of its Subsidiaries, or by such Person and one or more of its Subsidiaries and (iii) any limited partnership of which such Person or any of its Subsidiaries is a general partner.

"Trustee" means the Person named as the "Trustee" in the first paragraph of this instrument until a successor Trustee shall have become such pursuant to the applicable provisions of this Indenture, and thereafter "Trustee" shall mean such successor Trustee. The term "Trustee" as used with respect to a particular series of the Securities shall mean the trustee with respect to that series.

"Trust Indenture Act" means the Trust Indenture Act of 1939, as amended, subject to the provisions of Sections 9.01, 9.02, and 10.01, as in effect at the date of execution of this instrument; provided, however, that in the event the Trust Indenture Act is amended after such date, Trust Indenture Act means, to the extent required by such amendment, the Trust Indenture Act of 1939, as so amended, or any successor statute.

"Voting Stock," as applied to any Person, means shares, interests, participations or other equivalents in the equity interest (however designated) in such Person having ordinary voting power for the election of a majority of the directors (or the equivalent) of such Person, other than shares, interests, participations or other equivalents having such power only by reason of the occurrence of a contingency.

ARTICLE II

ISSUE, DESCRIPTION, TERMS, EXECUTION,

REGISTRATION AND EXCHANGE OF SECURITIES

SECTION 2.01 Designation and Terms of Securities.

&nbsp;&nbsp;&nbsp;&nbsp;(a) The
 aggregate principal amount of Securities that may be authenticated and delivered under this Indenture is unlimited. The Securities
 may be issued in one or more series up to the aggregate principal amount of Securities of that series from time to time authorized
 by or pursuant to a Board Resolution of the Company or pursuant to one or more indentures supplemental hereto. Prior to the initial
 issuance of Securities of a given series, there shall be established in or pursuant to a Board Resolution of the Company, and set
 forth in an Officers' Certificate of the Company, or established in one or more indentures supplemental hereto:

&nbsp;&nbsp;&nbsp;&nbsp;(1) the
 title of the Security of the series (which shall distinguish the Securities of the series from all other Securities);

&nbsp;&nbsp;&nbsp;&nbsp;(2) the
 aggregate principal amount of the Securities of such series initially to be issued and any limit upon the aggregate principal amount
 of the Securities of that series that may be authenticated and delivered under this Indenture (except for Securities authenticated
 and delivered upon registration of transfer of, or in exchange for, or in lieu of, other Securities of that series);

&nbsp;&nbsp;&nbsp;&nbsp;(3) the
 currency or units based on or relating to currencies in which debt securities of such series are denominated and the currency or
 units in which principal or interest or both will or may be payable;

&nbsp;&nbsp;&nbsp;&nbsp;(4) the
 date or dates on which the principal of the Securities of the series is payable and the place(s) of payment;

&nbsp;&nbsp;&nbsp;&nbsp;(5) the
 rate or rates at which the Securities of the series shall bear interest or the manner of calculation of such rate or rates, if any;

&nbsp;&nbsp;&nbsp;&nbsp;(6) the
 date or dates from which such interest shall accrue, the Interest Payment Dates on which such interest will be payable or the manner
 of determination of such Interest Payment Dates, the place(s) of payment, and the record date for the determination of holders to
 whom interest is payable on any such Interest Payment Dates or the method for determining such dates;

&nbsp;&nbsp;&nbsp;&nbsp;(7) the
 right, if any, to extend the interest payment periods or to defer the payment of interest and the duration of such extension;

&nbsp;&nbsp;&nbsp;&nbsp;(8) the
 period or periods within which, the price or prices at which and the terms and conditions upon which, Securities of the series may
 be redeemed, in whole or in part, at the option of the Company;

&nbsp;&nbsp;&nbsp;&nbsp;(9) the
 obligation, if any, of the Company to redeem or purchase Securities of the series pursuant to any sinking fund or analogous provisions
 (including payments made in cash in satisfaction of future sinking fund obligations) or at the option of a holder thereof and the
 period or periods within which, the price or prices at which, and the terms and conditions upon which, Securities of the series shall
 be redeemed or purchased, in whole or in part, pursuant to such obligation;

&nbsp;&nbsp;&nbsp;&nbsp;(10) whether
 or not the debt securities will be secured or unsecured, and the terms of any secured debt;

&nbsp;&nbsp;&nbsp;&nbsp;(11) the
 form of the Securities of the series including the form of the Certificate of Authentication for such series;

&nbsp;&nbsp;&nbsp;&nbsp;(12) if
 other than denominations of one thousand U.S. dollars ($1,000) or any integral multiple thereof, the denominations in which the Securities
 of the series shall be issuable;

&nbsp;&nbsp;&nbsp;&nbsp;(13) any
 and all other terms with respect to such series (which terms shall not be inconsistent with the terms of this Indenture, as amended
 by any supplemental indenture) including any terms which may be required by or advisable under United States laws or regulations
 or advisable in connection with the marketing of Securities of that series;

&nbsp;&nbsp;&nbsp;&nbsp;(14) whether
 the Securities are issuable as a Global Security and, in such case, the identity of the Depositary for such series;

&nbsp;&nbsp;&nbsp;&nbsp;(15) whether
 the Securities will be convertible into shares of common stock or other securities of the Company and, if so, the terms and conditions
 upon which such Securities will be so convertible, including the conversion price and the conversion period;

&nbsp;&nbsp;&nbsp;&nbsp;(16) if
 other than the principal amount thereof, the portion of the principal amount of Securities of the series which shall be payable upon
 declaration of acceleration of the maturity thereof pursuant to Section 6.01;

&nbsp;&nbsp;&nbsp;&nbsp;(17) any
 additional or different Events of Default or restrictive covenants provided for with respect to the Securities of the series; and

&nbsp;&nbsp;&nbsp;&nbsp;(18) the
 subordination terms of the Securities of the series.

All Securities of any one series shall be substantially identical except as to denomination and except as may otherwise be provided in or pursuant to any such Board Resolution or in any indentures supplemental hereto.

If any of the terms of the series are established by action taken pursuant to a Board Resolution of the Company, a copy of an appropriate record of such action shall be certified by the Secretary or an Assistant Secretary of the Company and delivered to the Trustee at or prior to the delivery of the Officers' Certificate of the Company setting forth the terms of the series.

Securities of any particular series may be issued at various times, with different dates on which the principal or any installment of principal is payable, with different rates of interest, if any, or different methods by which rates of interest may be determined, with different dates on which such interest may be payable and with different redemption dates.

SECTION 2.02 Form of Securities and Trustee's Certificate.

The Securities of any series and the Trustee's certificate of authentication to be borne by such Securities shall be substantially of the tenor and purport as set forth in one or more indentures supplemental hereto or as provided in a Board Resolution of the Company and as set forth in an Officers' Certificate of the Company and may have such letters, numbers or other marks of identification or designation and such legends or endorsements printed, lithographed or engraved thereon as the Company may deem appropriate and as are not inconsistent with the provisions of this Indenture, or as may be required to comply with any law or with any rule or regulation made pursuant thereto or with any rule or regulation of any stock exchange on which Securities of that series may be listed, or to conform to usage.

SECTION 2.03 Denominations: Provisions for Payment.

The Securities shall be issuable as registered Securities and in the denominations of one thousand U.S. dollars ($1,000) or any integral multiple thereof, subject to Section 2.01(a)(12). The Securities of a particular series shall bear interest payable on the dates and at the rate specified with respect to that series. The principal of and the interest on the Securities of any series, as well as any premium thereon in case of redemption thereof prior to maturity, shall be payable in the coin or currency of the United States of America that at the time is legal tender for public and private debt, at the office or agency of the Company maintained for that purpose in the Borough of Manhattan, the City and State of New York. Each Security shall be dated the date of its authentication. Interest on the Securities shall be computed on the basis of a 360-day year composed of twelve 30-day months.

The interest installment on any Security that is payable, and is punctually paid or duly provided for, on any Interest Payment Date for Securities of that series shall be paid to the Person in whose name said Security (or one or more Predecessor Securities) is registered at the close of business on the regular record date for such interest installment. In the event that any Security of a particular series or portion thereof is called for redemption and the redemption date is subsequent to a regular record date with respect to any Interest Payment Date and prior to such Interest Payment Date, interest on such Security will be paid upon presentation and surrender of such Security as provided in Section 3.03.

Any interest on any Security that is payable, but is not punctually paid or duly provided for, on any Interest Payment Date for Securities of the same series (herein called "Defaulted Interest") shall forthwith cease to be payable to the registered holder on the relevant regular record date by virtue of having been such holder; and such Defaulted Interest shall be paid by the Company, at its election, as provided in clause (1) or clause (2) below:

&nbsp;&nbsp;&nbsp;&nbsp;(1) The
 Company may make payment of any Defaulted Interest on Securities to the Persons in whose names such Securities (or their respective
 Predecessor Securities) are registered at the close of business on a special record date for the payment of such Defaulted Interest,
 which shall be fixed in the following manner: the Company shall notify the Trustee in writing of the amount of Defaulted Interest
 proposed to be paid on each such Security and the date of the proposed payment, and at the same time the Company shall deposit with
 the Trustee an amount of money equal to the aggregate amount proposed to be paid in respect of such Defaulted Interest or shall make
 arrangements satisfactory to the Trustee for such deposit prior to the date of the proposed payment, such money when deposited to
 be held in trust for the benefit of the Persons entitled to such Defaulted Interest as in this clause provided. Thereupon the Trustee
 shall fix a special record date for the payment of such Defaulted Interest which shall not be more than 15 nor less than 10 days
 prior to the date of the proposed payment and not less than 10 days after the receipt by the Trustee of the notice of the proposed
 payment. The Trustee shall promptly notify the Company of such special record date and, in the name and at the expense of the Company,
 shall cause notice of the proposed payment of such Defaulted Interest and the special record date therefor to be mailed, first class
 postage prepaid, to each Securityholder at his or her address as it appears in the Security Register, not less than 10 days prior
 to such special record date. Notice of the proposed payment of such Defaulted Interest and the special record date therefor having
 been mailed as aforesaid, such Defaulted Interest shall be paid to the Persons in whose names such Securities (or their respective
 Predecessor Securities) are registered on such special record date.

&nbsp;&nbsp;&nbsp;&nbsp;(2) The
 Company may make payment of any Defaulted Interest on any Securities in any other lawful manner not inconsistent with the requirements
 of any securities exchange on which such Securities may be listed, and upon such notice as may be required by such exchange, if,
 after notice given by the Company to the Trustee of the proposed payment pursuant to this clause, such manner of payment shall be
 deemed practicable by the Trustee.

Unless otherwise set forth in a Board Resolution of the Company or one or more indentures supplemental hereto establishing the terms of any series of Securities pursuant to Section 2.01 hereof, the term "regular record date" as used in this Section with respect to a series of Securities with respect to any Interest Payment Date for such series shall mean either the fifteenth day of the month immediately preceding the month in which an Interest Payment Date established for such series pursuant to Section 2.01 hereof shall occur, if such Interest Payment Date is the first day of a month, or the last day of the month immediately preceding the month in which an Interest Payment Date established for such series pursuant to Section 2.01 hereof shall occur, if such Interest Payment Date is the fifteenth day of a month, whether or not such date is a Business Day.

Subject to the foregoing provisions of this Section, each Security of a series delivered under this Indenture upon transfer of or in exchange for or in lieu of any other Security of such series shall carry the rights to interest accrued and unpaid, and to accrue, that were carried by such other Security.

SECTION 2.04 Execution and Authentications.

The Securities shall be signed on behalf of the Company by its President, or one of its Vice Presidents, or its Treasurer, or one of its Assistant Treasurers, or its Secretary, or one of its Assistant Secretaries, under its corporate seal attested by its Secretary or one of its Assistant Secretaries. Signatures may be in the form of a manual or facsimile signature. The Company may use the facsimile signature of any Person who shall have been a President or Vice President thereof, or of any Person who shall have been a Treasurer or Assistant Treasurer thereof, or of any Person who shall have been a Secretary or Assistant Secretary thereof, notwithstanding the fact that at the time the Securities shall be authenticated and delivered or disposed of such Person shall have ceased to be the President or a Vice President, the Treasurer or an Assistant Treasurer or the Secretary or an Assistant Secretary, of the Company. The seal of the Company may be in the form of a facsimile of such seal and may be impressed, affixed, imprinted or otherwise reproduced on the Securities. The Securities may contain such notations, legends or endorsements required by law, stock exchange rule or usage. Each Security shall be dated the date of its authentication.

A Security shall not be valid or obligatory for any purpose and shall not be entitled to any benefit under this Indenture, in each case, until authenticated with a certificate of authentication manually signed by an authorized signatory of the Trustee, or by an Authenticating Agent. Such certificate shall be conclusive evidence, and the only evidence, that the Security so authenticated has been duly authenticated and delivered hereunder and that the Security is entitled to the benefits of this Indenture. At any time and from time to time after the execution and delivery of this Indenture, the Company may deliver Securities of any series executed by the Company to the Trustee for authentication, together with a written order of the Company for the authentication and delivery of such Securities, signed by its President or any Vice President and its Secretary or any Assistant Secretary, and the Trustee in accordance with such written order shall authenticate and deliver such Securities.

In authenticating such Securities and accepting the additional responsibilities under this Indenture in relation to such Securities, the Trustee shall be entitled to receive, and (subject to Section 7.01) shall be fully protected in relying upon, an Opinion of Counsel stating that the form and terms thereof have been established in conformity with the provisions of this Indenture.

The Trustee shall not be required to authenticate such Securities if the issue of such Securities pursuant to this Indenture will affect the Trustee's own rights, duties or immunities under the Securities and this Indenture or otherwise in a manner that is not reasonably acceptable to the Trustee.

SECTION 2.05 Registration of Transfer and Exchange.

&nbsp;&nbsp;&nbsp;&nbsp;(a) Securities
 of any series may be exchanged upon presentation thereof at the office or agency of the Company designated for such purpose in the
 Borough of Manhattan, the City and State of New York, for other Securities of such series of authorized denominations, and for a
 like aggregate principal amount, upon payment of a sum sufficient to cover any tax or other governmental charge in relation thereto,
 all as provided in this Section. In respect of any Securities so surrendered for exchange, the Company shall execute, the Trustee
 shall authenticate and such office or agency shall deliver in exchange therefor the Security or Securities of the same series that
 the Securityholder making the exchange shall be entitled to receive, bearing numbers not contemporaneously outstanding.

&nbsp;&nbsp;&nbsp;&nbsp;(b) The
 Company shall keep, or cause to be kept, at its office or agency designated for such purpose in the Borough of Manhattan, the City
 and State of New York, or such other location designated by the Company a register or registers (herein referred to as the "Security
 Register") in which, subject to such reasonable regulations as it may prescribe, the Company shall register the Securities
 and the transfers of Securities as in this Article provided and which at all reasonable times shall be open for inspection by the
 Trustee. The registrar for the purpose of registering Securities and transfer of Securities as herein provided shall be appointed
 as authorized by Board Resolution (the "Security Registrar").

Upon surrender for transfer of any Security at the office or agency of the Company designated for such purpose, the Company shall execute, the Trustee shall authenticate and such office or agency shall deliver in the name of the transferee or transferees a new Security or Securities of the same series as the Security presented for a like aggregate principal amount.

All Securities presented or surrendered for exchange or registration of transfer, as provided in this Section, shall be accompanied (if so required by the Company or the Security Registrar) by a written instrument or instruments of transfer, in form satisfactory to the Company or the Security Registrar, duly executed by the registered holder or by such holder's duly authorized attorney in writing.

&nbsp;&nbsp;&nbsp;&nbsp;(c) No
 service charge shall be made for any exchange or registration of transfer of Securities, or issue of new Securities in case of partial
 redemption of any series, but the Company may require payment of a sum sufficient to cover any tax or other governmental charge in
 relation thereto, other than exchanges pursuant to Section 2.06, Section 3.03(b) and Section 9.04 not involving any transfer.

&nbsp;&nbsp;&nbsp;&nbsp;(d) The
 Company shall not be required (i) to issue, exchange or register the transfer of any Securities during a period beginning at the
 opening of business 15 days before the day of the mailing of a notice of redemption of less than all the Outstanding Securities of
 the same series and ending at the close of business on the day of such mailing, nor (ii) to register the transfer of or exchange
 any Securities of any series or portions thereof called for redemption. The provisions of this Section 2.05 are, with respect to
 any Global Security, subject to Section 2.11 hereof.

SECTION 2.06 Temporary Securities.

Pending the preparation of definitive Securities of any series, the Company may execute, and the Trustee shall authenticate and deliver, temporary Securities (printed, lithographed or typewritten) of any authorized denomination. Such temporary Securities shall be substantially in the form of the definitive Securities in lieu of which they are issued, but with such omissions, insertions and variations as may be appropriate for temporary Securities, all as may be determined by the Company. Every temporary Security of any series shall be executed by the Company and be authenticated by the Trustee upon the same conditions and in substantially the same manner, and with like effect, as the definitive Securities of such series. Without unnecessary delay the Company will execute and will furnish definitive Securities of such series and thereupon any or all temporary Securities of such series may be surrendered in exchange therefor (without charge to the holders), at the office or agency of the Company designated for the purpose in the Borough of Manhattan, the City and State of New York, and the Trustee shall authenticate and such office or agency shall deliver in exchange for such temporary Securities an equal aggregate principal amount of definitive Securities of such series, unless the Company advises the Trustee to the effect that definitive Securities need not be executed and furnished until further notice from the Company. Until so exchanged, the temporary Securities of such series shall be entitled to the same benefits under this Indenture as definitive Securities of such series authenticated and delivered hereunder.

SECTION 2.07 Mutilated, Destroyed, Lost or Stolen Securities.

In case any temporary or definitive Security shall become mutilated or be destroyed, lost or stolen, the Company (subject to the next succeeding sentence) shall execute, and upon the Company's request the Trustee (subject as aforesaid) shall authenticate and deliver, a new Security of the same series, bearing a number not contemporaneously outstanding, in exchange and substitution for the mutilated Security, or in lieu of and in substitution for the Security so destroyed, lost or stolen. In every case the applicant for a substituted Security shall furnish to the Company and the Trustee such security or indemnity as may be required by them to save each of them harmless, and, in every case of destruction, loss or theft, the applicant shall also furnish to the Company and the Trustee evidence to their satisfaction of the destruction, loss or theft of the applicant's Security and of the ownership thereof. The Trustee may authenticate any such substituted Security and deliver the same upon the written request or authorization of any officer of the Company. Upon the issuance of any substituted Security, the Company may require the payment of a sum sufficient to cover any tax or other governmental charge that may be imposed in relation thereto and any other expenses (including the fees and expenses of the Trustee) connected therewith. In case any Security that has matured or is about to mature shall become mutilated or be destroyed, lost or stolen, the Company may, instead of issuing a substitute Security, pay or authorize the payment of the same (without surrender thereof except in the case of a mutilated Security) if the applicant for such payment shall furnish to the Company and the Trustee such security or indemnity as they may require to save them harmless, and, in case of destruction, loss or theft, evidence to the satisfaction of the Company and the Trustee of the destruction, loss or theft of such Security and of the ownership thereof.

Every replacement Security issued pursuant to the provisions of this Section shall constitute an additional contractual obligation of the Company whether or not the mutilated, destroyed, lost or stolen Security shall be found at any time, or be enforceable by anyone, and shall be entitled to all the benefits of this Indenture equally and proportionately with any and all other Securities of the same series duly issued hereunder. All Securities shall be held and owned upon the express condition that the foregoing provisions are exclusive with respect to the replacement or payment of mutilated, destroyed, lost or stolen Securities, and shall preclude (to the extent lawful) any and all other rights or remedies, notwithstanding any law or statute existing or hereafter enacted to the contrary with respect to the replacement or payment of negotiable instruments or other securities without their surrender.

SECTION 2.08 Cancellation.

All Securities surrendered for the purpose of payment, redemption, exchange or registration of transfer shall, if surrendered to the Company or any paying agent, be delivered to the Trustee for cancellation, or, if surrendered to the Trustee, shall be cancelled by it, and no Securities shall be issued in lieu thereof except as expressly required or permitted by any of the provisions of this Indenture. On request of the Company at the time of such surrender, the Trustee shall deliver to the Company canceled Securities held by the Trustee. In the absence of such request the Trustee may dispose of canceled Securities in accordance with its standard procedures and deliver a certificate of disposition to the Company. If the Company shall otherwise acquire any of the Securities, however, such acquisition shall not operate as a redemption or satisfaction of the indebtedness represented by such Securities unless and until the same are delivered to the Trustee for cancellation.

SECTION 2.09 Benefits of Indenture.

Nothing in this Indenture or in the Securities, express or implied, shall give or be construed to give to any Person, other than the parties hereto and the holders of the Securities (and, with respect to the provisions of Article XIV, the holders of Senior Indebtedness, as defined in any supplement to this Indenture pursuant to Article XIV) any legal or equitable right, remedy or claim under or in respect of this Indenture, or under any covenant, condition or provision herein contained; all such covenants, conditions and provisions being for the sole benefit of the parties hereto and of the holders of the Securities (and, with respect to the provisions of Article XIV, the holders of Senior Indebtedness).

SECTION 2.10 Authenticating Agent.

So long as any of the Securities of any series remain Outstanding there may be an Authenticating Agent for any or all such series of Securities which the Trustee shall have the right to appoint. Said Authenticating Agent shall be authorized to act on behalf of the Trustee to authenticate Securities of such series issued upon exchange, transfer or partial redemption thereof, and Securities so authenticated shall be entitled to the benefits of this Indenture and shall be valid and obligatory for all purposes as if authenticated by the Trustee hereunder. All references in this Indenture to the authentication of Securities by the Trustee shall be deemed to include authentication by an Authenticating Agent for such series. Each Authenticating Agent shall be acceptable to the Company and shall be a corporation that has a combined capital and surplus, as most recently reported or determined by it, sufficient under the laws of any jurisdiction under which it is organized or in which it is doing business to conduct a trust business, and that is otherwise authorized under such laws to conduct such business and is subject to supervision or examination by Federal or State authorities. If at any time any Authenticating Agent shall cease to be eligible in accordance with these provisions, it shall resign immediately.

Any Authenticating Agent may at any time resign by giving written notice of resignation to the Trustee and to the Company. The Trustee may at any time (and upon request by the Company shall) terminate the agency of any Authenticating Agent by giving written notice of termination to such Authenticating Agent and to the Company. Upon resignation, termination or cessation of eligibility of any Authenticating Agent, the Trustee may appoint an eligible successor Authenticating Agent acceptable to the Company. Any successor Authenticating Agent, upon acceptance of its appointment hereunder, shall become vested with all the rights, powers and duties of its predecessor hereunder as if originally named as an Authenticating Agent pursuant hereto.

SECTION 2.10 Global Securities

&nbsp;&nbsp;&nbsp;&nbsp;(a) If
 the Company shall establish pursuant to Section 2.01 that some or all of the Securities of a particular series are to be issued as
 a Global Security, then the Company shall execute and the Trustee shall, in accordance with Section 2.04, authenticate and deliver,
 a Global Security that (i) shall represent, and shall be denominated in an amount equal to the aggregate principal amount of, the
 Outstanding Securities of such series which are to be issued as a Global Security, (ii) shall be registered in the name of the Depositary
 or its nominee, (iii) shall be delivered by the Trustee to the Depositary or pursuant to the Depositary's instruction and (iv)
 shall bear a legend substantially to the following effect: "Except as otherwise provided in Section 2.11 of the Indenture,
 this Security may be transferred, in whole but not in part, only to another nominee of the Depositary or to a successor Depositary
 or to a nominee of such successor Depositary."

&nbsp;&nbsp;&nbsp;&nbsp;(b) Notwithstanding
 the provisions of Section 2.05, the Global Security of a series may be transferred, in whole but not in part and in the manner provided
 in Section 2.05, only to another nominee of the Depositary for such series, or to a successor Depositary for such series selected
 or approved by the Company or to a nominee of such successor Depositary.

&nbsp;&nbsp;&nbsp;&nbsp;(c) If
 at any time the Depositary for a series of the Securities notifies the Company that it is unwilling or unable to continue as Depositary
 for such series or if at any time the Depositary for such series shall no longer be registered or in good standing under the Exchange
 Act, or other applicable statute or regulation, and a successor Depositary for such series is not appointed by the Company within
 90 days after the Company receives such notice or becomes aware of such condition, as the case may be, this Section 2.11 shall no
 longer be applicable to the Securities of such series and the Company will execute, and subject to Section 2.05, the Trustee will
 authenticate and deliver the Securities of such series in definitive registered form without coupons, in authorized denominations,
 and in an aggregate principal amount equal to the principal amount of the Global Security of such series in exchange for such Global
 Security. In addition, the Company may at any time determine that the Securities of any series shall no longer be represented by
 a Global Security and that the provisions of this Section 2.11 shall no longer apply to the Securities of such series. In such event
 the Company will execute and subject to Section 2.05, the Trustee, upon receipt of an Officers' Certificate evidencing such
 determination by the Company, will authenticate and deliver the Securities of such series in definitive registered form without coupons,
 in authorized denominations, and in an aggregate principal amount equal to the principal amount of the Global Security of such series
 in exchange for such Global Security. Upon the exchange of the Global Security for such Securities in definitive registered form
 without coupons, in authorized denominations, the Global Security shall be canceled by the Trustee. Such Securities in definitive
 registered form issued in exchange for the Global Security pursuant to this Section 2.11(c) shall be registered in such names and
 in such authorized denominations as the Depositary, pursuant to instructions from its direct or indirect participants or otherwise,
 shall instruct the Trustee. The Trustee shall deliver such Securities to the Depositary for delivery to the Persons in whose names
 such Securities are so registered.

ARTICLE III

REDEMPTION OF SECURITIES AND

SINKING FUND PROVISIONS

SECTION 3.01 Redemption.

The Company may redeem the Securities of any series issued hereunder on and after the dates and in accordance with the terms established for such series pursuant to Section 2.01 hereof.

SECTION 3.02 Notice of Redemption.

&nbsp;&nbsp;&nbsp;&nbsp;(a) In
 case the Company shall desire to exercise such right to redeem all or, as the case may be, a portion of the Securities of any series
 in accordance with the right reserved so to do, the Company shall, or shall cause the Trustee to, give notice of such redemption
 to holders of the Securities of such series to be redeemed by mailing, first class postage prepaid, a notice of such redemption not
 less than 30 days and not more than 90 days before the date fixed for redemption of that series to such holders at their last addresses
 as they shall appear upon the Security Register unless a shorter period is specified in the Securities to be redeemed. Any notice
 that is mailed in the manner herein provided shall be conclusively presumed to have been duly given, whether or not the registered
 holder receives the notice. In any case, failure duly to give such notice to the holder of any Security of any series designated
 for redemption in whole or in part, or any defect in the notice, shall not affect the validity of the proceedings for the redemption
 of any other Securities of such series or any other series. In the case of any redemption of Securities prior to the expiration of
 any restriction on such redemption provided in the terms of such Securities or elsewhere in this Indenture, the Company shall furnish
 the Trustee with an Officers' Certificate evidencing compliance with any such restriction.

Each such notice of redemption shall specify the date fixed for redemption and the redemption price at which Securities of that series are to be redeemed, and shall state that payment of the redemption price of such Securities to be redeemed will be made at the office or agency of the Company in the Borough of Manhattan, the City and State of New York, upon presentation and surrender of such Securities, that interest accrued to the date fixed for redemption will be paid as specified in said notice, that from and after said date interest will cease to accrue and that the redemption is for a sinking fund, if such is the case. If less than all the Securities of a series are to be redeemed, the notice to the holders of Securities of that series to be redeemed in whole or in part shall specify the particular Securities to be so redeemed. In case any Security is to be redeemed in part only, the notice that relates to such Security shall state the portion of the principal amount thereof to be redeemed, and shall state that on and after the redemption date, upon surrender of such Security, a new Security or Securities of such series in principal amount equal to the unredeemed portion thereof will be issued.

&nbsp;&nbsp;&nbsp;&nbsp;(b) If
 less than all the Securities of a series are to be redeemed, the Company shall give the Trustee at least 30 days' notice in
 advance of the date fixed for redemption as to the aggregate principal amount of Securities of the series to be redeemed, and thereupon
 the Trustee shall select, by lot or in such other manner as it shall deem appropriate and fair in its discretion and that may provide
 for the selection of a portion or portions (equal to one thousand U.S. dollars ($1,000) or any integral multiple thereof) of the
 principal amount of such Securities of a denomination larger than $1,000, the Securities to be redeemed and shall thereafter promptly
 notify the Company in writing of the numbers of the Securities to be redeemed, in whole or in part. The Company may, if and whenever
 it shall so elect, by delivery of instructions signed on its behalf by its President or any Vice President, instruct the Trustee
 or any paying agent to call all or any part of the Securities of a particular series for redemption and to give notice of redemption
 in the manner set forth in this Section, such notice to be in the name of the Company or its own name as the Trustee or such paying
 agent may deem advisable. In any case in which notice of redemption is to be given by the Trustee or any such paying agent, the Company
 shall deliver or cause to be delivered to, or permit to remain with, the Trustee or such paying agent, as the case may be, such Security
 Register, transfer books or other records, or suitable copies or extracts therefrom, sufficient to enable the Trustee or such paying
 agent to give any notice by mail that may be required under the provisions of this Section.

SECTION 3.03 Payment Upon Redemption.

&nbsp;&nbsp;&nbsp;&nbsp;(a) If
 the giving of notice of redemption shall have been completed as above provided, the Securities or portions of Securities of the series
 to be redeemed specified in such notice shall become due and payable on the date and at the place stated in such notice at the applicable
 redemption price, together with interest accrued to the date fixed for redemption and interest on such Securities or portions of
 Securities shall cease to accrue on and after the date fixed for redemption, unless the Company shall default in the payment of such
 redemption price and accrued interest with respect to any such Security or portion thereof. On presentation and surrender of such
 Securities on or after the date fixed for redemption at the place of payment specified in the notice, said Securities shall be paid
 and redeemed at the applicable redemption price for such series, together with interest accrued thereon to the date fixed for redemption
 (but if the date fixed for redemption is an interest payment date, the interest installment payable on such date shall be payable
 to the registered holder at the close of business on the applicable record date pursuant to Section 2.03).

&nbsp;&nbsp;&nbsp;&nbsp;(b) Upon
 presentation of any Security of such series that is to be redeemed in part only, the Company shall execute and the Trustee shall
 authenticate and the office or agency where the Security is presented shall deliver to the holder thereof, at the expense of the
 Company, a new Security of the same series of authorized denominations in principal amount equal to the unredeemed portion of the
 Security so presented.

SECTION 3.04 Sinking Fund.

The provisions of Sections 3.04, 3.05 and 3.06 shall be applicable to any sinking fund for the retirement of Securities of a series, except as otherwise specified as contemplated by Section 2.01 for Securities of such series.

The minimum amount of any sinking fund payment provided for by the terms of Securities of any series is herein referred to as a "mandatory sinking fund payment," and any payment in excess of such minimum amount provided for by the terms of Securities of any series is herein referred to as an "optional sinking fund payment." If provided for by the terms of Securities of any series, the cash amount of any sinking fund payment may be subject to reduction as provided in Section 3.05. Each sinking fund payment shall be applied to the redemption of Securities of any series as provided for by the terms of Securities of such series.

SECTION 3.05 Satisfaction of Sinking Fund Payments with Securities.

The Company (i) may deliver Outstanding Securities of a series (other than any Securities previously called for redemption) and (ii) may apply as a credit Securities of a series that have been redeemed either at the election of the Company pursuant to the terms of such Securities or through the application of permitted optional sinking fund payments pursuant to the terms of such Securities, in each case in satisfaction of all or any part of any sinking fund payment with respect to the Securities of such series required to be made pursuant to the terms of such Securities as provided for by the terms of such series, provided that such Securities have not been previously so credited. Such Securities shall be received and credited for such purpose by the Trustee at the redemption price specified in such Securities for redemption through operation of the sinking fund and the amount of such sinking fund payment shall be reduced accordingly.

SECTION 3.06 Redemption of Securities for Sinking Fund.

Not less than 45 days prior to each sinking fund payment date for any series of Securities, the Company will deliver to the Trustee an Officers' Certificate specifying the amount of the next ensuing sinking fund payment for that series pursuant to the terms of the series, the portion thereof, if any, that is to be satisfied by delivering and crediting Securities of that series pursuant to Section 3.05 and the basis for such credit and will, together with such Officers' Certificate, deliver to the Trustee any Securities to be so delivered. Not less than 30 days before each such sinking fund payment date the Trustee shall select the Securities to be redeemed upon such sinking fund payment date in the manner specified in Section 3.02 and cause notice of the redemption thereof to be given in the name of and at the expense of the Company in the manner provided in Section 3.02. Such notice having been duly given, the redemption of such Securities shall be made upon the terms and in the manner stated in Section 3.03.

ARTICLE IV

COVENANTS

SECTION 4.01 Payment of Principal, Premium and Interest.

The Company will duly and punctually pay or cause to be paid the principal of (and premium, if any) and interest on the Securities of that series at the time and place and in the manner provided herein and established with respect to such Securities.

SECTION 4.02 Maintenance of Office or Agency.

So long as any series of the Securities remain Outstanding, the Company agrees to maintain an office or agency in the Borough of Manhattan, the City and State of New York, with respect to each such series and at such other location or locations as may be designated as provided in this Section 4.02, where (i) Securities of that series may be presented or surrendered for payment, (ii) Securities of that series may be presented as herein above authorized for registration of transfer and exchange, and (iii) notices and demands to or upon the Company in respect of the Securities of that series and this Indenture may be given or served, such designation to continue with respect to such office or agency until the Company shall, by written notice signed by its President or a Vice President and delivered to the trustee, designate some other office or agency for such purposes or any of them. If at any time the Company shall fail to maintain any such required office or agency or shall fail to furnish the Trustee with the address thereof, such presentations, notices and demands may be made or served at the Corporate Trust Office of the Trustee, and the Company hereby appoints the Trustee as its agent to receive all such presentations, notices and demands.

SECTION 4.03 Paying Agents.

&nbsp;&nbsp;&nbsp;&nbsp;(a) If
 the Company shall appoint one or more paying agents for all or any series of the Securities, other than the Trustee, the Company
 will cause each such paying agent to execute and deliver to the Trustee an instrument in which such agent shall agree with the Trustee,
 subject to the provisions of this Section:

&nbsp;&nbsp;&nbsp;&nbsp;(1) that
 it will hold all sums held by it as such agent for the payment of the principal of (and premium, if any) or interest on the Securities
 of that series (whether such sums have been paid to it by the Company or by any other obligor of such Securities) in trust for the
 benefit of the Persons entitled thereto;

&nbsp;&nbsp;&nbsp;&nbsp;(2) that
 it will give the Trustee notice of any failure by the Company (or by any other obligor of such Securities) to make any payment of
 the principal of (and premium, if any) or interest on the Securities of that series when the same shall be due and payable;

&nbsp;&nbsp;&nbsp;&nbsp;(3) that
 it will, at any time during the continuance of any failure referred to in the preceding paragraph (a)(2) above, upon the written
 request of the Trustee, forthwith pay to the Trustee all sums so held in trust by such paying agent; and

&nbsp;&nbsp;&nbsp;&nbsp;(4) that
 it will perform all other duties of paying agent as set forth in this Indenture.

&nbsp;&nbsp;&nbsp;&nbsp;(b) If
 the Company shall act as its own paying agent with respect to any series of the Securities, it will on or before each due date of
 the principal of (and premium, if any) or interest on Securities of that series, set aside, segregate and hold in trust for the benefit
 of the Persons entitled thereto a sum sufficient with monies held by all other paying agents to pay such principal (and premium,
 if any) or interest so becoming due on Securities of that series until such sums shall be paid to such Persons or otherwise disposed
 of as herein provided and will promptly notify the Trustee of such action, or any failure (by it or any other obligor on such Securities)
 to take such action. Whenever the Company shall have one or more paying agents for any series of Securities, it will, prior to each
 due date of the principal of (and premium, if any) or interest on any Securities of that series, deposit with the paying agent a
 sum sufficient to pay the principal (an premium, if any) or interest so becoming due, such sum to be held in trust for the benefit
 of the Persons entitled to such principal, premium or interest, and (unless such paying agent is the Trustee) the Company will promptly
 notify the Trustee of this action or failure so to act.

&nbsp;&nbsp;&nbsp;&nbsp;(c) Notwithstanding
 anything in this Section to the contrary, (i) the agreement to hold sums in trust as provided in this Section is subject to the provisions
 of Section 11.05, and (ii) the Company may at any time, for the purpose of obtaining the satisfaction and discharge of this Indenture
 or for any other purpose, pay, or direct any paying agent to pay, to the Trustee all sums held in trust by the Company or such paying
 agent, such sums to be held by the Trustee upon the same terms and conditions as those upon which such sums were held by the Company
 or such paying agent; and, upon such payment by any paying agent to the Trustee, such paying agent shall be released from all further
 liability with respect to such money.

SECTION 4.04 Appointment to Fill Vacancy in Office of Trustee.

The Company, whenever necessary to avoid or fill a vacancy in the office of Trustee, will appoint, in the manner provided in Section 7.10, a Trustee, so that there shall at all times be a Trustee hereunder.

SECTION 4.05 Compliance with Consolidation Provisions.

The Company will not, while any of the Securities remain Outstanding, consolidate with or merge into any other Person, in either case where the Company is not the survivor of such transaction, or sell or convey all or substantially all of its property to any other company unless the provisions of Article X hereof are complied with.

ARTICLE V

SECURITYHOLDERS' LISTS AND REPORTS BY THE COMPANY AND THE TRUSTEE

SECTION 5.01 Company to Furnish Trustee Names and Addresses of Securityholders.

If the Company is not the Security Register, the Company will furnish or use reasonable efforts to cause to be furnished to the Trustee (a) on each regular record date (as defined in Section 2.03) a list, in such form as the Trustee may reasonably require, of the names and addresses of the holders of each series of Securities as of such regular record date, provided that the Company shall not be obligated to furnish or cause to furnish such list at any time that the list shall not differ in any respect from the most recent list furnished to the Trustee by the Company and (b) at such other times as the Trustee may request in writing within 30 days after the receipt by the Company of any such request, a list of similar form and content as of a date not more than 15 days prior to the time such list is furnished; provided, however, that, in either case, no such list need be furnished for any series for which the Trustee shall be the Security Registrar.

SECTION 5.02 Preservation of Information; Communications with Securityholders.

&nbsp;&nbsp;&nbsp;&nbsp;(a) The
 Trustee shall preserve, in as current a form as is reasonably practicable, all information as to the names and addresses of the holders
 of Securities contained in the most recent list furnished to it as provided in Section 5.01 and as to the names and addresses of
 holders of Securities received by the Trustee in its capacity as Security Registrar (if acting in such capacity) and shall otherwise
 comply with Section 312(a) of the Trust Indenture Act.

&nbsp;&nbsp;&nbsp;&nbsp;(b) The
 Trustee may destroy any list furnished to it as provided in Section 5.01 upon receipt of a new list so furnished.

&nbsp;&nbsp;&nbsp;&nbsp;(c) Securityholders
 may communicate as provided in Section 312(b) of the Trust Indenture Act with other Securityholders with respect to their rights
 under this Indenture or under the Securities.

SECTION 5.03 Reports by the Company.

&nbsp;&nbsp;&nbsp;&nbsp;(a) The
 Company covenants and agrees to file with the Trustee, within 15 days after the Company is required to file the same with the Commission,
 copies of the annual reports and of the information, documents and other reports (or copies of such portions of any of the foregoing
 as the Commission may from time to time by rules and regulations prescribe) that the Company may be required to file with the Commission
 pursuant to Section 13 or Section 15(d) of the Exchange Act; or, if the Company is not required to file information, documents or
 reports pursuant to either of such sections, then to file with the Trustee and the Commission, in accordance with the rules and regulations
 prescribed from time to time by the Commission, such of the supplementary and periodic information, documents and reports that may
 be required pursuant to Section 13 of the Exchange Act, in respect of a security listed and registered on a national securities exchange
 as may be prescribed from time to time in such rules and regulations; provided, however, the Company shall not be required to deliver
 to the Trustee any materials for which the Company has sought and received confidential treatment by the Commission. The Company
 also shall comply with the other provisions of Section 314(a) of the Trust Indenture Act.

&nbsp;&nbsp;&nbsp;&nbsp;(b) The
 Company covenants and agrees to file with the Trustee and the Commission, in accordance with the rules and regulations prescribed
 from to time by the Commission, such additional information, documents and reports with respect to compliance by the Company with
 the conditions and covenants provided for in this Indenture as may be required from time to time by such rules and regulations.

&nbsp;&nbsp;&nbsp;&nbsp;(c) The
 Company covenants and agrees to transmit by mail, first class postage prepaid, or reputable over-night delivery service that provides
 for evidence of receipt, to the Securityholders, as their names and addresses appear upon the Security Register, within 30 days after
 the filing thereof with the Trustee, such summaries of any information, documents and reports required to be filed by the Company
 pursuant to subsections (a) and (b) of this Section as may be required by rules and regulations prescribed from time to time by the
 Commission.

SECTION 5.04 Reports by the Trustee.

&nbsp;&nbsp;&nbsp;&nbsp;(a) The
 Trustee shall transmit to holders as provided in Section 313 of the Trust Indenture Act such reports concerning the Trustee and its
 actions under this Indenture as may be required by Section 313 of the Trust Indenture Act at the times and in the manner provided
 by the Trust Indenture Act.

&nbsp;&nbsp;&nbsp;&nbsp;(b) A
 copy of each such report shall, at the time of such transmission to Securityholders, be filed by the Trustee with the Company, with
 each stock exchange upon which any Securities are listed (if so listed) and, if required by Section 313 of the Trust Indenture Act,
 also with the Commission. The Company agrees to notify the Trustee when any Securities become listed on any stock exchange.

ARTICLE VI

REMEDIES OF THE TRUSTEE AND SECURITYHOLDERS ON EVENT OF DEFAULT

SECTION 6.01 Events of Default.

&nbsp;&nbsp;&nbsp;&nbsp;(a) Whenever
 used herein with respect to Securities of a particular series, "Event of Default" means any one or more of the following
 events that has occurred and is continuing:

&nbsp;&nbsp;&nbsp;&nbsp;(1) the
 Company defaults in the payment of any installment of interest upon any of the Securities of that series, as and when the same shall
 become due and payable, and continuance of such default for a period of 90 days; provided, however, that a valid extension of an
 interest payment period by the Company in accordance with the terms of any indenture supplemental hereto shall not constitute a default
 in the payment of interest for this purpose;

&nbsp;&nbsp;&nbsp;&nbsp;(2) the
 Company defaults in the payment of the principal of (or premium, if any, on) any of the Securities of that series as and when the
 same shall become due and payable whether at maturity, upon redemption, by declaration or otherwise, or in any payment required by
 any sinking or analogous fund established with respect to that series; provided, however, that a valid extension of the maturity
 of such Securities in accordance with the terms of any indenture supplemental hereto shall not constitute a default in the payment
 of principal or premium, if any;

&nbsp;&nbsp;&nbsp;&nbsp;(3) the
 Company fails to observe or perform any other of its covenants or agreements with respect to that series contained in this Indenture
 or otherwise established with respect to that series of Securities pursuant to Section 2.01 hereof (other than a covenant or agreement
 that has been expressly included in this Indenture solely for the benefit of one or more series of Securities other than such series)
 for a period of 90 days after the date on which written notice of such failure, requiring the same to be remedied and stating that
 such notice is a "Notice of Default" hereunder, shall have been given to the Company by the Trustee, by registered or
 certified mail, or to the Company and the Trustee by the holders of not less than a majority in principal amount of the Securities
 of that series at the time Outstanding;

&nbsp;&nbsp;&nbsp;&nbsp;(4) the
 Company pursuant to or within the meaning of any Bankruptcy Law (i) commences a voluntary case, (ii) consents to the entry of an
 order for relief against it in an involuntary case, (iii) consents to the appointment of a Custodian of it or for all or substantially
 all of its property or (iv) makes a general assignment for the benefit of its creditors; or

&nbsp;&nbsp;&nbsp;&nbsp;(5) a
 court of competent jurisdiction enters an order under any Bankruptcy Law that (i) is for relief against the Company in an involuntary
 case, (ii) appoints a Custodian of the Company for all or substantially all of its property, or (iii) orders the liquidation of the
 Company, and the order or decree remains unstayed and in effect for 90 consecutive days.

&nbsp;&nbsp;&nbsp;&nbsp;(b) In
 each and every such case, unless the principal of all the Securities of that series shall have already become due and payable, either
 the Trustee or the holders of not less than a majority in aggregate principal amount of the Securities of that series then Outstanding
 hereunder, by notice in writing to the Company (and to the Trustee if given by such Securityholders), may declare the principal (or,
 if any Securities of that series are discount securities, that portion of the principal amount as may be specified in the terms of
 that series pursuant to Section 2.01(a)(16)) of (and premium, if any, on) and accrued and unpaid interest, if any, on all the Securities
 of that series to be due and payable immediately, and upon any such declaration the same shall become and shall be immediately due
 and payable. Notwithstanding the foregoing, the payment of such principal (or, if any Securities of that series are discount securities,
 that portion of the principal amount as may be specified in the terms of that series pursuant to Section 2.01(a)(16)) of (and premium,
 if any, on) and accrued and unpaid interest, if any, on the Securities of such series shall remain subordinated to the extent provided
 in Article XIV.

&nbsp;&nbsp;&nbsp;&nbsp;(c) At
 any time after the principal of the Securities of that series shall have been so declared due and payable, and before a judgment
 or decree for the payment of the moneys due shall have been obtained or entered as hereinafter provided, the holders of a majority
 in aggregate principal amount of the Securities of that series then Outstanding hereunder (or, by action at a meeting of holders
 of the Securities of such series in accordance with Section 8.09, the holders of a majority in aggregate principal amount of the
 Securities of such series then Outstanding represented at such meeting), by written notice to the Company and the Trustee, may rescind
 and annul such declaration and its consequences if: (i) the Company has paid or deposited with the Trustee a sum sufficient to pay
 all matured installments of interest upon all the Securities of that series and the principal of (and premium, if any, on) any and
 all Securities of that series that shall have become due otherwise than by acceleration and (ii) any and all Events of Default under
 this Indenture with respect to such series, other than the nonpayment of principal of (and premium, if any, on) and accrued and unpaid
 interest, if any, on Securities of that series that shall have become due solely because of such acceleration, shall have been remedied,
 cured or waived as provided in Section 6.06. No such rescission and annulment shall extend to or shall affect any subsequent default
 or impair any right consequent thereon.

&nbsp;&nbsp;&nbsp;&nbsp;(d) In
 case the Trustee shall have proceeded to enforce any right with respect to Securities of that series under this Indenture and such
 proceedings shall have been discontinued or abandoned because of such rescission or annulment or for any other reason or shall have
 been determined adversely to the Trustee, then and in every such case, subject to any determination in such proceedings, the Company,
 and the Trustee shall be restored respectively to their former positions and rights hereunder, and all rights, remedies and powers
 of the Company and the Trustee shall continue as though no such proceedings had been taken.

SECTION 6.02 Collection of Indebtedness and Suits for Enforcement by Trustee.

&nbsp;&nbsp;&nbsp;&nbsp;(a) The
 Company covenants that (1) in case it shall default in the payment of any installment of interest on any of the Securities of a series,
 or any payment required by any sinking or analogous fund established with respect to that series as and when the same shall have
 become due and payable, and such default shall have continued for a period of 90 Business Days, or (2) in case it shall default in
 the payment of the principal of (or premium, if any, on) any of the Securities of a series when the same shall have become due and
 payable, whether upon maturity of the Securities of a series or upon redemption or upon declaration or otherwise, then, upon demand
 of the Trustee, the Company will pay to the Trustee, for the benefit of the holders of the Securities of that series, the whole amount
 that then shall have been become due and payable on all such Securities for principal (and premium, if any) or interest, or both,
 as the case may be, with interest upon the overdue principal (and premium, if any) and (to the extent that payment of such interest
 is enforceable under applicable law) upon overdue installments of interest at the rate per annum expressed in the Securities of that
 series; and, in addition thereto, such further amount as shall be sufficient to cover the costs and expenses of collection, and the
 amount payable to the Trustee under Section 7.06.

&nbsp;&nbsp;&nbsp;&nbsp;(b) If
 the Company shall fail to pay such amounts forthwith upon such demand, the Trustee, in its own name and as trustee of an express
 trust, shall be entitled and empowered to institute any action or proceedings at law or in equity for the collection of the sums
 so due and unpaid, and may prosecute any such action or proceeding to judgment or final decree, and may enforce any such judgment
 or final decree against the Company or other obligor upon the Securities of that series and collect the moneys adjudged or decreed
 to be payable in the manner provided by law out of the property of the Company or other obligor upon the Securities of that series,
 wherever situated.

&nbsp;&nbsp;&nbsp;&nbsp;(c) In
 case of any receivership, insolvency, liquidation, bankruptcy, reorganization, readjustment, arrangement, composition or judicial
 proceedings affected the Company, or its creditors or property, the Trustee shall have power to intervene in such proceedings and
 take any action therein that may be permitted by the court and shall (except as may be otherwise provided by law) be entitled to
 file such proofs of claim and other papers and documents as may be necessary or advisable in order to have the claims of the Trustee
 and of the holders of Securities of such series allowed for the entire amount due and payable by the Company under this Indenture
 at the date of institution of such proceedings and for any additional amount that may become due and payable by the Company after
 such date, and to collect and receive any moneys or other property payable or deliverable on any such claim, and to distribute the
 same after the deduction of the amount payable to the Trustee under Section 7.06; and any receiver, assignee or trustee in bankruptcy
 or reorganization is hereby authorized by each of the holders of Securities of such series to make such payments to the Trustee,
 and, in the event that the Trustee shall consent to the making of such payments directly to such Securityholders, to pay to the Trustee
 any amount due it under Section 7.06.

&nbsp;&nbsp;&nbsp;&nbsp;(d) All
 rights of action and of asserting claims under this Indenture, or under any of the terms established with respect to Securities of
 that series, may be enforced by the Trustee without the possession of any of such Securities, or the production thereof at any trial
 or other proceeding relative thereto, and any such suit or proceeding instituted by the Trustee shall be brought in its own name
 as trustee of an express trust, and any recovery of judgment shall, after provision for payment to the Trustee of any amounts due
 under Section 7.06, be for the ratable benefit of the holders of the Securities of such series.

In case of an Event of Default hereunder, the Trustee may in its discretion proceed to protect and enforce the rights vested in it by this Indenture by such appropriate judicial proceedings as the Trustee shall deem most effectual to protect and enforce any of such rights, either at law or in equity or in bankruptcy or otherwise, whether for the specific enforcement of any covenant or agreement contained in this Indenture or in aid of the exercise of any power granted in this Indenture, or to enforce any other legal or equitable right vested in the Trustee by this Indenture or by law.

Nothing contained herein shall be deemed to authorize the Trustee to authorize or consent to or accept or adopt on behalf of any Securityholder any plan of reorganization, arrangement, adjustment or composition affecting the Securities of that series or the rights of any holder thereof or to authorize the Trustee to vote in respect of the claim of any Securityholder in any such proceeding.

SECTION 6.03 Application of Moneys Collected.

Any moneys collected by the Trustee pursuant to this Article with respect to a particular series of Securities shall be applied in the following order, at the date or dates fixed by the Trustee and, in case of the distribution of such moneys on account of principal (or premium, if any) or interest, upon presentation of the Securities of that series, and notation thereon the payment, if only partially paid, and upon surrender thereof if fully paid:

---

| | |
|:---|:---|
| FIRST: | To the payment of costs and expenses of collection and of all amounts payable to the Trustee under Section 7.06; |

---

SECOND: To the payment of all Senior Indebtedness of the Company if and to the extent required by Article XIV; and

---

| | |
|:---|:---|
| THIRD: | To the payment of the amounts then due and unpaid upon Securities of such series for principal (and premium, if any) and interest, in respect of which or for the benefit of which such money has been collected, ratably, without preference or priority of any kind, according to the amounts due and payable on such Securities for principal (and premium, if any) and interest, respectively. |

---

SECTION 6.04 Limitation on Suits.

No holder of any Security of any series shall have any right by virtue or by availing of any provision of this Indenture to institute any suit, action or proceeding in equity or at law upon or under or with respect to this Indenture or for the appointment of a receiver or trustee, or for any other remedy hereunder, unless (i) such holder previously shall have given to the Trustee written notice of an Event of Default and of the continuance thereof with respect to the Securities of such series specifying such Event of Default, as hereinbefore provided; (ii) the holders of not less than a majority in aggregate principal amount of the Securities of such series then Outstanding shall have made written request upon the Trustee to institute such action, suit or proceeding in its own name as trustee hereunder; (iii) such holder or holders shall have offered to the Trustee such reasonable indemnity as it may require against the costs, expenses and liabilities to be incurred therein or thereby; and (iv) the Trustee for 60 days after its receipt of such notice, request and offer of indemnity, shall have failed to institute any such action, suit or proceeding and (v) during such 60 day period, the holders of a majority in principal amount of the Securities of that series (or such amount as shall have acted at a meeting of the holders of Securities of such series pursuant to the provisions of this Indenture) do not give the Trustee a direction inconsistent with the request; provided, however, that no one or more of such holders may use this Indenture to prejudice the rights of another holder or to obtain preference or priority over another holder.

Notwithstanding anything contained herein to the contrary, any other provisions of this Indenture, the right of any holder of any Security to receive payment of the principal of (and premium, if any) and interest on such Security, as therein provided, on or after the respective due dates expressed in such Security (or in the case of redemption, on the redemption date), or to institute suit for the enforcement of any such payment on or after such respective dates or redemption date, shall not be impaired or affected without the consent of such holder and by accepting a Security hereunder it is expressly understood, intended and covenanted by the taker and holder of every Security of such series with every other such taker and holder and the Trustee, that no one or more holders of Securities of such series shall have any right in any manner whatsoever by virtue or by availing of any provision of this Indenture to affect, disturb or prejudice the rights of the holders of any other of such Securities, or to obtain or seek to obtain priority over or preference to any other such holder, or to enforce any right under this Indenture, except in the manner herein provided and for the equal, ratable and common benefit of all holders of Securities of such series. For the protection and enforcement of the provisions of this Section, each and every Securityholder and the Trustee shall be entitled to such relief as can be given either at law or in equity.

SECTION 6.05 Rights and Remedies Cumulative; Delay or Omission Not Waiver.

&nbsp;&nbsp;&nbsp;&nbsp;(a) Except
 as otherwise provided in Section 2.07, all powers and remedies given by this Article to the Trustee or to the Securityholders shall,
 to the extent permitted by law, be deemed cumulative and not exclusive of any other powers and remedies available to the Trustee
 or the holders of the Securities, by judicial proceedings or otherwise, to enforce the performance or observance of the covenants
 and agreements contained in this Indenture or otherwise established with respect to such Securities.

&nbsp;&nbsp;&nbsp;&nbsp;(b) No
 delay or omission of the Trustee or of any holder of any of the Securities to exercise any right or power accruing upon any Event
 of Default occurring and continuing as aforesaid shall impair any such right or power, or shall be construed to be a waiver of any
 such default or on acquiescence therein; and, subject to the provisions of Section 6.04, every power and remedy given by this Article
 or by law to the Trustee or the Securityholders may be exercised from time to time, and as often as shall be deemed expedient, by
 the Trustee or by the Securityholders.

SECTION 6.06 Control by Securityholders.

The holders of a majority in aggregate principal amount of the Securities of any series at the time Outstanding, determined in accordance with Section 8.01, shall have the right to direct the time, method and place of conducting any proceeding for any remedy available to the Trustee, or exercising any trust or power conferred on the Trustee with respect to such series; provided, however, that such direction shall not be in conflict with any rule of law or with this Indenture or be unduly prejudicial to the rights of holders of Securities of any other series at the time Outstanding determined in accordance with Section 8.01. Subject to the provisions of Section 7.01, the Trustee shall have the right to decline to follow any such direction if the Trustee in good faith shall, by a Responsible Officer or Officers of the Trustee, determine that the proceeding so directed would involve the Trustee in personal liability.

The holders either (a) through the written consent of not less than a majority in aggregate principal amount of the Securities of any series at the time Outstanding or (b) by action at a meeting of holders of the Securities of such series in accordance with Section 8.09, by the holders of a majority in aggregate principal amount of the Securities of such series then Outstanding represented at such meeting, may on behalf of the holders of all of the Securities of such series waive any past default in the performance of any of the covenants contained herein or established pursuant to Section 2.01 with respect to such series and its consequences, except a default in the payment of the principal of, or premium, if any, or interest on, any of the Securities of that series as and when the same shall become due by the terms of such Securities otherwise than by acceleration (unless such default has been cured and a sum sufficient to pay all matured installments of interest and principal and any premium has been deposited with the Trustee (in accordance with Section 6.01(c)) and except in respect a provision hereof which, under Section 9.02, cannot be modified or amended without the consent of the holders of each Outstanding Security affected; provided however that this Section shall not limit the right of holders of Securities of a series to rescind and annul any acceleration as set forth in Section 6.01. Upon any such waiver, the default covered thereby shall be deemed to be cured for all purposes of this Indenture and the Company, the Trustee and the holders of the Securities of such series shall be restored to their former positions and rights hereunder, respectively; but no such waiver shall extend to any subsequent or other default or impair any right consequent thereon. The provisions which otherwise would be automatically deemed to be contained in this Indenture pursuant to Section 316(a)(1) of the Trust Indenture Act are hereby expressly excluded from this Indenture, except to the extent such provisions are expressly included herein.

SECTION 6.07 Undertaking to Pay Costs.

All parties to this Indenture agree, and each holder of any Securities by such holder's acceptance thereof shall be deemed to have agreed, that any court may in its discretion require, in any suit for the enforcement of any right or remedy under this Indenture, or in any suit against the Trustee for any action taken or omitted by it as Trustee, the filing by any party litigant in such suit of an undertaking to pay the costs of such suit, and that such court may in its discretion assess reasonable costs, including reasonable attorneys' fees, against any party litigant in such suit, having due regard to the merits and good faith of the claims or defenses made by such party litigant; but the provisions of this Section shall not apply to any suit instituted by the Trustee, to any suit instituted by any Securityholder, or group of Securityholders, holding more than 10% in aggregate principal amount of the Outstanding Securities of any series, or to any suit instituted by any Securityholder for the enforcement of the payment of the principal of (or premium, if any) or interest on any Security of such series, on or after the respective due dates expressed in such Security or established pursuant to this Indenture.

ARTICLE VII

CONCERNING THE TRUSTEE

SECTION 7.01 Certain Duties and Responsibilities of Trustee.

&nbsp;&nbsp;&nbsp;&nbsp;(a) The
 Trustee, prior to the occurrence of an Event of Default with respect to the Securities of a series and after the curing of all Events
 of Default with respect to the Securities of that series that may have occurred, shall undertake to perform with respect to the Securities
 of such series such duties and only such duties as are specifically set forth in this Indenture, and no implied covenants shall be
 read into this Indenture against the Trustee. In case an Event of Default with respect to the Securities of a series has occurred
 (that has not been cured or waived), the Trustee shall exercise with respect to Securities of that series such of the rights and
 powers vested in it by this Indenture, and use the same degree of care and skill in their exercise, as a prudent man would exercise
 or use under the circumstances in the conduct of his own affairs.

&nbsp;&nbsp;&nbsp;&nbsp;(b) No
 provision of this Indenture shall be construed to relieve the Trustee from liability for its own negligent action, its own negligent
 failure to act, or its own willful misconduct, except that:

&nbsp;&nbsp;&nbsp;&nbsp;(1) prior
 to the occurrence of an Event of Default with respect to the Securities of a series and after the curing or waiving of all such Events
 of Default with respect to that series that may have occurred:

&nbsp;&nbsp;&nbsp;&nbsp;(i) the
 duties and obligations of the Trustee shall with respect to the Securities of such series be determined solely by the express provisions
 of this Indenture, and the Trustee shall not be liable with respect to the Securities of such series except for the performance of
 such duties and obligations as are specifically set forth in this Indenture, and no implied covenants or obligations shall be read
 into this Indenture against the Trustee; and

&nbsp;&nbsp;&nbsp;&nbsp;(ii) in
 the absence of bad faith on the part of the Trustee, the Trustee may with respect to the Securities of such series conclusively rely,
 as to the truth of the statements and the correctness of the opinions expressed therein, upon any certificates or opinions furnished
 to the Trustee and conforming to the requirements of this Indenture; but in the case of any such certificates or opinions that by
 any provision hereof are specifically required to be furnished to the Trustee, the Trustee shall be under a duty to examine the same
 to determine whether or not they conform to the requirement of this Indenture;

&nbsp;&nbsp;&nbsp;&nbsp;(2) the
 Trustee shall not be liable for any error of judgment made in good faith by a Responsible Officer or Responsible Officers of the
 Trustee, unless it shall be proved that the Trustee, was negligent in ascertaining the pertinent facts;

&nbsp;&nbsp;&nbsp;&nbsp;(3) the
 Trustee shall not be liable with respect to any action taken or omitted to be taken by it in good faith in accordance with the direction
 of the holders of not less than a majority in principal amount of the Securities of any series at the time Outstanding relating to
 the time, method and place of conducting any proceeding for any remedy available to the Trustee, or exercising any trust or power
 conferred upon the Trustee under this Indenture with respect to the Securities of that series; and

&nbsp;&nbsp;&nbsp;&nbsp;(4) None
 of the provisions contained in this Indenture shall require the Trustee to expend or risk its own funds or otherwise incur personal
 financial liability in the performance of any of its duties or in the exercise of any of its rights or powers, if there is reasonable
 ground for believing that the repayment of such funds or liability is not reasonably assured to it under the terms of this Indenture
 or adequate indemnity against such risk is not reasonably assured to it.

SECTION 7.02 Certain Rights of Trustee.

Except as otherwise provided in Section 7.01:

&nbsp;&nbsp;&nbsp;&nbsp;(a) The
 Trustee may rely and shall be protected in acting or refraining from acting upon any resolution, certificate, statement, instrument,
 opinion, report, notice, request, consent, order, approval, bond, security or other paper or document believed by it to be genuine
 and to have been signed or presented by the proper party or parties;

&nbsp;&nbsp;&nbsp;&nbsp;(b) Any
 request, direction, order or demand of the Company mentioned herein shall be sufficiently evidenced by a Board Resolution or an instrument
 signed in the name of the Company, by the President or any Vice President and by the Secretary or an Assistant Secretary or the Treasurer
 or an Assistant Treasurer thereof (unless other evidence in respect thereof is specifically prescribed herein);

&nbsp;&nbsp;&nbsp;&nbsp;(c) The
 Trustee may consult with counsel and the written advice of such counsel or any Opinion of Counsel shall be full and complete authorization
 and protection in respect of any action taken or suffered or omitted hereunder in good faith and in reliance thereon;

&nbsp;&nbsp;&nbsp;&nbsp;(d) The
 Trustee shall be under no obligation to exercise any of the rights or powers vested in it by this Indenture at the request, order
 or direction of any of the Securityholders, pursuant to the provisions of this Indenture, unless such Securityholders shall have
 offered to the Trustee reasonable security or indemnity against the costs, expenses and liabilities that may be incurred therein
 or thereby; nothing contained herein shall, however, relieve the Trustee of the obligation, upon the occurrence of an Event of Default
 with respect to a series of the Securities (that has not been cured or waived) to exercise with respect to Securities of that series
 such of the rights and powers vested in it by this Indenture, and to use the same degree of care and skill in their exercise, as
 a prudent man would exercise or use under the circumstances in the conduct of his own affairs;

&nbsp;&nbsp;&nbsp;&nbsp;(e) The
 Trustee shall not be liable for any action taken or omitted to be taken by it in good faith and believed by it to be authorized or
 within the discretion or rights or powers conferred upon it by this Indenture;

&nbsp;&nbsp;&nbsp;&nbsp;(f) The
 Trustee shall not be bound to make any investigation into the facts or matters stated in any resolution, certificate, statement,
 instrument, opinion, report, notice, request, consent, order, approval, bond, security, or other papers or documents, unless requested
 in writing so to do by the holders of not less than a majority in principal amount of the Outstanding Securities of the particular
 series affected thereby (determined as provided in Section 8.04); provided, however, that if the payment within a reasonable time
 to the Trustee of the costs, expenses or liabilities likely to be incurred by it in the making of such investigation is, in the opinion
 of the Trustee, not reasonably assured to the Trustee by the security afforded to it by the terms of this Indenture, the Trustee
 may require reasonable indemnity against such costs, expenses or liabilities as a condition to so proceeding. The reasonable expense
 of every such examination shall be paid by the Company or, if paid by the Trustee, shall be repaid by the Company upon demand; and

&nbsp;&nbsp;&nbsp;&nbsp;(g) The
 Trustee may execute any of the trusts or powers hereunder or perform any duties hereunder either directly or by or through agents
 or attorneys and the Trustee shall not be responsible for any misconduct or negligence on the part of any agent or attorney appointed
 with due care by it hereunder.

SECTION 7.03 Trustee Not Responsible for Recitals or Issuance of Securities.

&nbsp;&nbsp;&nbsp;&nbsp;(a) The
 recitals contained herein and in the Securities shall be taken as the statements of the Company, and the Trustee assumes no responsibility
 for the correctness of the same.

&nbsp;&nbsp;&nbsp;&nbsp;(b) The
 Trustee makes no representations as to the validity or sufficiency of this Indenture or of the Securities.

&nbsp;&nbsp;&nbsp;&nbsp;(c) The
 Trustee shall not be accountable for the use or application by the Company of any of the Securities or of the proceeds of such Securities,
 or for the use or application of any moneys paid over by the Trustee in accordance with any provision of this Indenture or established
 pursuant to Section 2.01, or for the use or application of any moneys received by any paying agent other than the Trustee.

SECTION 7.04 May Hold Securities.

The Trustee or any paying agent or Security Registrar, in its individual or any other capacity, may become the owner or pledgee of Securities with the same rights it would have if it were not Trustee, paying agent or Security Registrar.

SECTION 7.05 Moneys Held in Trust.

Subject to the provisions of Section 11.05, all moneys received by the Trustee shall, until used or applied as herein provided, be held in trust for the purposes for which they were received, but need not be segregated from other funds except to the extent required by law. The Trustee shall be under no liability for interest on any moneys received by it hereunder except such as it may agree with the Company to pay thereon.

SECTION 7.06 Compensation and Reimbursement.

&nbsp;&nbsp;&nbsp;&nbsp;(a) The
 Company covenants and agrees to pay to the Trustee, and the Trustee shall be entitled to, such reasonable compensation (which shall
 not be limited by any provision of law in regard to the compensation of a trustee of an express trust), as the Company, and the Trustee
 may from time to time agree in writing, for all services rendered by it in the execution of the trusts hereby created and in the
 exercise and performance of any of the powers and duties hereunder of the Trustee, and, except as otherwise expressly provided herein,
 the Company will pay or reimburse the Trustee upon its request for all reasonable expenses, disbursements and advances incurred or
 made by the Trustee in accordance with any of the provisions of this Indenture (including the reasonable compensation and the expenses
 and disbursements of its counsel and of all Persons not regularly in its employ) except any such expense, disbursement or advance
 as may arise from its negligence or bad faith. The Company also covenants to indemnify the Trustee (and its officers, agents, directors
 and employees) for, and to hold it harmless against, any loss, liability or expense incurred without negligence or bad faith on the
 part of the Trustee and arising out of or in connection with the acceptance or administration of this trust, including the costs
 and expenses of defending itself against any claim of liability in the premises.

&nbsp;&nbsp;&nbsp;&nbsp;(b) The
 obligations of the Company under this Section to compensate and indemnify the Trustee and to pay or reimburse the Trustee for expenses,
 disbursements and advances shall constitute additional indebtedness hereunder. Such additional indebtedness shall be secured by a
 lien prior to that of the Securities upon all property and funds held or collected by the Trustee as such, except funds held in trust
 for the benefit of the holders of particular Securities.

SECTION 7.07 Reliance on Officers' Certificate.

Except as otherwise provided in Section 7.01, whenever in the administration of the provisions of this Indenture the Trustee shall deem it necessary or desirable that a matter be proved or established prior to taking or suffering or omitting to take any action hereunder, such matter (unless other evidence in respect thereof be herein specifically prescribed) may, in the absence of negligence or bad faith on the part of the Trustee, be deemed to be conclusively proved and established by an Officers' Certificate delivered to the Trustee and such certificate, in the absence of negligence or bad faith on the part of the Trustee, shall be full warrant to the Trustee for any action taken, suffered or omitted to be taken by it under the provisions of this Indenture upon the faith thereof.

SECTION 7.08 Disqualification; Conflicting Interests.

If the Trustee has or shall acquire any "conflicting interest" within the meaning of Section 310(b) of the Trust Indenture Act, the Trustee and the Company shall in all respects comply with the provisions of Section 310(b) of the Trust Indenture Act.

SECTION 7.09 Corporate Trustee Required; Eligibility.

There shall at all times be a Trustee with respect to the Securities issued hereunder which shall at all times be a corporation organized and doing business under the laws of the United States of America or any State or Territory thereof or of the District of Columbia, or a corporation or other Person permitted to act as trustee by the Commission, authorized under such laws to exercise corporate trust powers, having a combined capital and surplus of at least 50 million U.S. dollars ($50,000,000), and subject to supervision or examination by Federal, State, Territorial, or District of Columbia authority. If such corporation publishes reports of condition at least annually, pursuant to law or to the requirements of the aforesaid supervising or examining authority, then for the purposes of this Section, the combined capital and surplus of such corporation shall be deemed to be its combined capital and surplus as set forth in its most recent report of condition so published. The Company may not, nor may any Person directly or indirectly controlling, controlled by, or under common control with the Company, serve as Trustee. In case at any time the Trustee shall cease to be eligible in accordance with the provisions of this Section, the Trustee shall resign immediately in the manner and with the effect specified in Section 7.10.

SECTION 7.10 Resignation and Removal; Appointment of Successor.

&nbsp;&nbsp;&nbsp;&nbsp;(a) The
 Trustee or any successor hereafter appointed, may at any time resign with respect to the Securities of one or more series by giving
 written notice thereof to the Company and by transmitting notice of resignation by mail, first class postage prepaid, to the Securityholders
 of such series, as their names and addresses appear upon the Security Register. Upon receiving such notice of resignation, the Company
 shall promptly appoint a successor trustee with respect to Securities of such series by written instrument, in duplicate, executed
 by order of the Board of Directors, one copy of which instrument shall be delivered to the resigning Trustee and one copy to the
 successor trustee. If no successor trustee shall have been so appointed and have accepted appointment within 30 days after the mailing
 of such notice of resignation, the resigning Trustee may petition any court of competent jurisdiction for the appointment of a successor
 trustee with respect to Securities of such series, or any Securityholder of that series who has been a bona fide holder of a Security
 or Securities for at least six months may on behalf of himself and all others similarly situated, petition any such court for the
 appointment of a successor trustee. Such court may thereupon after such notice, if any, as it may deem proper and prescribe, appoint
 a successor trustee.

&nbsp;&nbsp;&nbsp;&nbsp;(b) In
 case at any time any one of the following shall occur:

&nbsp;&nbsp;&nbsp;&nbsp;(1) the
 Trustee shall fail to comply with the provisions of Section 7.08 after written request therefor by the Company or by any Securityholder
 who has been a bona fide holder of a Security or Securities for at least six months; or

&nbsp;&nbsp;&nbsp;&nbsp;(2) the
 Trustee shall cease to be eligible in accordance with the provisions of Section 7.09 and shall fail to resign after written request
 therefor by the Company or by any such Securityholder; or

&nbsp;&nbsp;&nbsp;&nbsp;(3) the
 Trustee shall become incapable of acting, or shall be adjudged a bankrupt or insolvent, or commence a voluntary bankruptcy proceeding,
 or a receiver of the Trustee or of its property shall be appointed or consented to, or any public officer shall take charge or control
 of the Trustee or of its property or affairs for the purpose of rehabilitation, conservation or liquidation, then, in any such case,
 the Company may remove the Trustee with respect to all Securities and appoint a successor trustee by written instrument, in duplicate,
 executed by order of the Board of Directors, one copy of which instrument shall be delivered to the Trustee so removed and one copy
 to the successor trustee, or, unless the Trustee's duty to resign is stayed as provided herein, any Securityholder who has
 been a bona fide holder of a Security or Securities for at least six months may, on behalf of that holder and all others similarly
 situated, petition any court of competent jurisdiction for the removal of the Trustee and the appointment of a successor trustee.
 Such court may thereupon after such notice, if any, as it may deem proper and prescribe, remove the Trustee and appoint a successor
 trustee.

&nbsp;&nbsp;&nbsp;&nbsp;(c) The
 holders of a majority in aggregate principal amount of the Securities of any series at the time Outstanding may at any time remove
 the Trustee with respect to such series by so notifying the Trustee and the Company and may appoint a successor Trustee for such
 series with the consent of the Company.

&nbsp;&nbsp;&nbsp;&nbsp;(d) Any
 resignation or removal of the Trustee and appointment of a successor trustee with respect to the Securities of a series pursuant
 to any of the provisions of this Section shall become effective upon acceptance of appointment by the successor trustee as provided
 in Section 7.11.

&nbsp;&nbsp;&nbsp;&nbsp;(e) Any
 successor trustee appointed pursuant to this Section may be appointed with respect to the Securities of one or more series or all
 of such series, and at any time there shall be only one Trustee with respect to the Securities of any particular series.

SECTION 7.11 Acceptance of Appointment By Successor.

&nbsp;&nbsp;&nbsp;&nbsp;(a) In
 case of the appointment hereunder of a successor trustee with respect to all Securities, every such successor trustee so appointed
 shall execute, acknowledge and deliver to the Company and to the retiring Trustee an instrument accepting such appointment, and thereupon
 the resignation or removal of the retiring Trustee shall become effective and such successor trustee, without any further act, deed
 or conveyance, shall become vested with all the rights, powers, trusts and duties of the retiring Trustee; but, on the request of
 the Company or the successor trustee, such retiring Trustee shall, upon payment of its charges, execute and deliver an instrument
 transferring to such successor trustee all the rights, powers, and trusts of the retiring Trustee and shall duly assign, transfer
 and deliver to such successor trustee all property and money held by such retiring Trustee hereunder.

&nbsp;&nbsp;&nbsp;&nbsp;(b) In
 case of the appointment hereunder of a successor trustee with respect to the Securities of one or more (but not all) series, the
 Company, the retiring Trustee and each successor trustee with respect to the Securities of one or more series shall execute and deliver
 an indenture supplemental hereto wherein each successor trustee shall accept such appointment and which (1) shall contain such provisions
 as shall be necessary or desirable to transfer and confirm to, and to vest in, each successor trustee all the rights, powers, trusts
 and duties of the retiring Trustee with respect to the Securities of that or those series to which the appointment of such successor
 trustee relates, (2) shall contain such provisions as shall be deemed necessary or desirable to confirm that all the rights, powers,
 trusts and duties of the retiring Trustee with respect to the Securities of that or those series as to which the retiring Trustee
 is not retiring shall continue to be vested in the retiring Trustee, and (3) shall add to or change any of the provisions of this
 Indenture as shall be necessary to provide for or facilitate the administration of the trusts hereunder by more than one Trustee,
 it being understood that nothing herein or in such supplemental indenture shall constitute such Trustees co-trustees of the same
 trust, that each such Trustee shall be trustee of a trust or trusts hereunder separate and apart from any trust or trusts hereunder
 administered by any other such Trustee and that no Trustee shall be responsible for any act or failure to act on the part of any
 other Trustee hereunder; and upon the execution and delivery of such supplemental indenture the resignation or removal of the retiring
 Trustee shall become effective to the extent provided therein, such retiring Trustee shall with respect to the Securities of that
 or those series to which the appointment of such successor trustee relates have no further responsibility for the exercise of rights
 and powers or for the performance of the duties and obligations vested in the Trustee under this Indenture, and each such successor
 trustee, without any further act, deed or conveyance, shall become vested with all the rights, powers, trusts and duties of the retiring
 Trustee with respect to the Securities of that or those series to which the appointment of such successor trustee relates; but, on
 request of the Company or any successor trustee, such retiring Trustee shall duly assign, transfer and deliver to such successor
 trustee, to the extent contemplated by such supplemental indenture, the property and money held by such retiring Trustee hereunder
 with respect to the Securities of that or those series to which the appointment of such successor trustee relates.

&nbsp;&nbsp;&nbsp;&nbsp;(c) Upon
 request of any such successor trustee, the Company shall execute any and all instruments for more fully and certainly vesting in
 and confirming to such successor trustee all such rights, powers and trusts referred to in paragraph (a) or (b) of this Section,
 as the case may be.

&nbsp;&nbsp;&nbsp;&nbsp;(d) No
 successor trustee shall accept its appointment unless at the time of such acceptance such successor trustee shall be qualified and
 eligible under this Article.

&nbsp;&nbsp;&nbsp;&nbsp;(e) Upon
 acceptance of appointment by a successor trustee as provided in this Section, the Company shall transmit notice of the succession
 of such trustee hereunder by mail, first class postage prepaid, to the Securityholders, as their names and addresses appear upon
 the Security Register. If the Company fails to transmit such notice within ten days after acceptance of appointment by the successor
 trustee, the successor trustee shall cause such notice to be transmitted at the expense of the Company.

SECTION 7.12 Merger, Conversion, Consolidation or Succession to Business.

Any corporation into which the Trustee may be merged or converted or with which it may be consolidated, or any corporation resulting from any merger, conversion or consolidation to which the Trustee shall be a party, or any corporation succeeding to the corporate trust business of the Trustee, shall be the successor of the Trustee hereunder, provided that such corporation shall be qualified under the provisions of Section 7.08 and eligible under the provisions of Section 7.09, without the execution or filing of any paper or any further act on the part of any of the parties hereto, anything herein to the contrary notwithstanding. In case any Securities shall have been authenticated, but not delivered, by the Trustee then in office, any successor by merger, conversion or consolidation to such authenticating Trustee may adopt such authentication and deliver the Securities so authenticated with the same effect as if such successor Trustee had itself authenticated such Securities.

SECTION 7.13 Preferential Collection of Claims Against the Company.

The Trustee shall comply with Section 311(a) of the Trust Indenture Act, excluding any creditor relationship described in Section 311(b) of the Trust Indenture Act. A Trustee who has resigned or been removed shall be subject to Section 311(a) of the Trust Indenture Act to the extent included therein.

ARTICLE VIII

CONCERNING THE SECURITYHOLDERS

SECTION 8.01 Evidence of Action by Securityholders.

Whenever in this Indenture it is provided that the holders of a majority or specified percentage in aggregate principal amount of the Securities of a particular series may take any action (including the making of any demand or request, the giving of any notice, consent or waiver or the taking of any other action), the fact that at the time of taking any such action the holders of such majority or specified percentage of that series have joined therein may be evidenced by any instrument or any number of instruments of similar tenor executed by such holders of Securities of that series in Person or by agent or proxy appointed in writing.

If the Company shall solicit from the Securityholders of any series any request, demand, authorization, direction, notice, consent, waiver or other action, the Company may, at its option, as evidenced by an Officers' Certificate, fix in advance a record date for such series for the determination of Securityholders entitled to give such request, demand, authorization, direction, notice, consent, waiver or other action, but the Company shall have no obligation to do so. If such a record date is fixed, such request, demand, authorization, direction, notice, consent, waiver or other action may be given before or after the record date, but only the Securityholders of record at the close of business on the record date shall be deemed to be Securityholders for the purposes of determining whether Securityholders of the requisite proportion of Outstanding Securities of that series have authorized or agreed or consented to such request, demand, authorization, direction, notice, consent, waiver or other action, and for that purpose the Outstanding Securities of that series shall be computed as of the record date; provided, however, that no such authorization, agreement or consent by such Securityholders on the record date shall be deemed effective unless it shall become effective pursuant to the provisions of this Indenture not later than six months after the record date.

SECTION 8.02 Proof of Execution by Securityholders.

Subject to the provisions of Section 7.01, proof of the execution of any instrument by a Securityholder (such proof will not require notarization) or his agent or proxy and proof of the holding by any Person of any of the Securities shall be sufficient if made in the following manner:

&nbsp;&nbsp;&nbsp;&nbsp;(a) The
 fact and date of the execution by any such Person of any instrument may be proved in any reasonable manner acceptable to the Trustee.

&nbsp;&nbsp;&nbsp;&nbsp;(b) The
 ownership of Securities shall be proved by the Security Register of such Securities or by a certificate of the Security Registrar
 thereof.

&nbsp;&nbsp;&nbsp;&nbsp;(c) The
 Trustee may require such additional proof of any matter referred to in this Section as it shall deem necessary.

SECTION 8.03 Who May be Deemed Owners.

Prior to the due presentment for registration of transfer of any Security, the Company, the Trustee, any paying agent and any Security Registrar may deem and treat the Person in whose name such Security shall be registered upon the books of the Company as the absolute owner of such Security (whether or not such Security shall be overdue and notwithstanding any notice of ownership or writing thereon made by anyone other than the Security Registrar) for the purpose of receiving payment of or on account of the principal of, premium, if any, and (subject to Section 2.03) interest on such Security and for all other purposes; and neither the Company nor the Trustee nor any paying agent nor any Security Registrar shall be affected by any notice to the contrary.

SECTION 8.04 Certain Securities Owned by Company Disregarded.

In determining whether the holders of the requisite aggregate principal amount of Securities of a particular series have concurred in any direction, consent of waiver under this Indenture, the Securities of that series that are owned by the Company or any other obligor on the Securities of that series or by any Person directly or indirectly controlling or controlled by or under common control with the Company or any other obligor on the Securities of that series shall be disregarded and deemed not to be Outstanding for the purpose of any such determination, except that for the purpose of determining whether the Trustee shall be protected in relying on any such direction, consent or waiver, only Securities of such series that the Trustee actually knows are so owned shall be so disregarded. The Securities so owned that have been pledged in good faith may be regarded as Outstanding for the purposes of this Section, if the pledgee shall establish to the satisfaction of the Trustee the pledgee's right so to act with respect to such Securities and that the pledgee is not a Person directly or indirectly controlling or controlled by or under direct or indirect common control with the Company or any such other obligor. In case of a dispute as to such right, any decision by the Trustee taken upon the advice of counsel shall be full protection to the Trustee.

SECTION 8.05 Actions Binding on Future Securityholders.

At any time prior to (but not after) the evidencing to the Trustee, as provided in Section 8.01, of the taking of any action by the holders of the majority or percentage in aggregate principal amount of the Securities of a particular series specified in this Indenture in connection with such action, any holder of a Security of that series that is shown by the evidence to be included in the Securities the holders of which have consented to such action may, by filing written notice with the Trustee, and upon proof of holding as provided in Section 8.02, revoke such action so far as concerns such Security. Except as aforesaid any such action taken by the holder of any Security shall be conclusive and binding upon such holder and upon all future holders and owners of such Security, and of any Security issued in exchange therefor, on registration of transfer thereof or in place thereof, irrespective of whether or not any notation in regard thereto is made upon such Security. Any action taken by the holders of the majority or percentage in aggregate principal amount of the Securities of a particular series specified in this Indenture in connection with such action shall be conclusively binding upon the Company, the Trustee and the holders of all the Securities of that series.

SECTION 8.06 Purposes for Which Meetings May Be Called.

A meeting of holders of any series of Securities may be called at any time and from time to time pursuant to this Article to make, give or take any request, demand, authorization, direction, notice, consent, waiver or other action provided by this Indenture to be made, given or taken by holders of such series of Securities.

Notwithstanding anything contained in this Article VIII, the Trustee may, during the pendency of a Default or an Event of Default, call a meeting of holders of any series of Securities in accordance with its standard practices.

SECTION 8.07 Call Notice and Place of Meetings.

&nbsp;&nbsp;&nbsp;&nbsp;(a) The
 Trustee may at any time call a meeting of holders of any series of Securities for any purpose specified in Section 8.06 hereof, to
 be held at such time and at such place in The City of New York. Notice of every meeting of holders of any series of Securities, setting
 forth the time and the place of such meeting, in general terms the action proposed to be taken at such meeting and the percentage
 of the principal amount of the Outstanding Securities of such series which shall constitute a quorum at such meeting, shall be given,
 in the manner provided in Section 13.04 hereof, not less than 21 nor more than 180 days prior to the date fixed for the meeting to
 holders of Outstanding Securities of such series.

&nbsp;&nbsp;&nbsp;&nbsp;(b) In
 case at any time the Company, pursuant to a Board Resolution, or the holders of at least 10% in principal amount of the Outstanding
 Securities of any series shall have requested the Trustee to call a meeting of the holders of Securities of such series for any purpose
 specified in Section 8.06 hereof, by written request setting forth in reasonable detail the action proposed to be taken at the meeting,
 and the Trustee shall not have made the first publication of the notice of such meeting within 21 days after receipt of such request
 or shall not thereafter proceed to cause the meeting to be held as provided herein, then the Company or the holders of Securities
 of such series in the amount specified, as the case may be, may determine the time and the place in The City of New York for such
 meeting and may call such meeting for such purposes by giving notice thereof as provided in paragraph (a) of this Section.

SECTION 8.08 Persons Entitled To Vote at Meetings.

To be entitled to vote at any meeting of holders of Securities of a given series, a Person shall be (a) a holder of one or more Outstanding Securities of such series or (b) a Person appointed by an instrument in writing as proxy for a holder or holders of one or more Outstanding Securities of such series by such holder or holders. The only Persons who shall be entitled to be present or to speak at any meeting of holders shall be the Persons entitled to vote at such meeting and their counsel, any representatives of the Trustee and its counsel and any representatives of the Company and its counsel.

SECTION 8.09 Quorum; Action.

The Persons entitled to vote a majority in aggregate principal amount of the Outstanding Securities of a given series shall constitute a quorum with respect to a meeting of holders of Outstanding Securities of such series. In the absence of a quorum within 30 minutes of the time appointed for any such meeting, the meeting shall, if convened at the request of holders of Securities of such series, be dissolved. In any other case, the meeting may be adjourned for a period of not less than 10 days as determined by the chairman of the meeting prior to the adjournment of such meeting. In the absence of a quorum at any such adjourned meeting, such adjourned meeting may be further adjourned for a period of not less than 10 days as determined by the chairman of the meeting prior to the adjournment of such adjourned meeting. Notice of the reconvening of any adjourned meeting shall be given as provided in Section 8.07(a) hereof, except that such notice need be given only once and not less than five days prior to the date on which the meeting is scheduled to be reconvened.

At a meeting or an adjourned meeting duly reconvened and at which a quorum is present as aforesaid, any resolution and all matters (except as limited by the proviso to the first paragraph of Section 9.02 hereof) shall be effectively passed and decided if passed or decided by the Persons entitled to vote not less than a majority in aggregate principal amount of Outstanding Securities of a series represented and voting at such meeting with respect to a meeting of holders of Outstanding Securities of such series.

Any resolution passed or decisions taken at any meeting of holders of Securities duly held in accordance with this Section shall be binding on all the holders of Securities of such series, whether or not present or represented at the meeting.

SECTION 8.10 Determination of Voting Rights; Conduct and Adjournment of Meetings.

&nbsp;&nbsp;&nbsp;&nbsp;(a) Notwithstanding
 any other provisions of this Indenture, the Trustee may make such reasonable regulations as it may deem advisable for any meeting
 of holders of Securities in regard to proof of the holding of Securities and of the appointment of proxies and in regard to the appointment
 and duties of inspectors of votes, the submission and examination of proxies, certificates and other evidence of the right to vote,
 and such other matters concerning the conduct of the meeting as it shall deem appropriate.

&nbsp;&nbsp;&nbsp;&nbsp;(b) The
 Trustee shall, by an instrument in writing, appoint a temporary chairman (which may be the Trustee) of the meeting, unless the meeting
 shall have been called by the Company or by holders of Securities of a given series as provided in Section 8.07(b) hereof, in which
 case the Company or the holders of Securities of such series calling the meeting, as the case may be, shall in like manner appoint
 a temporary chairman. A permanent chairman and a permanent secretary of the meeting shall be elected by vote of the Persons entitled
 to vote a majority in principal amount of the Outstanding Securities of such series represented at the meeting.

&nbsp;&nbsp;&nbsp;&nbsp;(c) At
 any meeting, each holder of a Security of the series in respect of which such meeting is being held or proxy shall be entitled to
 one vote for each $1,000 principal amount of Securities of such series held or represented by him; provided, however, that no vote
 shall be cast or counted at any meeting in respect of any Security of such series challenged as not Outstanding and ruled by the
 chairman of the meeting to be not Outstanding. The chairman of the meeting shall have no right to vote, except as a holder of a Security
 of such series or proxy.

&nbsp;&nbsp;&nbsp;&nbsp;(d) Any
 meeting of holders of Securities duly called pursuant to Section 8.07 hereof at which a quorum is present may be adjourned from time
 to time by Persons entitled to vote a majority in principal amount of the Outstanding Securities of the series in respect of which
 such meeting is being held represented at the meeting, and the meeting may be held as so adjourned without further notice.

SECTION 8.11 Counting Votes and Recording Action of Meetings.

The vote upon any resolution submitted to any meeting of holders of Securities of a given series shall be by written ballots on which shall be subscribed the signatures of the holders of Securities of such series or of their representatives by proxy and the principal amounts and serial numbers of the Outstanding Securities of such series held or represented by them. The permanent chairman of the meeting shall appoint two inspectors of votes who shall count all votes cast at the meeting for or against any resolution and who shall make and file with the secretary of the meeting their verified written reports in duplicate of all votes cast at the meeting. A record, at least in duplicate, of the proceedings of each meeting of holders of Securities of such series shall be prepared by the secretary of the meeting and there shall be attached to said record the original reports of the inspectors of votes on any vote by ballot taken thereat and affidavits by one or more Persons having knowledge of the facts setting forth a copy of the notice of the meeting and showing that said notice was given as provided in Section 8.07 hereof and, if applicable, Section 8.09 hereof. Each copy shall be signed and verified by the affidavits of the permanent chairman and secretary of the meeting and one such copy shall be delivered to the Company and another to the Trustee to be preserved by the Trustee, the latter to have attached thereto the ballots voted at the meeting. Any record so signed and verified shall be conclusive evidence of the matters therein stated.

ARTICLE IX

SUPPLEMENTAL INDENTURES

SECTION 9.01 Supplemental Indentures Without the Consent of Securityholders.

In addition to any supplemental indenture otherwise authorized by this Indenture, the Company and the Trustee may from time to time and at any time enter into an indenture or indentures supplemental hereto (which shall conform to the provisions of the Trust Indenture Act as then in effect), without the consent of the Securityholders, for one or more of the following purposes:

&nbsp;&nbsp;&nbsp;&nbsp;(a) cure
 any ambiguity, correct or supplement any provision herein which may be inconsistent with any other provision herein or which is otherwise
 defective, or make any other provisions with respect to matters or questions arising under this Indenture which the Company and the
 Trustee may deem necessary or desirable and which shall not be inconsistent with the provisions of this Indenture;

&nbsp;&nbsp;&nbsp;&nbsp;(b) to
 comply with Article X;

&nbsp;&nbsp;&nbsp;&nbsp;(c) to
 provide for uncertificated Securities in addition to or in place of certificated Securities;

&nbsp;&nbsp;&nbsp;&nbsp;(d) to
 add to the covenants of the Company for the benefit of the holders of all or any Series of Securities (and if such covenants are
 to be for the benefit of less than all series of Securities, stating that such covenants are expressly being included solely for
 the benefit of such series) or to surrender any right or power herein conferred upon the Company;

&nbsp;&nbsp;&nbsp;&nbsp;(e) to
 add to, delete from, or revise the conditions, limitations, and restrictions on the authorized amount, terms, or purposes of issue,
 authentication, and delivery of Securities, as herein set forth;

&nbsp;&nbsp;&nbsp;&nbsp;(f) to
 make any change that does not adversely affect the rights of any Securityholder in any material respect;

&nbsp;&nbsp;&nbsp;&nbsp;(g) to
 provide for the issuance of and establish the form and terms and conditions of the Securities of any series as provided in Section
 2.01, to establish the form of any certifications required to be furnished pursuant to the terms of this Indenture or any series
 of Securities, or to add to the rights of the holders of any series of Securities; or

&nbsp;&nbsp;&nbsp;&nbsp;(h) comply
 with the requirements of the Commission in order to effect or maintain the qualification of this Indenture under the Trust Indenture
 Act.

The Trustee is hereby authorized to join with the Company in the execution of any such supplemental indenture, and to make any further appropriate agreements and stipulations that may be therein contained, but the Trustee shall not be obligated to enter into any such supplemental indenture that affects the Trustee's own rights, duties or immunities under this Indenture or otherwise.

Any supplemental indenture authorized by the provisions of this Section may be executed by the Company and the Trustee without the consent of the holders of any of the Securities at the time Outstanding, notwithstanding any of the provisions of Section 9.02.

SECTION 9.02 Supplemental Indentures With Consent of Securityholders.

With the written consent of the holders of at least a majority in aggregate principal amount of the Outstanding Securities of any series or by action at a meeting of holders of the Securities of such series in accordance with Section 8.09, by the holders of a majority in aggregate principal amount of the Securities of such series then Outstanding represented at such meeting, the Company, when authorized by Board Resolutions, and the Trustee may from time to time and at any time enter into an indenture or indentures supplemental hereto (which shall conform to the provisions of the Trust Indenture Act as then in effect) for the purpose of adding any provisions to or changing in any manner or eliminating any of the provisions of this Indenture or of any supplemental indenture or of modifying in any manner not covered by Section 9.01 the rights of the holders of the Securities of such series under this Indenture; provided, however, that no such supplemental indenture shall, without the consent of the holders of each Security then Outstanding and affected thereby, (i) extend the fixed maturity of any Securities of any series, or reduce the principal amount thereof, or reduce the rate or extend the time of payment of interest thereon, or reduce any premium payable upon the redemption thereof, (ii) reduce the aforesaid percentage of Securities, the holders of which are required to consent to any such supplemental indenture, or any consent or waiver, (iii) reduce the principal amount of discount securities payable upon acceleration of the maturity of any Securities of any series or (iv) make the principal of or premium or interest on any Security of a series payable in currency or currency units other than that stated in the Securities of such series.

It shall not be necessary for the consent of the Securityholders of any series affected thereby under this Section to approve the particular form of any proposed supplemental indenture, but it shall be sufficient if such consent shall approve the substance thereof.

SECTION 9.03 Effect of Supplemental Indentures.

Upon the execution of any supplemental indenture pursuant to the provisions of this Article or of Section 10.01, this Indenture shall, with respect to such series, be and be deemed to be modified and amended in accordance therewith and the respective rights, limitations of rights, obligations, duties and immunities under this Indenture of the Trustee, the Company and the holders of Securities of the series affected thereby shall thereafter be determined, exercised and enforced hereunder subject in all respects to such modifications and amendments, and all the terms and conditions of any such supplemental indenture shall be and be deemed to be part of the terms and conditions of this Indenture for any and all purposes.

SECTION 9.04 Securities Affected by Supplemental Indentures.

Securities of any series affected by a supplemental indenture, authenticated and delivered after the execution of such supplemental indenture pursuant to the provisions of this Article or of Section 10.01, may bear a notation in form approved by the Company, provided such form meets the requirements of any exchange upon which such series may be listed, as to any matter provided for in such supplemental indenture. If the Company shall so determine, new Securities of that series so modified as to conform, in the opinion of the Board of Directors of the Company, to any modification of this Indenture contained in any such supplemental indenture may be prepared by the Company, authenticated by the Trustee and delivered in exchange for the Securities of that series then Outstanding.

SECTION 9.05 Execution of Supplemental Indentures.

Upon the request of the Company, accompanied by its Board Resolutions authorizing the execution of any such supplemental indenture, and upon the filing with the Trustee of evidence of the consent of Securityholders required to consent thereto as aforesaid, the Trustee shall join with the Company in the execution of such supplemental indenture unless such supplemental indenture affects the Trustee's own rights, duties or immunities under this Indenture or otherwise, in which case the Trustee may in its discretion but shall not be obligated to enter into such supplemental indenture. The Trustee, subject to the provisions of Section 7.01, may receive an Opinion of Counsel as conclusive evidence that any supplemental indenture executed pursuant to this Article is authorized or permitted by, and conforms to, the terms of this Article and that it is proper for the Trustee under the provisions of this Article to join in the execution thereof; provided, however, that such Opinion of Counsel need not be provided in connection with the execution of a supplemental indenture that establishes the terms of a series of Securities pursuant to Section 2.01 hereof.

Promptly after the execution by the Company and the Trustee of any supplemental indenture pursuant to the provisions of this Section, the Trustee shall transmit by mail, first class postage prepaid, a notice, setting forth in general terms the substance of such supplemental indenture, to the Securityholders of all series affected thereby as their names and addresses appear upon the Security Register. Any failure of the Trustee to mail such notice, or any defect therein, shall not, however, in any way impair or affect the validity of any such supplemental indenture.

ARTICLE X

SUCCESSOR ENTITY

SECTION 10.01 Company May Consolidate, Etc.

Nothing contained in this Indenture or in any of the Securities shall prevent any consolidation or merger of the Company with or into any other Person (whether or not affiliated with the Company) or successive consolidations or mergers in which the Company or its successor or successors shall be a party or parties, or shall prevent any sale, conveyance, transfer or other disposition of the property of the Company or its successor or successors as an entirety, or substantially as an entirety, to any other corporation (whether or not affiliated with the Company or its successor or successors) authorized to acquire and operate the same; provided, however, the Company hereby covenants and agrees that, upon any such consolidation or merger (in each case, if the Company is not the survivor of such transaction), sale, conveyance, transfer or other disposition, the due and punctual payment of the principal of (premium, if any) and interest on all of the Securities of all series in accordance with the terms of each series, according to their tenor and the due and punctual performance and observance of all the covenants and conditions of this Indenture with respect to each series or established with respect to such series pursuant to Section 2.01 to be kept or performed by the Company shall be expressly assumed, by supplemental indenture (which shall conform to the provisions of the Trust Indenture Act, as then in effect) satisfactory in form to the Trustee executed and delivered to the Trustee by the entity formed by such consolidation, or into which the Company shall have been merged, or by the entity which shall have acquired such property.

SECTION 10.02 Successor Entity Substituted.

&nbsp;&nbsp;&nbsp;&nbsp;(a) In
 case of any such consolidation, merger, sale, conveyance, transfer or other disposition and upon the assumption by the successor
 entity by supplemental indenture, executed and delivered to the Trustee and satisfactory in form to the Trustee, of the due and punctual
 payment of the principal of, premium, if any, and interest on all of the Securities of all series Outstanding and the due and punctual
 performance of all of the covenants and conditions of this Indenture or established with respect to each series of the Securities
 pursuant to Section 2.01 to be performed by the Company with respect to each series, such successor entity shall succeed to and be
 substituted for the Company with the same effect as if it had been named as the Company herein, and thereupon the predecessor corporation
 shall be relieved of all obligations and covenants under this Indenture and the Securities.

&nbsp;&nbsp;&nbsp;&nbsp;(b) In
 case of any such consolidation, merger, sale, conveyance, transfer or other disposition such changes in phraseology and form (but
 not in substance) may be made in the Securities thereafter to be issued as may be appropriate.

&nbsp;&nbsp;&nbsp;&nbsp;(c) Nothing
 contained in this Article shall require any action by the Company in the case of a consolidation or merger of any Person into the
 Company where the Company is the survivor of such transaction, or the acquisition by the Company, by purchase or otherwise, of all
 or any part of the property of any other Person (whether or not affiliated with the Company).

SECTION 10.03 Evidence of Consolidation, Etc. to Trustee.

The Trustee, subject to the provisions of Section 7.01, may receive an Opinion of Counsel as conclusive evidence that any such consolidation, merger, sale, conveyance, transfer or other disposition, and any such assumption, comply with the provisions of this Article.

ARTICLE XI

SATISFACTION AND DISCHARGE

SECTION 11.01 Satisfaction and Discharge of Indenture.

If at any time: (a) the Company shall have delivered to the Trustee for cancellation all Securities of a series theretofore authenticated (other than any Securities that shall have been destroyed, lost or stolen and that shall have been replaced or paid as provided in Section 2.07) and Securities for whose payment money or Governmental Obligations have theretofore been deposited in trust or segregated and held in trust by the Company (and thereupon repaid to the Company or discharged from such trust, as provided in Section 11.05); or (b) all such Securities of a particular series not theretofore delivered to the Trustee for cancellation shall have become due and payable, or are by their terms to become due and payable within one year or are to be called for redemption within one year under arrangements satisfactory to the Trustee for the giving of notice of redemption, and the Company shall deposit or cause to be deposited with the Trustee as trust funds the entire amount in moneys or Governmental Obligations sufficient or a combination thereof, sufficient (assuming that no tax liability will be imposed on the Trustee) in the opinion of a nationally recognized firm of independent public accountants expressed in a written certification thereof delivered to the Trustee, to pay at maturity or upon redemption all Securities of that series not theretofore delivered to the Trustee for cancellation, including principal (and premium, if any) and interest due or to become due to such date of maturity or date fixed for redemption, as the case may be, and if the Company shall also pay or cause to be paid all other sums payable hereunder with respect to such series by the Company then this Indenture shall thereupon cease to be of further effect with respect to such series except for the provisions of Sections 2.03, 2.05, 2.07, 4.01, 4.02, 4.03 and 7.10, that shall survive until the date of maturity or redemption date, as the case may be, and Sections 7.06 and 11.05, that shall survive to such date and thereafter, and the Trustee, on demand of the Company and at the cost and expense of the Company shall execute proper instruments acknowledging satisfaction of and discharging this Indenture with respect to such series.

SECTION 11.02 Discharge of Obligations.

If at any time all such Securities of a particular series not heretofore delivered to the Trustee for cancellation or that have not become due and payable as described in Section 11.01 shall have been paid by the Company by depositing irrevocably with the Trustee as trust funds moneys or an amount of Governmental Obligations sufficient to pay at maturity or upon redemption all such Securities of that series not theretofore delivered to the Trustee for cancellation, including principal (and premium, if any) and interest due or to become due to such date of maturity or date fixed for redemption, as the case may be, and if the Company shall also pay or cause to be paid all other sums payable hereunder by the Company with respect to such series, then after the date such moneys or Governmental Obligations, as the case may be, are deposited with the Trustee the obligations of the Company under this Indenture with respect to such series shall cease to be of further effect except for the provisions of Sections 2.03, 2.05, 2.07, 4,01, 4.02, 4.03, 7.06, 7.10 and 11.05 hereof that shall survive until such Securities shall mature and be paid. Thereafter, Sections 7.06 and 11.05 shall survive.

SECTION 11.03 Deposited Moneys to be Held in Trust.

Subject to Section 11.05, all moneys or Governmental Obligations deposited with the Trustee pursuant to Sections 11.01 or 11.02 shall be held in trust and shall be available for payment as due, either directly or through any paying agent (including the Company acting as its own paying agent), to the holders of the particular series of Securities for the payment or redemption of which such moneys or Governmental Obligations have been deposited with the Trustee.

SECTION 11.04 Payment of Moneys Held by Paying Agents.

In connection with the satisfaction and discharge of this Indenture all moneys or Governmental Obligations then held by any paying agent under the provisions of this Indenture shall, upon demand of the Company, be paid to the Trustee and thereupon such paying agent shall be released from all further liability with respect to such moneys or Governmental Obligations.

SECTION 11.05 Repayment to Company.

Any moneys or Governmental Obligations deposited with any paying agent or the Trustee, or then held by the Company, in trust for payment of principal of or premium or interest on the Securities of a particular series that are not applied but remain unclaimed by the holders of such Securities for two years after the date upon which the principal of (and premium, if any) or interest on such Securities shall have respectively become due and payable, shall be repaid to the Company or (if then held by the Company) shall be discharged from such trust in each case, promptly after the end of any such two-year period or, at the request of the Company, on a later date specified by the Company; and thereupon the paying agent and the Trustee shall be released from all further liability with respect to such moneys or Governmental Obligations, and the holder of any of the Securities entitled to receive such payment shall thereafter, as an unsecured general creditor, look only to the Company for the payment thereof.

ARTICLE XII

IMMUNITY OF INCORPORATORS, STOCKHOLDERS, OFFICERS AND DIRECTORS

SECTION 12.01 No Recourse.

No recourse under or upon any obligation, covenant or agreement of this Indenture, or of any Security, or for any claim based thereon or otherwise in respect thereof, shall be had against any incorporator, stockholder, officer or director, past, present or future as such, of the Company or of any predecessor or successor corporation, either directly or through the Company or any such predecessor or successor corporation, whether by virtue of any constitution, statute or rule of law, or by the enforcement of any assessment or penalty or otherwise; it being expressly understood that this Indenture and the obligations issued hereunder are solely corporate obligations, and that no such personal liability whatever shall attach to, or is or shall be incurred by, the incorporators, stockholders, officers or directors as such, of the Company or of any predecessor or successor corporation, or any of them, because of the creation of the indebtedness hereby authorized, or under or by reason of the obligations, covenants or agreements contained in this Indenture or in any of the Securities or implied therefrom; and that any and all such personal liability of every name and nature, either at common law or in equity or by constitution or statute, of, and any and all such rights and claims against, every such incorporator, stockholder, officer or director as such, because of the creation of the indebtedness hereby authorized, or under or by reason of the obligations, covenants or agreements contained in this Indenture or in any of the Securities or implied therefrom, are hereby expressly waived and released as a condition of, and as a consideration for, the execution of this Indenture and the issuance of such Securities.

ARTICLE XIII

MISCELLANEOUS PROVISIONS

SECTION 13.01 Effect on Successors and Assigns.

All the covenants, stipulations, promises and agreements in this Indenture contained by or on behalf of the Company shall bind its successors and assigns, whether so expressed or not.

SECTION 13.02 Actions by Successor.

Any act or proceeding by any provision of this Indenture authorized or required to be done or performed by any board, committee or officer of the Company shall and may be done and performed with like force and effect by the corresponding board, committee or officer of any corporation that shall at the time be the lawful successor of the Company.

SECTION 13.03 Surrender of Company Powers.

The Company by instrument in writing executed by authority of its Board of Directors and delivered to the Trustee may surrender any of the powers reserved to the Company, and thereupon such power so surrendered shall terminate both as to the Company and as to any successor corporation.

SECTION 13.04 Notices.

Except as otherwise expressly provided herein any notice or demand that by any provision of this Indenture is required or permitted to be given or served by the Trustee or by the holders of Securities to or on the Company may be given or served by being deposited first class postage prepaid in a post-office letterbox addressed (until another address is filed in writing by the Company with the Trustee), as follows: Wrap Technologies, Inc., Attn: [ ], 3480 Main Hwy, Suite 202, Miami, Florida 33133. Any notice, election, request or demand by the Company or any Securityholder to or upon the Trustee shall be deemed to have been sufficiently given or made, for all purposes, if given or made in writing at the Corporate Trust Office of the Trustee. Any notice or communication to a holder shall be mailed by first-class mail to his address shown on the Security Register kept by the Security Registrar. Failure to mail a notice or communication to a holder or any defect in such notice or communication shall not affect its sufficiency with respect to other holders. If a notice or communication is mailed or sent in the manner provided above within the time prescribed, it is duly given as of the date it is mailed, whether or not the addressee receives it, except that notice to the Trustee or the Company shall only be effective upon receipt thereof by the Trustee or the Company, respectively. If the Company mails a notice or communication to holders of Securities, it shall mail a copy to the Trustee at the same time.

SECTION 13.05 Governing Law.

This Indenture and each Security shall be deemed to be a contract made under the internal laws of the State of New York, and for all purposes shall be construed in accordance with the laws of said State.

SECTION 13.06 Treatment of Securities as Debt.

It is intended that the Securities will be treated as indebtedness and not as equity for federal income tax purposes. The provisions of this Indenture shall be interpreted to further this intention.

SECTION 13.07 Compliance Certificates and Opinions.

&nbsp;&nbsp;&nbsp;&nbsp;(a) Upon
 any application or demand by the Company to the Trustee to take any action under any of the provisions of this Indenture, the Company,
 shall furnish to the Trustee an Officers' Certificate stating that all conditions precedent provided for in this Indenture
 relating to the proposed action have been complied with and an Opinion of Counsel stating that in the opinion of such counsel all
 such conditions precedent have been complied with, except that in the case of any such application or demand as to which the furnishing
 of such documents is specifically required by any provision of this Indenture relating to such particular application or demand,
 no additional certificate or opinion need be furnished.

&nbsp;&nbsp;&nbsp;&nbsp;(b) Each
 certificate or opinion provided for in this Indenture and delivered to the Trustee with respect to compliance with a condition or
 covenant in this Indenture shall include (1) a statement that the Person making such certificate or opinion has read such covenant
 or condition; (2) a brief statement as to the nature and scope of the examination or investigation upon which the statements or opinions
 contained in such certificate or opinion are based; (3) a statement that, in the opinion of such Person, he has made such examination
 or investigation as is necessary to enable him to express an informed opinion as to whether or not such covenant or condition has
 been complied with; and (4) a statement as to whether or not, in the opinion of such Person, such condition or covenant has been
 complied with.

SECTION 13.08 Payments on Business Days.

Except as provided pursuant to Section 2.01 pursuant to a Board Resolution, and as set forth in an Officers' Certificate, or established in one or more indentures supplemental to this Indenture, in any case where the date of maturity of interest or principal of any Security or the date of redemption of any Security shall not be a Business Day, then payment of interest or principal (and premium, if any) may be made on the next succeeding Business Day with the same force and effect as if made on the nominal date of maturity or redemption, and no interest shall accrue for the period after such nominal date.

SECTION 13.09 Conflict with Trust Indenture Act.

If and to the extent that any provision of this Indenture limits, qualifies or conflicts with the duties imposed by Sections 310 to 317, inclusive, of the Trust Indenture Act, such imposed duties shall control.

SECTION 13.10 Counterparts.

This Indenture may be executed in any number of counterparts, each of which shall be an original, but such counterparts shall together constitute but one and the same instrument.

SECTION 13.11 Separability.

In case any one or more of the provisions contained in this Indenture or in the Securities of any series shall for any reason be held to be invalid, illegal or unenforceable in any respect, such invalidity, illegality or unenforceability shall not affect any other provisions of this Indenture or of such Securities, but this Indenture and such Securities shall be construed as if such invalid or illegal or unenforceable provision had never been contained herein or therein.

SECTION 13.12 Assignment.

The Company will have the right at all times to assign any of its rights or obligations under this Indenture to a direct or indirect wholly-owned Subsidiary of the Company, provided that, in the event of any such assignment, the Company, will remain liable for all such obligations. Subject to the foregoing, this Indenture is binding upon and inures to the benefit of the parties thereto and their respective successors and assigns. This Indenture may not otherwise be assigned by the parties thereto.

ARTICLE XIV

SUBORDINATION OF SECURITIES

SECTION 14.01 Subordination Terms.

The payment by the Company of the principal of, premium, if any, and interest on any series of Securities issued hereunder shall be subordinated to the extent set forth in an indenture supplemental hereto relating to the Securities of such series.

IN WITNESS WHEREOF, the parties hereto have caused this Indenture to be duly executed all as of the day and year first above written.

---

| |
|:---|
| WRAP TECHNOLOGIES, INC. |
| By: |
| Name: |
| Title: |
| [ ], |
| As Trustee |
| By: |
| Name: |
| Title: |

---

## Exhibit 5.1

**Exhibit 5.1**

---

| | |
|:---|:---|
| ![](ex5-1_001.jpg) | ![](ex5-1_002.jpg) |

---

November 21, 2025

Wrap Technologies, Inc.

3480 Main Hwy, Suite 202

Miami, Florida 33133

Ladies and Gentlemen:

We have acted as counsel to Wrap Technologies, Inc., a Delaware corporation (the "<u>Company</u>"), in connection with the filing with the Securities and Exchange Commission (the "<u>Commission</u>") on the date hereof, under the Securities Act of 1933, as amended (the "<u>Act</u>") of a registration statement on Form S-3 (the "<u>Registration Statement</u>") by the Company relating to (i) shares of common stock, $0.0001 par value per share, of the Company (the "<u>Common Stock</u>"), (ii) shares of preferred stock, $0.0001 par value per share, of the Company (the "<u>Preferred Stock</u>"), (iii) one or more series of debt securities of the Company, which may be convertible into or exchangeable for shares of Common Stock or other securities of the Company (the "<u>Debt Securities</u>"), (iv) warrants to purchase Common Stock or Preferred Stock (the "<u>Warrants</u>"), (v) subscription rights to purchase Common Stock or other securities of the Company (the "<u>Subscription Rights</u>"), and (vi) units comprised of one or more shares of Common Stock, shares of Preferred Stock, Debt Securities, Warrants, or Subscription Rights in any combination (the "<u>Units</u>" and, together with the Common Stock, the Preferred Stock, the Debt Securities, the Warrants and the Subscription Rights, the "<u>Securities</u>" and each individually, a "<u>Security</u>") that may be issued and sold from time to time pursuant to Rule 415 under the Act for an aggregate initial offering price not to exceed $200,000,000.

The Securities will be offered in amounts, at prices, and on terms to be determined in light of market conditions at the time of sale and to be set forth in supplements to the prospectus contained in the Registration Statement.

For purposes of the opinions we express below, we have examined originals, or copies certified or otherwise identified, of (i) the Company's Amended and Restated Certificate of Incorporation and Amended and Restated Bylaws, each as amended and/or restated as of the date hereof (the "<u>Charter Documents</u>"); (ii) the base prospectus for the offer and sale of the Securities (as may be amended or supplemented, the "<u>Base Prospectus</u>"); (iii) the form of Indenture filed as Exhibit 4.18 to the Registration Statement to be executed by the Company, as issuer, and the trustee thereunder (referred to herein, together with any supplements to such Indenture entered into in the future, collectively, as the "<u>Senior Debt Indenture</u>") pursuant to which senior Debt Securities may be issued; (iv) the form of Indenture filed as Exhibit 4.19 to the Registration Statement to be executed by the Company, as issuer, and the trustee thereunder (referred to herein, together with any supplement to such Indenture entered into in the future, collectively, as the "<u>Subordinated Debt Indenture</u>") pursuant to which subordinated Debt Securities may be issued; (v) certain resolutions of the Company Board (as defined below) related to the filing of the Registration Statement and the Base Prospectus, the authorization and issuance of the Securities and related matters; (vi) the Registration Statement and all exhibits thereto; (vii) a certificate executed by an officer of the Company, dated as of the date hereof and (viii) such other records, documents and instruments as we have deemed necessary or appropriate for purposes of the opinions hereafter expressed.

As to questions of fact material to the opinions expressed below, we have, without independent verification of their accuracy, relied to the extent we deem reasonably appropriate upon the representations and warranties of the Company contained in such documents, records, certificates, instruments or representations furnished or made available to us by the Company.

In making the foregoing examination, we have assumed (i) the genuineness of all signatures, (ii) the authenticity of all documents submitted to us as originals, (iii) the conformity to original documents of all documents submitted to us as certified or photostatic copies, (iv) that all agreements or instruments we have examined are the valid, binding and enforceable obligations of the parties thereto, and (v) that all factual information on which we have relied was accurate and complete.

Wrap Technologies, Inc. <br> November 21, 2025 <br> Page 2

We have also assumed that (i) the Company will continue to be incorporated and in existence and good standing in its jurisdiction of organization, (ii) the Registration Statement, and any amendments thereto (including post-effective amendments), will have become effective; (iii) no stop order of the Commission preventing or suspending the use of the Base Prospectus contained in the Registration Statement or any prospectus supplement will have been issued; (iv) a prospectus supplement will have been prepared and filed with the Commission properly describing the Securities offered thereby and will have been delivered to the purchaser(s) of the Securities as required in accordance with applicable law; (v) all Securities will be offered, issued and sold in compliance with applicable federal and state securities laws and in the manner stated in the Registration Statement and the appropriate prospectus supplement; (vi) a definitive purchase, underwriting or similar agreement with respect to any Securities offered will have been duly authorized and validly executed and delivered by the Company and the other parties thereto and will be an enforceable obligation of the parties thereto; (vii) any applicable indenture and indenture supplement entered into in connection with the issuance of Debt Securities will comply with applicable law and be enforceable in all respects in accordance with its terms; (viii) in connection with the sale of Warrants, any required warrant agreement or agreement relating to the Warrants (a "<u>Warrant Agreement</u>") will have been executed and delivered by all applicable parties and will be enforceable in all respects in accordance with its terms; (ix) in connection with the sale of Subscription Rights, any required agreement or agreement relating to the Subscription Rights will have been executed and delivered by all applicable parties and will be enforceable in all respects in accordance with its terms (a "<u>Subscription Rights Agreement</u>") and (x) in connection with the sale of any Units, any required unit agreement relating to the Units (a "<u>Unit Agreement</u>") will have been executed and delivered by all applicable parties and will be enforceable in all respects in accordance with its terms; (xi) any securities issuable upon conversion, exchange, redemption or exercise of any Securities being offered will be duly and validly authorized, created and, if appropriate, reserved for issuance upon such conversion, exchange, redemption or exercise; and (xii) with respect to shares of Common Stock or Preferred Stock offered or underlying the Securities offered, there will be sufficient shares of Common Stock or Preferred Stock authorized under the Charter Documents and not otherwise reserved for issuance.

Based on the foregoing, and subject to the limitations and qualifications set forth herein, we are of the opinion that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. With
 respect to shares of Common Stock, when (i) the Board of Directors of the Company or, to the extent permitted by the General Corporation
 Law of the State of Delaware and the Charter Documents, a duly constituted and acting committee thereof (such Board of Directors
 or committee being hereinafter referred to as the " <u>Company Board</u> ") has taken all necessary corporate action to
 approve the issuance thereof and the terms of the offering of shares of Common Stock and related matters, and (ii) certificates representing
 the shares of Common Stock have been duly executed, countersigned, registered and delivered, or if uncertificated, valid book-entry
 notations have been made in the share register of the Company, in each case in accordance with the provisions of the Charter Documents,
 either (a) in accordance with the applicable definitive purchase, underwriting or similar agreement approved by the Company Board
 and upon payment of the consideration therefor (which shall not be less than the par value of the Common Stock) provided for therein,
 all in accordance with the Registration Statement and any applicable prospectus supplement, or (b) upon conversion, exchange, redemption
 or exercise of any other Security, in accordance with the terms of such Security or the instrument governing such Security providing
 for such conversion, exchange, redemption or exercise as approved by the Company Board, and for the consideration approved by the
 Company Board (which shall not be less than the par value of the Common Stock), all in accordance with the Registration Statement
 and any applicable prospectus supplement, the shares of Common Stock will be validly issued, fully paid and non-assessable. The Common
 Stock covered in the opinion in this paragraph includes any shares of Common Stock that may be issued upon exercise, conversion or
 exchange pursuant to the terms of any other Securities.

Wrap Technologies, Inc. <br> November 21, 2025 <br> Page 3

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. With
 respect to shares of Preferred Stock, when (i) the Company Board has taken all necessary corporate action to approve and establish
 the terms of the shares of Preferred Stock, to approve the issuance thereof and the terms of the offering thereof and related matters,
 including the adoption of a Certificate of Designations relating to such Preferred Stock (a " <u>Certificate of Designations</u> "),
 and such Certificate of Designations has been filed with the Secretary of State of the State of Delaware, and (ii) certificates representing
 the shares of Preferred Stock have been duly executed, countersigned, registered and delivered, or if uncertificated, valid book-entry
 notations have been made in the share register of the Company, in each case in accordance with the provisions of the Charter Documents,
 either (a) in accordance with the applicable definitive purchase, underwriting or similar agreement approved by the Company Board
 and upon payment of the consideration therefor (which shall not be less than the par value of the Preferred Stock) provided for therein,
 all in accordance with the Registration Statement and any applicable prospectus supplement, or (b) upon conversion, exchange, redemption
 or exercise of any other Security, in accordance with the terms of such Security or the instrument governing such Security providing
 for such conversion, exchange, redemption or exercise as approved by the Company Board, and for the consideration approved by the
 Company Board (which shall not be less than the par value of the Preferred Stock), all in accordance with the Registration Statement
 and any applicable prospectus supplement, the shares of Preferred Stock will be validly issued, fully paid and non-assessable.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. With
 respect to Debt Securities to be issued under the Senior Debt Indenture, when (i) the Senior Debt Indenture has been duly authorized
 and validly executed and delivered by the Company and the trustee thereunder, (ii) the trustee under the Senior Debt Indenture is
 qualified to act as trustee under the Senior Debt Indenture, (iii) the Senior Debt Indenture has been duly qualified under the Trust
 Indenture Act of 1939, as amended (the " <u>Trust Indenture Act</u> "), (iv) the Company Board has taken all necessary
 corporate action to approve and establish the terms of such Debt Securities, to approve the issuance thereof and the terms of the
 offering thereof and related matters and such Debt Securities do not include any provision that is unenforceable, and (v) such Debt
 Securities have been duly established, executed, authenticated, issued and delivered in accordance with both the provisions of the
 Senior Debt Indenture and either (a) the provisions of the applicable definitive purchase, underwriting or similar agreement approved
 by the Company Board and upon payment of the consideration therefor provided for therein or (b) upon conversion, exchange, redemption
 or exercise of any other Security, in accordance with the terms of such Security or the instrument governing such Security providing
 for such conversion, exchange, redemption or exercise as approved by the Company Board and for the consideration approved by the
 Company Board, all in accordance with the Registration Statement and any applicable prospectus supplement, such Debt Securities will
 constitute legal, valid and binding obligations of the Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. With
 respect to Debt Securities to be issued under the Subordinated Debt Indenture, when (i) the Subordinated Debt Indenture has been
 duly authorized and validly executed and delivered by the Company and the trustee thereunder, (ii) the trustee under the Subordinated
 Debt Indenture is qualified to act as trustee under the Subordinated Debt Indenture, (iii) the Subordinated Debt Indenture has been
 duly qualified under the Trust Indenture Act, (iv) the Company Board has taken all necessary corporate action to approve and establish
 the terms of such Debt Securities, to approve the issuance thereof and the terms of the offering thereof and related matters and
 such Debt Securities do not include any provision that is unenforceable, and (v) such Debt Securities have been duly established,
 executed, authenticated, issued and delivered in accordance with both the provisions of the Subordinated Debt Indenture and either
 (a) the provisions of the applicable definitive purchase, underwriting or similar agreement approved by the Company Board and upon
 payment of the consideration therefor provided for therein or (b) upon conversion, exchange, redemption or exercise of any other
 Security, in accordance with the terms of such Security or the instrument governing such Security providing for such conversion,
 exchange, redemption or exercise as approved by the Company Board and for the consideration approved by the Company Board, all in
 accordance with the Registration Statement and any applicable prospectus supplement, such Debt Securities will constitute legal,
 valid and binding obligations of the Company.

Wrap Technologies, Inc. <br> November 21, 2025 <br> Page 4

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5. With
 respect to the Warrants, when (i) the Company Board has taken all necessary corporate action to approve the creation of and the issuance
 and terms of the Warrants, the terms of the offering thereof and related matters, (ii) the Warrant Agreements and Warrants have been
 duly prepared, authorized and validly executed and delivered by the Company and the other parties thereto (if any) in compliance
 with all applicable laws, and (iii) the Warrants or certificates representing the Warrants have been duly registered and delivered
 in accordance with the appropriate Warrant Agreements and the applicable definitive purchase, underwriting or similar agreement approved
 by the Company Board and upon payment of the consideration therefor provided for therein (which shall not be less than the par value
 of any Common Stock or Preferred Stock underlying such Warrants), all in accordance with the Registration Statement and any prospectus
 supplement, the Warrants will constitute valid and legally binding obligations of the Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6. With
 respect to the Subscription Rights, when (i) the Company Board has taken all necessary corporate action to approve the creation of
 and the issuance and terms of the Subscription Rights, the terms of the offering thereof and related matters, (ii) the Subscription
 Rights Agreements and Subscription Rights have been duly prepared, authorized and validly executed and delivered by the Company and
 the other parties thereto (if any) in compliance with all applicable laws, and (iii) the Subscription Rights or certificates representing
 the Subscription Rights have been duly registered and delivered in accordance with the appropriate Subscription Rights Agreement
 and the applicable definitive purchase, underwriting or similar agreement approved by the Company Board and upon payment of the consideration
 therefor provided for therein (which shall not be less than the par value of any Common Stock or Preferred Stock underlying such
 Subscription Rights), all in accordance with the Registration Statement and any prospectus supplement, the Subscription Agreement
 will constitute valid and legally binding obligations of the Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7. With
 respect to Units, when (i) the Company Board has taken all necessary corporate action to approve the creation of and the issuance
 and terms of the Units, the terms of the offering thereof and related matters, (ii) the Unit Agreements and Units have been duly
 prepared, authorized and validly executed and delivered by the Company and the other parties thereto (if any) in compliance with
 all applicable laws, and (iii) the Units or certificates representing the Units have been duly registered and delivered in accordance
 with the appropriate Unit Agreements and the applicable definitive purchase, underwriting or similar agreement approved by the Company
 Board and upon payment of the consideration therefor provided for therein (which shall not be less than the par value of any Common
 Stock or Preferred Stock underlying such Units), all in accordance with the Registration Statement and any prospectus supplement,
 the Units will constitute valid and legally binding obligations of the Company.

The opinions set forth above are subject to the following qualifications, limitations and exceptions:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) The opinions are subject to (i) the effect of any applicable bankruptcy, insolvency, reorganization, moratorium, rearrangement, liquidation, conservatorship or other similar laws now or hereafter in effect relating to or affecting the rights of creditors generally, (ii) provisions of applicable law pertaining to the voidability of preferential or fraudulent transfers and conveyances and (iii) the fact that the remedy of specific performance and injunctive and other forms of equitable relief may be subject to equitable defenses and to the discretion of the court before which any proceeding therefor may be brought.

Wrap Technologies, Inc. <br> November 21, 2025 <br> Page 5

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) The opinions are subject to the effect of (i) general principles of equity, including (without limitation) concepts of materiality, reasonableness, good faith and fair dealing, general matters of public policy and other similar doctrines generally affecting the enforceability of agreements (regardless of whether considered in a proceeding in equity or at law) (ii) obligations of good faith and fair dealing under New York law, and (iii) other commonly-recognized statutory and judicial constraints on enforceability, including statutes of limitation, limitations on rights to indemnification that contravene law or public policy and the effectiveness of waivers of rights or benefits that cannot be effectively waived under applicable law.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) In rendering the opinions, we have assumed that, at the time of the sale of the Securities, (i) the resolutions of the Company Board or similar governing body, as reflected in the minutes and proceedings of the Company, will not have been modified or rescinded, (ii) there will not have occurred any change in the laws affecting the authorization, execution, delivery, issuance, sale, ranking, validity or enforceability of the Securities, (iii) all third party consents required in connection with the sale of the Securities will have been received by the Company, (iv) the Registration Statement will have been declared effective by the Commission and will continue to be effective, (v) none of the particular terms of a series of Securities will violate any applicable law or the terms of any applicable governing documents and (vi) neither the issuance and sale thereof nor the compliance by the Company with the terms thereof will result in a violation of any agreement or instrument then binding upon the Company or any order of any court or governmental body having jurisdiction over the Company.

The opinions expressed herein are limited to the federal laws of the United States of America, and, to the extent relevant to the opinions expressed herein, (i) the Delaware General Corporation Law and (ii) the laws of the State of New York, in each case as in effect on the date hereof (all of the foregoing being referred to as the "<u>Opined on Law</u>"). We do not express any opinion with respect to any other laws, or the laws of any other jurisdiction (including, without limitation, any laws of any other jurisdiction which might be referenced by the choice-of-law rules of the Opined on Law), other than the Opined on Law or as to the effect of any such other laws on the opinions herein stated.

We hereby consent to the filing of this opinion as Exhibit 5.1 to the Registration Statement and to the reference to our firm contained therein under the heading "Legal Matters." In giving this consent, we do not hereby admit we are in the category of persons whose consent is required under Section 7 of the Act or the rules and regulations of the Commission thereunder. This opinion is given as of the date hereof and we assume no obligation to update or supplement such opinion after the date hereof to reflect any facts or circumstances that may thereafter come to our attention or any changes that may thereafter occur.

---

| |
|:---|
| Very truly yours, |
| /s/ Haynes and Boone, LLP |
| Haynes and Boone, LLP |

---

## Exhibit 23.1

**Exhibit 23.1**

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the reference to our firm under the caption "Experts" and the incorporation by reference in this Registration Statement on Form S-3 dated November 21, 2025 of our report dated March 31, 2025, relating to the consolidated financial statements of Wrap Technologies, Inc., as of and for the years ended December 31, 2024 and 2023, appearing in the Annual Report on Form 10-K of Wrap Technologies, Inc. filed with the Securities and Exchange Commission on March 31, 2025.

/s/ HTL International, LLC

Houston, Texas

November 21, 2025

## Ex-Filing

?xml version='1.0' encoding='ASCII'?

**Exhibit 107**

**Calculation of Filing Fee Tables**

**Form S-3**

(Form Type)

**Wrap Technologies, Inc.**

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered and Carry Forward Securities

---

| | | | | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | Security Type | Security Class <br>Title | Fee <br>Calculation <br>or Carry <br>Forward <br>Rule | Amount <br>Registered | | Proposed <br>Maximum <br>Offering <br>Price Per <br>Unit |  | Maximum Aggregate <br>Offering Price | Fee Rate | Amount of <br>Registration <br>Fee | Carry Forward <br>Form Type | Carry <br>Forward <br>File <br>Number | Carry <br>Forward <br>Initial <br>Effective <br>Date | Filing Fee <br>Previously <br>Paid In <br>Connection <br>With Unsold <br>Securities to <br>be Carried <br>Forward |
| **Newly Registered Securities** | **Newly Registered Securities** | **Newly Registered Securities** | **Newly Registered Securities** | **Newly Registered Securities** | **Newly Registered Securities** | **Newly Registered Securities** | **Newly Registered Securities** | **Newly Registered Securities** | **Newly Registered Securities** | **Newly Registered Securities** | **Newly Registered Securities** | **Newly Registered Securities** | **Newly Registered Securities** | **Newly Registered Securities** |
| Fees to be Paid | Equity | Common Stock, $0.0001 par value per share |  |  | (1)(2) |  |  |  |  |  |  |  |  |  |
| Fees to be Paid | Equity | Preferred Stock, $0.0001 par value per share |  |  | (1)(2) |  |  |  |  |  |  |  |  |  |
| Fees to be Paid | Debt | Debt Securities |  |  | (1)(2) |  |  |  |  |  |  |  |  |  |
| Fees to be Paid | Other | Warrants |  |  | (1)(2) |  |  |  |  |  |  |  |  |  |
| Fees to be Paid | Other | Subscription Rights |  |  | (1)(2) |  |  |  |  |  |  |  |  |  |
| Fees to be Paid | Other | Units |  |  | (1)(2) |  |  |  |  |  |  |  |  |  |
| Fees to be Paid | Unallocated (Universal) Shelf | Unallocated (Universal) Shelf | 457(o) |  | (1)(2) |  | (2) | $200000000.00 | $0.0001381 | $27620.00 |  |  |  |  |
| Fees Previously Paid |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| **Carry Forward Securities** | **Carry Forward Securities** | **Carry Forward Securities** | **Carry Forward Securities** | **Carry Forward Securities** | **Carry Forward Securities** | **Carry Forward Securities** | **Carry Forward Securities** | **Carry Forward Securities** | **Carry Forward Securities** | **Carry Forward Securities** | **Carry Forward Securities** | **Carry Forward Securities** | **Carry Forward Securities** | **Carry Forward Securities** |
| Carry Forward Securities |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|  |  |  | Total Offering Amounts | Total Offering Amounts | Total Offering Amounts | Total Offering Amounts |  | $200000000 |  | $27620.00 |  |  |  |  |
|  |  |  | Total Fees Previously Paid | Total Fees Previously Paid | Total Fees Previously Paid | Total Fees Previously Paid |  |  |  | - |  |  |  |  |
|  |  |  | Total Fee Offsets | Total Fee Offsets | Total Fee Offsets | Total Fee Offsets |  |  |  | $- |  |  |  |  |
|  |  |  | Net Fee Due | Net Fee Due | Net Fee Due | Net Fee Due |  |  |  | $27620.00 |  |  |  |  |

---

(1) Pursuant to Rule 416 of
 the Securities Act of 1933, as amended (the "Securities Act"), this Registration Statement also includes additional shares
 of common stock and/or preferred stock issuable upon stock splits, stock dividends or similar transactions. These offered securities
 may be sold separately, together or as units with other offered securities. An unspecified number of securities or aggregate principal
 amount, as applicable, is being registered as may from time to time be offered at unspecified prices.

(2) Pursuant to Rule 457(o) under the Securities Act, which permits the registration fee to be calculated on the basis of the maximum offering price of all the securities listed, the table does not specify by each class information as to the amount to be registered, proposed maximum offering price per unit or proposed maximum aggregate offering price. The aggregate public offering price of securities sold by the Registrant (including newly listed securities and carry-forward securities) will not exceed $200,000,000.